<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-15T18:27:48Z</responseDate><request verb="ListRecords" metadataPrefix="qdc" set="col_10336_926">https://repository.urosario.edu.co/oai/request</request><ListRecords><record><header><identifier>oai:repository.urosario.edu.co:10336/9069</identifier><datestamp>2021-06-03T00:47:39Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Efecto  del Heliox sobre  la resistencia en la vía aérea en niños con patología bronquial obstructiva que requieren ventilación mecánica</dc:title>
   <dc:creator>Contreras Díaz, María</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:subject>niños</dc:subject>
   <dc:subject>Heliox</dc:subject>
   <dc:subject>patología bronquial obstructiva</dc:subject>
   <dcterms:abstract>The heliox effect on airway resistance in children with bronchial obstructive pathology who require mechanical ventilation&#xd;
Contreras, ML; Angarita, D; Fernandez, J; Godoy, J; Mullet, H; Briceño, G.&#xd;
&#xd;
Summary: Patients with obstructive airway disease who require mechanical ventilation have an increased airway resistance that produces deleterious effects on the respiratory mechanics. Use of Heliox has been proposed as a therapy in obstructive airway disease due to its physical properties: it reduces airway resistance, improves gas exchange and reduces ventilatory time support. The aim of this Quasi-experimental study was to measure and compare the resistance of the airway in children with obstructive airway disease, before and after the use of Heliox during mechanical ventilation.&#xd;
Methods: Children who needed mechanical ventilation were included. Airway inspiratory and expiratory resistances of with Hamilton G5 ventilator were measured, before the start of mechanical ventilation and every 30 minutes after until extubation was done. Friedman’s Test and Kendall’s Coefficient of Concordance were used to analyze  the differences of all measurements. &#xd;
Results: In a sample of 17 patients, it was found that there was a statistical significant decrease (p&lt;0.05), of airway inspiratory and expiratory resistance the measurements, from the second hour after the beginning of mechanical ventilation with Heliox. This effect was maintained until the time of extubation.</dcterms:abstract>
   <dcterms:dateAccepted>2014-12-10T16:35:51Z</dcterms:dateAccepted>
   <dcterms:available>2014-12-10T16:35:51Z</dcterms:available>
   <dcterms:created>2014-12-10T16:35:51Z</dcterms:created>
   <dcterms:issued>2014</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_9069 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/9069</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. 
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. 
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.
--------------------------------------
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>3.	Wong Judith, Lee Jan Hau, Turner David A, Rehder Kyle J, A review of the use of adjunctive therapies in severe acute asthma exacerbation in critically ill children. Expert Review of Respiratory Medicine.  2014 Aug;  8(4):423-441</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/19035</identifier><datestamp>2025-10-09T14:46:00Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Caracterización de pacientes pediátricos con cetoacidosis diabética de acuerdo a la presentación de la diabetes mellitus en hospitales de Colombia, 2017 – 2018</dc:title>
   <dc:creator>Lara Bernal, Marleny Aurora</dc:creator>
   <dc:contributor>Pardo, Rosalba</dc:contributor>
   <dc:subject>Cetoacidosis</dc:subject>
   <dc:subject>Diabetes mellitus</dc:subject>
   <dc:subject>Acidosis metabólica</dc:subject>
   <dc:subject>Niños</dc:subject>
   <dc:subject>Tratamiento</dc:subject>
   <dcterms:abstract>Introduction: Diabetic ketoacidosis (CAD) in pediatrics is a common complication of diabetes mellitus type 1 (DM-1). Several factors influence the response to treatment and its metabolic behavior may vary according to whether the diabetic is known or is a debut. Objective: We describe the variables associated with CAD in patients under 18 years of age, including demographic, clinical, paraclinical characteristics, hospital stay and complications. Materials and methods: Cross-sectional study of a sample of 391 pediatric patients stratified by severity of CAD on admission between July 2007 and August 2018. Demographic, clinical, biochemical and omplications during the event (CAD) are described. Results: Of the 391 patients, 236 patients identified as known diabetics. 155 patients debut. Of the total 59.8% women vs 40.2% men. If CAD is classified by the pH value, the percentage of patients with mild CAD is 43.7% followed by moderate CAD 25.6% and severe CAD 30.7%, while if it is classified by the value of bicarbonate cases of CAD are predominantly moderate with 43.1%, followed by severe CAD with 28.3% and slight 28.1%. The stay of patients with CAD debut is greater both in hospitalization and in the intensive care unit. Conclusion: CAD has a different metabolic behavior and a degree of severity according to the variable used to classify it either pH or bicarbonate, using the bicarbonate values allows biochemically classifying the disorder more specifically, the most frequent complication was cerebral edema and it occurs in cases of severe CAD. The hospital stay is longer in cases of severe CAD.</dcterms:abstract>
   <dcterms:dateAccepted>2019-02-11T16:41:00Z</dcterms:dateAccepted>
   <dcterms:available>2019-02-11T16:41:00Z</dcterms:available>
   <dcterms:created>2019-02-11T16:41:00Z</dcterms:created>
   <dcterms:issued>2019</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_19035 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/19035</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016(1):CD011281.</dc:source>
   <dc:source>Federation ID. IDF Diabetes Atlas: International Diabetes Federation; 2015. Available from: http://www.diabetesatlas.org/.</dc:source>
   <dc:source>Tamayo DC. Descripción de la epidemiología actual. Observatorio de Diabetes de Colombia [Internet]. 2013:[1-11 pp.]. Available from: http://www.odc.org.co/files/Diabetes_en_Colombia_descripcion_de_la_epidemiolo gia_actual.pdf.</dc:source>
   <dc:source>Ballesteros Calderón AL, Meneses Muñoz AP, Ríos Patiño D, Flórez Gómez ID, Quevedo Vélez A. Características epidemiológicas y clínicas y hallazgos de laboratorio de los niños menores de 15 años con cetoacidosis diabética atendidos en el Hospital Universitario San Vicente Fundación en Medellín, Colombia, entre enero de 2001 y diciembre de 2010. Iatreia. 2013;26(3):278-90.</dc:source>
   <dc:source>Alzate Flórez JA, Alzate Ramos SA, Castaño Castrillón JJ, Gonzalez Cuartas J, Herrera Bustamante M, Herrera Muñoz V, et al. Morbimortalidad de los pacientes con cetoacidosis diabética que ingresaron a la unidad de cuidados intensivos pediátricos del Hospital Infantil Universitario de la Cruz Roja, Rafael Henao Toro, de la ciudad de Manizales (Colombia), 2004-2010. Archivos de medicina (Manizales). 2012;12(2):168-77.</dc:source>
   <dc:source>Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146(5):688-92.</dc:source>
   <dc:source>Kordonouri O, Klingensmith G, Knip M, Holl RW, Aanstoot HJ, Menon PS, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetesassociated conditions in children and adolescents. Pediatr Diabetes. 2014;15 Suppl 20:270-8.</dc:source>
   <dc:source>Zucchini S, Scaramuzza AE, Bonfanti R, Buono P, Cardella F, Cauvin V, et al. A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes. J Diabetes Res. 2016;2016:5719470.</dc:source>
   <dc:source>Dhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G. National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2016;33(2):252-60.</dc:source>
   <dc:source>Xu Y, Bai J, Wang G, Zhong S, Su X, Huang Z, et al. Clinical profile of diabetic ketoacidosis in tertiary hospitals in China: a multicentre, clinic-based study. Diabet Med. 2016;33(2):261-8.</dc:source>
   <dc:source>Levin DL. Cerebral edema in diabetic ketoacidosis. Pediatr Crit Care Med. 2008;9(3):320-9.</dc:source>
   <dc:source>Arieff AI, Kleeman CR. Studies on mechanisms of cerebral edema in diabetic comas: effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits (J. Clin. Invest. 52:571-583, 1973). J Am Soc Nephrol. 2000;11(9):1776-88.</dc:source>
   <dc:source>Kennedy A, C., Linton AL, Luke RG, Renfrew S, Dinwoodie A. The Pathogenesis and Prevention of Cerebral Dysfunction During Dialysis. Lancet. 1964;1(7337):790-3.</dc:source>
   <dc:source>Prockop LD. Hyperglycemia, polyol accumulation, and increased intracranial pressure. Arch Neurol. 1971;25(2):126-40.</dc:source>
   <dc:source>Harris GD, Fiordalisi I, Finberg L. Safe management of diabetic ketoacidemia. J Pediatr. 1988;113(1 Pt 1):65-8.</dc:source>
   <dc:source>Glaser NS, Marcin JP, Wootton-Gorges SL, Buonocore MH, Rewers A, Strain J, et al. Correlation of clinical and biochemical findings with diabetic ketoacidosis-related cerebral edema in children using magnetic resonance diffusion-weighted imaging. J Pediatr. 2008;153(4):541-6.</dc:source>
   <dc:source>Krane EJ, Rockoff MA, Wallman JK, Wolfsdorf JI. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med. 1985;312(18):1147-51.</dc:source>
   <dc:source>Hoffman WH, Steinhart CM, el Gammal T, Steele S, Cuadrado AR, Morse PK. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR Am J Neuroradiol. 1988;9(4):733-9.</dc:source>
   <dc:source>Sperling MA. Cerebral edema in diabetic ketoacidosis: an underestimated complication? Pediatr Diabetes. 2006;7(2):73-4.</dc:source>
   <dc:source>Yuen N, Anderson SE, Glaser N, Tancredi DJ, O'Donnell ME. Cerebral blood flow and cerebral edema in rats with diabetic ketoacidosis. Diabetes. 2008;57(10):2588-94.</dc:source>
   <dc:source>Whalen MJ. Cerebrovascular autoregulation in diabetic ketoacidosis: time to go with the (microvascular cerebral blood) flow! Pediatr Crit Care Med. 2014;15(8):779-80.</dc:source>
   <dc:source>Hoffman WH, Stamatovic SM, Andjelkovic AV. Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis. Brain Res. 2009;1254:138-48.</dc:source>
   <dc:source>Vavilala MS, Richards TL, Roberts JS, Chiu H, Pihoker C, Bradford H, et al. Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment. Pediatr Crit Care Med. 2010;11(3):332-8</dc:source>
   <dc:source>Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes. 2009;10(8):534-41.</dc:source>
   <dc:source>Glaser NS, Tancredi DJ, Marcin JP, Caltagirone R, Lee Y, Murphy C, et al. Cerebral hyperemia measured with near infrared spectroscopy during treatment of diabetic ketoacidosis in children. J Pediatr. 2013;163(4):1111-6.</dc:source>
   <dc:source>Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith MA. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res. 2011;1369:194- 202.</dc:source>
   <dc:source>Dekker TJ, Janson JA, Hoorn EJ, Sijpkens YW. [Fatal cerebral oedema during the treatment of diabetic ketoacidosis in an adult male]. Ned Tijdschr Geneeskd. 2017;161(0):D734.</dc:source>
   <dc:source>Glaser NS, Ghetti S, Casper TC, Dean JM, Kuppermann N, Group PECARNPDFS. Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial. Pediatr Diabetes. 2013;14(6):435-46.</dc:source>
   <dc:source>Edge JA, Jakes RW, Roy Y, Hawkins M, Winter D, Ford-Adams ME, et al. The UK casecontrol study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49(9):2002-9.</dc:source>
   <dc:source>Bureau MA, Bégin R, Berthiaume Y, Shapcott D, Khoury K, Gagnon N. Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr. 1980;96(6):968-73.</dc:source>
   <dc:source>Durward A, Ferguson LP, Taylor D, Murdoch IA, Tibby SM. The temporal relationship between glucose-corrected serum sodium and neurological status in severe diabetic ketoacidosis. Arch Dis Child. 2011;96(1):50-7.</dc:source>
   <dc:source>Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999;81(4):318-23.</dc:source>
   <dc:source>Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care. 1990;13(1):22-33.</dc:source>
   <dc:source>Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000;23(10):1516-26.</dc:source>
   <dc:source>Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. Jama. 2013;310(4):427-8.</dc:source>
   <dc:source>Svensson J, Cerqueira C, Kjærsgaard P, Lyngsøe L, Hertel NT, Madsen M, et al. Danish Registry of Childhood and Adolescent Diabetes. Clin Epidemiol. 2016;8:679-83.</dc:source>
   <dc:source>11. Children and Adolescents (Standards of Medical Care in Diabetes—2016). Diabetes Care. 2016;39(Supplement 1):S86-S93.</dc:source>
   <dc:source>Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva: World Health Organization; 2006. Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/.</dc:source>
   <dc:source>2. Classification and Diagnosis of Diabetes (Standards of Medical Care in Diabetes —2016). Diabetes Care. 2016;39(Supplement 1):S13-S22.</dc:source>
   <dc:source>Rewers A, Klingensmith G, Davis C, Petitti DB, Pihoker C, Rodriguez B, et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics. 2008;121(5):e1258-66.</dc:source>
   <dc:source>Gale EA. Dying of diabetes. Lancet. 2006;368(9548):1626-8.</dc:source>
   <dc:source>Hekkala A, Reunanen A, Koski M, Knip M, Veijola R, Register FPD. Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents. Diabetes Care. 2010;33(7):1500-2.</dc:source>
   <dc:source>Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011;343:d4092.</dc:source>
   <dc:source>de Vries L, Oren L, Lazar L, Lebenthal Y, Shalitin S, Phillip M. Factors associated with diabetic ketoacidosis at onset of Type 1 diabetes in children and adolescents. Diabet Med. 2013;30(11):1360-6.</dc:source>
   <dc:source>Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002;287(19):2511-8.</dc:source>
   <dc:source>Curtis JR, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in ontario children. Diabetes Care. 2002;25(9):1591-6.</dc:source>
   <dc:source>Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014;15 Suppl 20:154-79.</dc:source>
   <dc:source>Corwell B, Knight B, Olivieri L, Willis GC. Current diagnosis and treatment of hyperglycemic emergencies. Emerg Med Clin North Am. 2014;32(2):437-52.</dc:source>
   <dc:source>Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004;89(2):188-94.</dc:source>
   <dc:source>Chase HP, Garg SK, Jelley DH. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev. 1990;11(10):297-304.</dc:source>
   <dc:source>Rosival V. Pathophysiology of diabetic ketoacidosis. Diabet Med. 2015;32(11):1527.</dc:source>
   <dc:source>Botham KM, Mayes PA, Bender DA. Bioenergética y el metabolismo de carbohidratos y lípidos. In: de León Fraga J, editor. HARPER Bioquimica Ilustrada. 28a ed. Mexico: Mc Graw Hill; 2010. p. 92-224.</dc:source>
   <dc:source>Komatsu M, Takei M, Ishii H, Sato Y. Glucose-stimulated insulin secretion: A newer perspective. J Diabetes Investig. 2013;4(6):511-6.</dc:source>
   <dc:source>Leney SE, Tavaré JM. The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol. 2009;203(1):1-18.</dc:source>
   <dc:source>Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the beta-cell and insulin secretion. Diabetes. 2006;55 Suppl 2:S16-23.</dc:source>
   <dc:source>Bhattacharya S, Dey D, Roy SS. Molecular mechanism of insulin resistance. J Biosci. 2007;32(2):405-13.</dc:source>
   <dc:source>Kalsbeek A, la Fleur S, Fliers E. Circadian control of glucose metabolism. Mol Metab. 2014;3(4):372-83.</dc:source>
   <dc:source>Donnelly D. The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br J Pharmacol. 2012;166(1):27-41.</dc:source>
   <dc:source>Quesada I, Tudurí E, Ripoll C, Nadal A. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol. 2008;199(1):5-19.</dc:source>
   <dc:source>Silber HE, Jauslin PM, Frey N, Karlsson MO. An integrated model for the glucoseinsulin system. Basic Clin Pharmacol Toxicol. 2010;106(3):189-94.</dc:source>
   <dc:source>Patel SG, Hsu JW, Jahoor F, Coraza I, Bain JR, Stevens RD, et al. Pathogenesis of A⁻β⁺ ketosis-prone diabetes. Diabetes. 2013;62(3):912-22.</dc:source>
   <dc:source>Feenstra RA, Kiewiet MK, Boerma EC, ter Avest E. Lactic acidosis in diabetic ketoacidosis. BMJ Case Rep. 2014;2014.</dc:source>
   <dc:source>Rosenbloom AL. Obesity, Insulin Resistance, beta-Cell Autoimmunity, and the Changing Clinical Epidemiology of Childhood Diabetes. Diabetes Care. 2003;26(10):2954-6.</dc:source>
   <dc:source>Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. N Engl J Med. 1983;309(3):159-69.</dc:source>
   <dc:source>Abdulaziz S, Dabbagh O, Al Daker MO, Hassan I. Hypokalaemia and refractory asystole complicating diabetic ketoacidosis, lessons for prevention. BMJ Case Rep. 2012;2012.</dc:source>
   <dc:source>Cox K, Cocchi MN, Salciccioli JD, Carney E, Howell M, Donnino MW. Prevalence and significance of lactic acidosis in diabetic ketoacidosis. J Crit Care. 2012;27(2):132-7.</dc:source>
   <dc:source>Linares MY, Schunk JE, Lindsay R. Laboratory presentation in diabetic ketoacidosis and duration of therapy. Pediatr Emerg Care. 1996;12(5):347-51.</dc:source>
   <dc:source>Napolova O, Urbach S, Davids MR, Halperin ML. Assessing the degree of extracellular fluid volume contraction in a patient with a severe degree of hyperglycaemia. Nephrol Dial Transplant. 2003;18(12):2674-7.</dc:source>
   <dc:source>Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957;19(5):823-32.</dc:source>
   <dc:source>Al-Matrafi J, Vethamuthu J, Feber J. Severe acute renal failure in a patient with diabetic ketoacidosis. Saudi J Kidney Dis Transpl. 2009;20(5):831-4.</dc:source>
   <dc:source>Mitsuishi S, Matoba K, Yamazaki H. Acute respiratory distress syndrome in diabetic ketoacidosis. Intern Med. 2014;53(14):1581.</dc:source>
   <dc:source>Aboulhosn K, Arnason T. Acute pancreatitis and severe hypertriglyceridaemia masking unsuspected underlying diabetic ketoacidosis. BMJ Case Rep. 2013;2013.</dc:source>
   <dc:source>Carmody D, Naylor RN, Philipson LH. Insulin dosing in pediatric diabetic ketoacidosis: where to start? JAMA. 2015;313(22):2274-5.</dc:source>
   <dc:source>Al Hanshi S, Shann F. Insulin infused at 0.05 versus 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis. Pediatr Crit Care Med. 2011;12(2):137-40.</dc:source>
   <dc:source>Duhon B, Attridge RL, Franco-Martinez AC, Maxwell PR, Hughes DW. Intravenous sodium bicarbonate therapy in severely acidotic diabetic ketoacidosis. Ann Pharmacother. 2013;47(7-8):970-5.</dc:source>
   <dc:source>Muir AB, Quisling RG, Yang MC, Rosenbloom AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004;27(7):1541-6.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/2980</identifier><datestamp>2021-06-03T00:46:51Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Modos ventilatorios avanzados : Ventilación de Soporte Adaptativo (ASV)</dc:title>
   <dc:creator>Miguelena Muñoz, Dayra</dc:creator>
   <dc:creator>Fernández Sarmiento, Jaime</dc:creator>
   <dc:creator>Mulett, Hernando</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:subject>Ventilación asa cerrada</dc:subject>
   <dc:subject>Ventilación mecánica</dc:subject>
   <dc:subject>Ventilación Soporte Adaptativo (ASV)</dc:subject>
   <dcterms:abstract>Mechanical ventilation is one of the most frequently used intervention in intensive care units. Despite its “lifesaving” role, it can bear risks for the patient if not adequately performed. In order to reduce the implied risks, advanced modes of ventilation continue to be developed in order to improve the clinical outcomes of patients. These advancements include closed-loop control systems, which facilitate the manipulation of&#xd;
ventilation variables based on measurements of respiratory parameters. Adaptive support ventilation (ASV) is a mode that uses this control system. It adjusts automatically&#xd;
to the patient’s requirements.It is important for medical staff members to understand this mode of ventilation, including its effects on pulmonary&#xd;
mechanics. This article discusses ASV with particular emphasis on its parameters, advantages, and disadvantages with&#xd;
regard to oxygenation and ventilation.</dcterms:abstract>
   <dcterms:dateAccepted>2012-04-23T12:19:08Z</dcterms:dateAccepted>
   <dcterms:available>2012-04-23T12:19:08Z</dcterms:available>
   <dcterms:created>2012-04-23T12:19:08Z</dcterms:created>
   <dcterms:issued>2012</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_2980 </dc:identifier>
   <dc:identifier>TEME 0078 2011</dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/2980</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/closedAccess</dc:rights>
   <dc:rights>Bloqueado (Texto referencial)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/14194</identifier><datestamp>2021-06-03T00:48:27Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Nutritional Support of the Critically Ill Pediatric Patient : Foundations and Controversies</dc:title>
   <dc:creator>Ardila Gomez, Iván Jose</dc:creator>
   <dc:creator>Bonilla González, Carolina</dc:creator>
   <dc:creator>Martínez Palacio, Paula Andrea</dc:creator>
   <dc:creator>Mercado Santis, Elida Teresa</dc:creator>
   <dc:creator>Tibaduiza Bayona, José Daniel</dc:creator>
   <dc:creator>Contreras Hernández, Juan</dc:creator>
   <dc:creator>Fernández Sarmiento, Jaime</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:subject>Pediatric</dc:subject>
   <dc:subject>Intensive care</dc:subject>
   <dc:subject>Enteral nutrition</dc:subject>
   <dc:subject>Parenteral nutrition</dc:subject>
   <dcterms:abstract>Critically ill children require nutritional support that will give them nutritional and non-nutritional support to successfully deal with their disease. In the past few years, we have been able to better understand the pathophysiology of critical illness, which has made possible the establishment of nutritional strategies resulting in an improved nutritional status, thus optimizing the pediatric intensive care unit (PICU) stay and decreasing morbidity and mortality. Critical illness is associated with significant metabolic stress. It is crucial to understand the physiological response to stress to create nutritional recommendations for critically ill pediatric patients in the PICU.</dcterms:abstract>
   <dcterms:dateAccepted>2018-01-15T16:55:13Z</dcterms:dateAccepted>
   <dcterms:available>2018-01-15T16:55:13Z</dcterms:available>
   <dcterms:created>2018-01-15T16:55:13Z</dcterms:created>
   <dcterms:issued>2017</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_14194 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/14194</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. 
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. 
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.
--------------------------------------
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>1. Askegard-Giesmann JR, Kenney BD. Controversies in nutritional support for critically ill children. Semin Pediatr Surg. 2015;24:20–24.</dc:source>
   <dc:source>Belén A, Consuelo M. Soporte nutricional en la infancia. Nutr Enteral. 2011;9:358–366.</dc:source>
   <dc:source>Oosterveld MJ, Van Der Kuip M, De Meer K, De Greef HJ, Gemke RJ. Energy expenditure and balance following pediatric intensive care unit admission: a longitudinal study of critically ill children. Pediatr Crit Care Med. 2006;7:147–153.</dc:source>
   <dc:source>Joffe A, Anton N. Nutritional support for critically ill children (Review). Cochrane Database Syst Rev. 2009;2:CD005144.</dc:source>
   <dc:source>Bankhead R, Boullata J, Brantley S, et al. A.S.P.E.N. Enteral nutrition practice recommendations. J Parenter Enter Nutr. 2009;33:122–167.</dc:source>
   <dc:source>Joosten KFM, Kerklaan D, Verbruggen SC. Nutritional support and the role of the stress response in critically ill children. Curr Opin Clin Nutr Metab Care. 2016;19:226–233.</dc:source>
   <dc:source>Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310:1591–1600</dc:source>
   <dc:source>Cuervo AM, MacIan F. Autophagy, nutrition and immunology. Mol Aspects Med. 2012;33:2–13.</dc:source>
   <dc:source>Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469:323–335.</dc:source>
   <dc:source>Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506–517</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/2705</identifier><datestamp>2021-06-03T00:46:22Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Eficacia diagnóstica y terapéutica de las radiografías de tórax rutinarias matutinas en cuidado intensivo pediátrico</dc:title>
   <dc:creator>Oñoro Ramos, Oscar Antonio</dc:creator>
   <dc:contributor>Pardo, Rosalba</dc:contributor>
   <dc:contributor>Suescun-Vargas, Jose-Miguel</dc:contributor>
   <dc:contributor>Manrique Abril, Fred</dc:contributor>
   <dc:contributor>Ospina, Juan Manuel</dc:contributor>
   <dc:subject>Radiografía de tórax</dc:subject>
   <dc:subject>Rayos x de tórax</dc:subject>
   <dc:subject>Radiología</dc:subject>
   <dc:subject>Unidad de cuidado intensivo</dc:subject>
   <dc:subject>Unidad de cuidado crítico</dc:subject>
   <dcterms:abstract>Introduction: The usefulness of morning routine chest X rays in under debate, some studies support their use, while on the other hand, some find marginal benefit. Objectives: To determine the diagnostic and therapeutic efficacy of morning routine chest X rays in mechanically ventilated patients and the identification of subgroups of patients in whom said X rays may be of greater usefulness. Methodology: Prospective, cross sectional, in patients under mechanical ventilation for minimum 48 hours, with age among 1 month to 18 years old, data recollected from December 2010 to November 2011. Contingency tables were done and later X2 Pearson function and Fischer´s exact test calculating the value of P, odds ratio, with confidence interval in the 95% for qualitative variables. For the data analysis we used programs Statgraphics and SPSS, version 15. Results: 53 patients and 536 chest X rays were evaluated. The findings were mostly minor. Only 10. 3% of the cases belong to major findings, mainly tube malposition and new infectious infiltrates. It was not possible to establish subgroups of patients but the data suggest greater benefit from X rays in patient with very young and low weight and those mechanically ventilated. Conclusions: The usefulness of routine films is marginal. Are needs more studies to establish the usefulness in patient’s subgroups. Key words: chest radiography, chest X ray, radiology, intensive care unit, critical care unit </dcterms:abstract>
   <dcterms:dateAccepted>2011-12-09T17:46:08Z</dcterms:dateAccepted>
   <dcterms:available>2011-12-09T17:46:08Z</dcterms:available>
   <dcterms:created>2011-12-09T17:46:08Z</dcterms:created>
   <dcterms:issued>2011</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_2705 </dc:identifier>
   <dc:identifier>TEME 0077 2011</dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/2705</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/1800</identifier><datestamp>2021-06-03T00:46:41Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Factores de riesgo asociados al síndrome de dificultad respiratoria aguda en una unidad de cuidados intensivos pediátrica</dc:title>
   <dc:creator>Brito Brito, Thirsa</dc:creator>
   <dc:contributor>Ochoa, Cristina</dc:contributor>
   <dc:contributor>Pardo, Rosalba</dc:contributor>
   <dc:contributor>Ibáñez Pinilla, Milcíades</dc:contributor>
   <dc:subject>Dificultad respiratoria aguda</dc:subject>
   <dc:subject>Factores de riesgo</dc:subject>
   <dc:subject>niños</dc:subject>
   <dcterms:abstract>The Acute Respiratory Distress Syndrome (ARDS) is a complex syndrome that was first described in the late "60s, affects critically ill patients and is associated with high morbidity and mortality, and touted as a serious illness. &#xd;
Objective: To identify risk factors associated with the onset of ARDS, and to identify demographic, PaO2/FiO2 levels, presence of malnutrition, prematurity, chronic lung disease in pediatric ICU patients in Colsubsidio Child Clinic in Bogotá, between January 2003 to December 2008. &#xd;
Materials and methods:   We performed an analitical  study of cases and controls were done , with  relation  control   and  cases of 2:1 .the control group was composed of 62 patients and 31 cases. &#xd;
Results: It was found tobe significantly associated to the three main factors of risk  for ADRS : Sepsis 33.9% vs. 15.6% (p = 0.0002, OR = 5.6, 95% CI = 2.20, 14.03), pneumonia (p = 0.6380, OR = 0.80, 95% CI = 0.32, 2.00) and bronchiolitis (p = 0.0515, OR = 0.395, CI 95 % = 0.157, 1.01). Hospital stay 14.7 ± 16.3 vs. 7.4 ± 4.7 days (p = 0.001), mechanical ventilation time 11.7 ± 14.1 vs. 5.3 ± 2.8 days (p = 0.002) and mortality 45.2% vs. 3.2% (p &lt;0.001, OR = 25, 95% CI = 5.1, 125). &#xd;
Conclusions: The factors of risk significantly    presence of sepsis, hospital stay, mechanical ventilation time and mortality.  And also the values of the PAFI.</dcterms:abstract>
   <dcterms:dateAccepted>2010-04-20T18:03:40Z</dcterms:dateAccepted>
   <dcterms:available>2010-04-20T18:03:40Z</dcterms:available>
   <dcterms:created>2010-04-20T18:03:40Z</dcterms:created>
   <dcterms:issued>2010</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_1800 </dc:identifier>
   <dc:identifier>TEME 0024 2010</dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/1800</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/12833</identifier><datestamp>2021-06-03T00:45:24Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Incidencia de síndrome de abstinencia secundario a opioides y/o benzodiacepinas en dos unidades de cuidados intensivos pediátricos</dc:title>
   <dc:creator>Ríos Gálvez, Blanca Isabel</dc:creator>
   <dc:creator>Alvarado, Manuel</dc:creator>
   <dc:contributor>Pardo, Rosalba</dc:contributor>
   <dc:contributor>Cárdenas Müller, Adriana</dc:contributor>
   <dc:contributor>De la Hoz, Jose Antonio</dc:contributor>
   <dc:subject>Escala SOPHIA</dc:subject>
   <dc:subject>Síndrome de abstinencia</dc:subject>
   <dc:subject>Opioides</dc:subject>
   <dc:subject>Benzodiacepinas</dc:subject>
   <dc:subject>Sedación</dc:subject>
   <dcterms:abstract>Introduction: Withdrawal syndrome (WS) is the set of symptoms and signs that occur when abruptly stops the administration of a drug once physical dependence has been established.&#xd;
&#xd;
 •Objective: To characterize patients with secondary WS to opioids and / or benzodiazepines during hospitalization in the pediatric intensive care Clínica Infantil Colsubsidio (CIC) and the Hospital del Niño in Panama (HDN) from 1 April to 30 September 2016.&#xd;
 &#xd;
• Materials and Methods: This was a descriptive, longitudinal, prospective study. We included 189 patients in the CIC and 144 patients in the HDN.  The SOPHIA scale was used for the diagnosing of withdrawal; the COMFORT scales for evaluating sedation in unrelaxed ventilated patients and the FLACC scale for evaluating analgesia. The StataV12® software was used for statistical analysis.&#xd;
 &#xd;
• Results:  A global incidence rate of WS of 6.1 / 100 days people was reported. The cumulative incidence of WS was 56.08% and 29.86% for the CIC and HDN respectively.  At the CIC in the 69.81% of patients who required infusion of opioids and benzodiazepines developed WS. Acumulative dose of fentanyl of 530.34 ± 276.49 mcg / kg was reported. At the HDN, 53.49% of the patients who received opioids and benzodiazepines developed the syndrome. &#xd;
&#xd;
Conclusion:  WS secondary to opioids and / or benzodiazepines is frequent in our intensive care units with a variable incidence, and a higher frequency of WS with the use of both medications, higher cumulative doses and more days of continuous infusion.</dcterms:abstract>
   <dcterms:dateAccepted>2017-02-01T13:13:59Z</dcterms:dateAccepted>
   <dcterms:available>2017-02-01T13:13:59Z</dcterms:available>
   <dcterms:created>2017-02-01T13:13:59Z</dcterms:created>
   <dcterms:issued>2017</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_12833 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/12833</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>1. 	 Orive P, López Fernández , Morteruel Arizkuren E. Protocolo de Síndrome de Abstinencia. Soc y Fund Española Cuid intensivos pediátricos. 2013.</dc:source>
   <dc:source>2. 	Moon YE. Paradoxical reaction to midazolam in children. Korean J Anesthesiol.2013;65(1):2–3</dc:source>
   <dc:source>3. 	Ista E, Van Dijk M, Gamel C, Tibboel D, De Hoog M. Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics. Intensive Care Med.2007;33(8):1396–406.</dc:source>
   <dc:source>4. 	Valdivielso-Serna A. Analgesia, sedación y relajación en el niño con ventilación mecánica. Med Intensiva. 2008;32 Supl 1:115-24 115</dc:source>
   <dc:source>5. 	Galinkin J, Koh JL. Recognition and management of iatrogenically induced opioid dependence and withdrawal in children. Pediatrics. 2014;133(1):152–5.</dc:source>
   <dc:source>6. 	Best KM, Boullata JI, Curley MAQ. Risk Factors Associated With Iatrogenic Opioid and Benzodiazepine Withdrawal in Critically Ill Pediatric Patients. Pediatr Crit Care Med. 2015;16(2):175–83.</dc:source>
   <dc:source>7. 	Jenkins I, Playfor SD, Bevan C, Davies G, Wolf AR. Current United Kingdom sedation practice in pediatric intensive care. Paediatr Anaesth. 2007;17:675–83.</dc:source>
   <dc:source>8. 	Sfoggia A, Scolari P MA. Sedation and analgesia in children submitted to mechanical ventilation could be overestimated? J Pediatr (Rio J) 2003;79(4)343-8.</dc:source>
   <dc:source>9. 	Fonsmark L, Rasmussen YH, Carl P. Occurrence of withdrawal in critically ill sedated children. Critical care medicine. 1999. p. 196–9.</dc:source>
   <dc:source>10. 	Katz R, Kelly HW HA. Prospective study on the occurrence of withdrawal in critically ill childreil who receive fentanyl by continUO \ lS infusion. Critical Care Medicine. 22(5):763-767, May 1994.</dc:source>
   <dc:source>11. 	Pediátricos U de CI. Estadísticas Clínica Infantil Colsubsidio. Bogotá Colombia; 2015.</dc:source>
   <dc:source>12. 	Estadísticas Hospital del Niño de Panamá. Panamá; 2015</dc:source>
   <dc:source>13. 	Perrot L, Barrios K. Frecuencia del síndrome de abstinencia en la unidad de terapia intensiva del hospital del niño doctor josé renán esquivel. Marzo-mayo 2015. Archivos biblioteca Hospital del niño de Panamá. 2015</dc:source>
   <dc:source>14. 	Richman PS, Baram D, Varela M, Glass PS. Sedation during mechanical ventilation: a trial of benzodiazepine and opiate in combination. Crit Care Med. 2006;34(5):1395–401</dc:source>
   <dc:source>15. 	Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541–8.</dc:source>
   <dc:source>16. 	Playfor S, Jenkins I, Boyles C, Choonara I, Davies G, Haywood T, et al. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med. 2006;32(8):1125–36</dc:source>
   <dc:source>17. 	Twite MD, Rashid A, Zuk J, Friesen RH. Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med. 2004;5(6):521–32.</dc:source>
   <dc:source>18. 	Nolent P, Laudenbach V. Sédation et analgésie en réanimation – Aspects pédiatriques. Ann Fr Anesth Reanim. 2008;27(7–8):623–32.</dc:source>
   <dc:source>19. 	Mencía SB, López-Herce JC, Freddi N. Analgesia and sedation in children: practical approach for the most frequent situations. J Pediatr (Rio J). 2007;83:S71–82.</dc:source>
   <dc:source>20. 	Fernández-Carrión F, Gaboli M, González-Celador R, Gómez de Quero-Masía P, Fernández-de Miguel S, Murga-Herrera V, et al. Síndrome de abstinencia en Cuidados Intensivos Pediátricos. Incidencia y factores de riesgo. Med Intensiva. 2012;37(2):67-74</dc:source>
   <dc:source>21. 	Volkow ND, McLellan TA. Characteristics of Opioid Prescriptions in 2009. JAMA  J Am Med Assoc. 2011;305(13):1299–301.</dc:source>
   <dc:source>22. 	Rhoney DH, Murry KR. National survey on the use of sedatives and neuromuscular blocking agents in the pediatric intensive care unit. Pediatr Crit Care Med. 2002;3(2):129–33.</dc:source>
   <dc:source>23. 	Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med. 2012;185(5):486–97.</dc:source>
   <dc:source>24. 	Devlin J, Roberts RJ. Pharmacology of Commonly Used Analgesics and Sedatives in the  ICU : Benzodiazepines, Propofol, and Opioids. Anesthesiology Clin 29(2011):567–585</dc:source>
   <dc:source>25. 	Mencía S. Monitorización de analgesia, sedación y bnm en ucip. Protocolo del grupo de sedoanalgesia de la secip. Secip. 2013;1–10.</dc:source>
   <dc:source>26. 	Bai J, Hsu L, Tang Y, Van Dijk M. Validation of the COMFORT Behavior Scale and the FLACC Scale for Pain Assessment in Chinese Children after Cardiac Surgery. Pain Manag Nurs. American Society for Pain Management Nursing; 2012;13(1):18–26.</dc:source>
   <dc:source>27. 	Voepel-Lewis T, Zanotti J, Dammeyer JA, Merkel S. Reliability and validity of the face, legs, activity, cry, consolability behavioral tool in assessing acute pain in critically ill patients. Am J Crit Care. 2010;19(1):55–61.</dc:source>
   <dc:source>28. 	Vet NJ, Ista E, De Wildt SN, Van Dijk M, Tibboel D, De Hoog M. Optimal sedation in pediatric intensive care patients: a systematic review. Intensive Care Med. 2013;39(9):1524–34.</dc:source>
   <dc:source>29. 	Sauder P, Andreoletti M, Cambonie G, Capellier G, Feissel M, Gall O, et al. Sédation-analgésie en réanimation (nouveau-né exclu). Ann Fr Anesth Reanim. 2008;27(7–8):541–51.</dc:source>
   <dc:source>30. 	Andersen RD, Bernklev T, Langius-Eklof A, Nakstad B, Jylli L. The COMFORT behavioural scale provides a useful assessment of sedation, pain and distress in toddlers undergoing minor elective surgery. Acta Paediatr. 2015;104(9):904–9.</dc:source>
   <dc:source>31. 	Dorfman TL, Sumamo Schellenberg E, Rempel GR, Scott SD, Hartling L. An evaluation of instruments for scoring physiological and behavioral cues of pain, non-pain related distress, and adequacy of analgesia and sedation in pediatric mechanically ventilated patients: A systematic review. Int J Nurs Stud. Elsevier Ltd; 2014;51(4):654–76.</dc:source>
   <dc:source>32. 	Bustos R, Fuentes C. Correlación entre análisis biespectral y escala COMFORT en la evaluación de sedación en la Unidad de Cuidados Intensivos Pediátricos. Rev Chil pediatría. 2007;78(6):592–8.</dc:source>
   <dc:source>33. 	Harris J, Ramelet AS, Van Dijk M, Pokorna P, Wielenga J, Tume L, et al. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med. Springer Berlin Heidelberg; 2016;42(6):972–86.</dc:source>
   <dc:source>34. 	Neunhoeffer F, Kumpf M, Renk H, Hanelt M, Berneck N, Bosk A, et al. Nurse-driven pediatric analgesia and sedation protocol reduces withdrawal symptoms in critically ill medical pediatric patients. 2015;25:786–94.</dc:source>
   <dc:source>35. 	Franck LS, Vilardi J, Durand D, Powers R. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care. 1998;7(5):364–9.</dc:source>
   <dc:source>36. 	Franck LS, Naughton I, Winter I. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients. Intensive Crit Care Nurs. 2004;20:344–51.</dc:source>
   <dc:source>37. 	Birchley G. Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: a review of recent literature. Nurs Crit Care. 2009;14(1):26–37.</dc:source>
   <dc:source>38. 	Gardner D. NIH Public Access. Neonatal Abstinence Syndrome (NAS): Transitioning Methadone Treated Infants From An Inpatient to an Outpatient Setting. 2013;32(6):425–30.</dc:source>
   <dc:source>39. 	Finnegan LP, Connaughton JF, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addictive diseases. 1975:141–58.</dc:source>
   <dc:source>40. 	Cunliffe M, McArthur L, Dooley F. Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward. Paediatric Anaesthesia. 2004. p. 293–8.</dc:source>
   <dc:source>41. 	Amigoni A, Vettore E, Brugnolaro V, Brugnaro L, Gaffo D, Masola M, et al. High doses of benzodiazepine predict analgesic and sedative drug withdrawal syndrome in paediatric intensive care patients. Acta Paediatr. 2014;103(12):e538–43.</dc:source>
   <dc:source>42. 	Franck LS, Scoppettuolo L, Wypij D, Curley M. Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients. Pain. International Association for the Study of Pain; 2012;153(1):142–8.</dc:source>
   <dc:source>43. 	Ista E, Van Dijk M, Hoog M, Tibboel D, Duivenvoorden HJ. Construction of the Sophia Observation withdrawal Symptoms-scale (SOS) for critically ill children. Intensive Care Med. 2009;35(6):1075–81.</dc:source>
   <dc:source>44. 	Ista E, De Hoog M, Tibboel D, Duivenvoorden HJ, Van Dijk M. Psychometric evaluation of the Sophia Observation withdrawal symptoms scale in critically ill children. Pediatr Crit Care Med. 2013;14(8):761–9.</dc:source>
   <dc:source>45. 	Fernández F, Sara M. Sedoanalgesia En Ucip. SECIP 2013:1–20. Disponible en: www.secip.com/publicaciones.../92-protocolos-gt-sedoanelgesia-2...</dc:source>
   <dc:source>46. 	Bauer T, Ritz R, Haberthür C, Haefeli W, Hunkeler W, Sleight J, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. The lancet.July1995;356(8969):145–7.</dc:source>
   <dc:source>47. 	Johnson PN, Miller JL, Hagemann TM. Sedation and Analgesia in Critically Ill Children. AACN Adv Crit Care. 2012;23(4):415–34.</dc:source>
   <dc:source>48. 	Celis-Rodríguez E, Birchenall C, De la Cal M.A, Arellano GC, Jimenez EJ, García JOS, et al. Guía de práctica clínica basada en la evidencia para el manejo de la sedoanalgesia en el paciente adulto críticamente enfermo. Med Intensiva 2013 http//dx.doi.org/101016/j.medin201304001. 2013;(xx).</dc:source>
   <dc:source>49. 	Bicudo JN, Souza N De, Mângia CMF, Carvalho WB. Síndrome de abstinência associada à interrupção da infusão de fentanil e midazolam em pediatria. Rev Assoc Med Bras. 1999;45(1):15–8.</dc:source>
   <dc:source>50. 	Dominguez KD. Withdrawal from Lorazepam in Critically Ill Children. Annals of Pharmacotherapy. 2006. p. 1035–9.</dc:source>
   <dc:source>51. 	Poh YN, Poh PF, Buang SNH, Lee JH. Sedation Guidelines, Protocols, and Algorithms in PICUs. Pediatr Crit Care Med. 2014;15(9):885–92.</dc:source>
   <dc:source>52. 	Franck LS, Scoppettuolo LA, Curley MAQ. Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients. NIH Public Access. 2013;153(1):142–8.</dc:source>
   <dc:source>53. 	Meyer MM, Berens RJ. Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients. Pediatr Crit Care Med. 2001;2(4):329–33.</dc:source>
   <dc:source>54. 	Lewandowski CM,. Protocolo de Metadona. University of Minnesota Amplatz Children’s Hospital. Eff Br mindfulness Interv acute pain Exp An Exam Individ Differ. 2015;1:1689–99.</dc:source>
   <dc:source>55. 	Fisher D, Grap MJ, Younger JB, Ameringer S, Elswick RK. Opioid withdrawal signs and symptoms in children: Frequency and determinants. Hear Lung J Acute Crit Care. Elsevier Inc; 2013;42(6):407–13.</dc:source>
   <dc:source>56. 	Subramaniam R, Playfor SD. Sedation and analgesia in critically ill children. Pediatrics and Child Health. 2011:25(4): 177-181.</dc:source>
   <dc:source>57. 	Hernández-Delgadillo GP, Cruz SL. Mecanismos de tolerancia analgésica a los opioides. Salud Ment.2005;28(3):22–31</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/34811</identifier><datestamp>2022-08-31T07:57:15Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Marcadores inflamatorios y factores clínicos asociados en niños y adolescentes con infección por SARS COV-2 y la relación con su severidad en dos instituciones de Bogotá</dc:title>
   <dc:creator>Rodríguez Suesca, María Angélica</dc:creator>
   <dc:contributor>Casallas Vega, Alexander</dc:contributor>
   <dc:contributor>Ruiz Rodríguez, Diana Alejandra</dc:contributor>
   <dc:subject>SARS CoV2</dc:subject>
   <dc:subject>Covid 19</dc:subject>
   <dc:subject>Biomarcadores</dc:subject>
   <dc:subject>Biomarcadores en niños</dc:subject>
   <dc:subject>Población pediátrica</dc:subject>
   <dcterms:abstract>Backround: To date there are few studies that describe the behavior of inflammatory markers, and its relationship with the severity of the disease, in children with SARS CoV-2 infection so it is intended to carry out a case-control study in the pediatric population of the Hospital Universitario Clínica San Rafael (HUCSR) and the Clínica Infantil Colsubsidio (CIC) in the period between April 2020 and March 2022. Methods: A multicenter case-control study was conducted. A random sampling was made, using the information of patients with severe SARS-COV2 as cases vs patients with mild SARS-COV2 as controls, the values of different serum markers of inflammation were compared in a 1:2 ratio. The analysis was done through a bivariate analysis according to the clinical variables of interest. Results: A total of 171 patients, 51 cases, 120 controls were analyzed in a ratio of approximately 1:2. Critically ill patients were smaller than controls (median 19 months vs. 30 months, cases vs. controls, respectively); when evaluating the markers for critical illness, it was found that the absolute count of leukocytes, neutrophils, platelets, LDH, CRP value and D-dimer upon admission to the institution, and the absolute count of lymphocytes, monocytes and platelet count at 72 hours made a significant difference as markers of critical illness. Discussion: The physiological characteristics of infants, maturity of the immunoassay system, vaccination and exposure to pathogens can explain the differences in response to infection when copared to adults, also reflecting the trends observed in the lab. However, leukocytes, platelets, LDH RCP value and D-dimer can guide critical disease in this population. In the same way, the variation in the count of lymphocytes, monocytes and platelets taken in a control at 72 hours of admission.</dcterms:abstract>
   <dcterms:dateAccepted>2022-08-26T14:17:04Z</dcterms:dateAccepted>
   <dcterms:available>2022-08-26T14:17:04Z</dcterms:available>
   <dcterms:created>2022-08-26T14:17:04Z</dcterms:created>
   <dc:type>bachelorThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_34811</dc:identifier>
   <dc:identifier>https://repository.urosario.edu.co/handle/10336/34811</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395(10223):497–506.</dc:source>
   <dc:source>2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 382(8):727–33.</dc:source>
   <dc:source>3. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - J Am Med Assoc. 324(8):782–93.</dc:source>
   <dc:source>4. Ministerio Protección social “La salud es de todos.” Coronavirus COVID 19. Siruación actual nuevo coronavirus (Covid 19). 2020.</dc:source>
   <dc:source>5. Yuki, K; Fujiogi, M; Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427.</dc:source>
   <dc:source>6. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383(4):334–46.</dc:source>
   <dc:source>7. Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020;16(3):240–6.</dc:source>
   <dc:source>8. Ciuca IM. COVID-19 in children: An ample review. Risk Manag Healthc Policy. 2020;13:661–9.</dc:source>
   <dc:source>9. Elshazli, RM; Toraih, EA; Elgaml, A; El-Mowafy, M; El-Mesery, M; Amin M. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 2020;15(8):1–20.</dc:source>
   <dc:source>10. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020;53(3):371–2.</dc:source>
   <dc:source>11. Ludvigsson J. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr Int J Paediatr. 2020;109(6):1088–95.</dc:source>
   <dc:source>12. Rivera-Diaz; RR-HM. Sindome inflamatorio multisistémico asociado a COVID 19 en niños y adolescentes. Rev Latinoam Infectología Pediátrica. 2020;33(3):115–8.</dc:source>
   <dc:source>13. ACNP. Asociación Colombiana de Pediatría. Sagra Catalina Vasquez, et al. Guías de manejo de COVID-19 en niños [Internet]. 2020. p. 1–11. Available from: https://portal.neumopediatriacolombia.com/guias-de-manejo-de-covid-19-en-ninos/</dc:source>
   <dc:source>14. Orellana;, Jesem Douglas, Geraldo Marcelo, da Cunha;Lihsieh M. Explosión de la mortalidad en el epicentro amazónico de la epidemia de COVID-19. Cad Saúde Pública. 2020;36(7).</dc:source>
   <dc:source>15. Otoya, Ana M; García, María; Jaramillo, Catalina; Wills, Carlos; Campos AM. COVID-19: generalidades, comportamiento epidemiológico y medidas adoptadas en medio de la pandemia en Colombia. Acta Otorrinolaringol y Cirugía Cabeza y cuello [Internet]. 2020;4(13). Available from: https://www.revista.acorl.org.co/index.php/acorl/article/view/475</dc:source>
   <dc:source>16. Wiersinga, WJ; Rhodes, A; Cheng, AC; Peacock, SJ; Prescott H. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 324(8):782–93.</dc:source>
   <dc:source>17. Guan, W; Ni, Z; Hu, Y; Liang, W; Ou, C; He J. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–12.</dc:source>
   <dc:source>18. Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency. Vol. 221, Revista Clinica Espanola. Elsevier Doyma; 2021. p. 55–61.</dc:source>
   <dc:source>19. Zhou, P; Yang X, Lou;Wang, XG; Hu, B; Zhang, L, Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.</dc:source>
   <dc:source>20. Liu YC, Yu MM, Shou ST, Chai YF. Sepsis-induced cardiomyopathy: Mechanisms and treatments. Front Immunol. 2017;8(AUG):1–8.</dc:source>
   <dc:source>21. Bohn, MK; Hall, A; Sepiashvili, L; Jung, B; Steele SA. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiol. 2020;35(5):288.</dc:source>
   <dc:source>22. Liu, Y; Yan, Li-Men; Wan, L; Xiang, Tian-Xin; Le A. Viral dynamics in mild and severe cases of COVID-19. Lancet. 2020;20(6):19–21.</dc:source>
   <dc:source>23. Jia, HP; Look, DC; Shi, L; Hickey, M; Pewe, L; Netland J. ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia. J Virol. 2005;79(23):146–21.</dc:source>
   <dc:source>24. Li, M; Yao, D; Zeng, X; Kasakovski, D; Zhang, Y; Chen S. Age related human T cell subset evolution and senescence. Immun Ageing. 2019;16(1):1–7.</dc:source>
   <dc:source>25. Lee, PI; Hu, YL; Chen, PY; Huang, YC; Hsueh P. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020;53(3):371–2.</dc:source>
   <dc:source>26. Trujillo CHS. Consenso colombiano de atención, diagnóstico y manejo de la infección por sars-cov-2/covid 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio [Internet]. 2020;24(2). Available from: http://www.revistainfectio.org/index.php/infectio/article/view/851/896</dc:source>
   <dc:source>27. Chen, ZM; Fu, JF; Shu, Q; Chen, YH; Hua, CZ;Li F. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020;160(3):240–6.</dc:source>
   <dc:source>28. Rothan, HA; Byrareddy S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;</dc:source>
   <dc:source>29. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131–4.</dc:source>
   <dc:source>30. Lippi, G; Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58(7):1131–4.</dc:source>
   <dc:source>31. Liu, F; Li, L; Xu, M; Wu, J; Luo, D; Zhu Y. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127.</dc:source>
   <dc:source>32. Ruan, Q; Yang, K; Wang, W; Jiang, L; Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med [Internet]. 2020;46(5):846–8.</dc:source>
   <dc:source>33. Storch-de-Gracia, P; Leoz-Gordillo, I; Andina, D; Flores, P; Villalobos, E; Escalada-Pellitero S. Espectro clínico y factores de riesgo de enfermedad complicada en niños ingresados con infección por SARS-CoV-2. An Pediatría. 2020;93(5):323–33.</dc:source>
   <dc:source>34. Kosmeri, C; Koumpis, E; Tsabouri, S; Siomou, E; Makis A. Hematological manifestations of SARS-CoV-2 in children. Pediatr Blood Cancer. 2020;67(12).</dc:source>
   <dc:source>35. Henry, BM; Lippi, G; Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020;58(7):1135–8.</dc:source>
   <dc:source>36. Esteves, R; Castro V, De; Carla, D; Souza, D; Flavio, L; Lima P. Pediatric patients with COVID-19 admitted to intensive care units in Brazil: a prospective multicenter study. J Pediatr (Rio J). 2020;</dc:source>
   <dc:source>37. Elizabeth; VPMIL. Alteraciones hematológicas en COVID-19. NOVA. 2020;18(35):73–7.</dc:source>
   <dc:source>38. Pío; BReILMEL. Diferencias entre niños y adultos por el nuevo coronavirus 2019, SARS-CoV-2/COVID 19. Rev Latinoam Infectología pediátrica. 2020;33(4):165–73.</dc:source>
   <dc:source>39. Mundial AM. Declaración de Helsinky. Principios éticos para las investigaciones médicas en seres humanos. Acta Bioeth. 1964;</dc:source>
   <dc:source>40. MPS Ministerio de la Protección social. Resolucion 8430/1993 Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación á. Bogotá. In 1993.</dc:source>
   <dc:source>41. Henry, Brandon Michael et al. “Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.” Clinical biochemistry vol. 81 (2020): 1-8. doi:10.1016/j.clinbiochem.2020.05.012</dc:source>
   <dc:source>42. Wu H, Zhu H, Yuan C, Yao C, Luo W, Shen X, Wang J, Shao J, Xiang Y. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China. JAMA Netw Open. 2020 Jun 1;3(6):e2010895. doi: 10.1001/jamanetworkopen.2020.10895. PMID: 32492165; PMCID: PMC7272117.</dc:source>
   <dc:source>43. Zheng Y, Zhang Y, Chi H, Chen S, Peng M, Luo L, Chen L, Li J, Shen B, Wang D. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study. Clin Chem Lab Med. 2020 Jun 25;58(7):1106-1115. doi: 10.1515/cclm-2020-0377. PMID: 32352397.</dc:source>
   <dc:source>44. Fernandes DM, Oliveira CR, Guerguis S, et al; Tri-State Pediatric COVID-19 Research Consortium. Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J Pediatr. 2021;230:23–31.e10.</dc:source>
   <dc:source>45. Das BB. COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?. Medicina (Kaunas). 2020;56(12):716. Published 2020 Dec 19. doi:10.3390/medicina56120716.</dc:source>
   <dc:source>46. Xia, Wei et al. “Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.” Pediatric pulmonology vol. 55,5 (2020): 1169-1174. doi:10.1002/ppul.24718.</dc:source>
   <dc:source>47. Langford, B. J., So, M., Raybardhan, S., Leung, V., Soucy, J. R., Westwood, D., Daneman, N., &amp; MacFadden, D. R. (2021). Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(4), 520–531. https://doi.org/10.1016/j.cmi.2020.12.018</dc:source>
   <dc:source>48. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China. Pediatrics. 2020 doi: 10.1542/peds.2020-0702.</dc:source>
   <dc:source>49. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-426. Published 2020 Apr 10. doi:10.15585/mmwr.mm6914e4.</dc:source>
   <dc:source>50. Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, Rosenblatt A, Walchok J, Omar W, Khera R, Hegde AA, Drazner MH, Neeland IJ, Grodin JL. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021 Jan 12;143(2):135-144. doi: 10.1161/CIRCULATIONAHA.120.051936. Epub 2020 Nov 17. PMID: 33200947.</dc:source>
   <dc:source>51. Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J, et al. Factores de riesgo de COVID-19 grave en niños. Pediatr Infect Dis J. (2021) 40 :e137–e45. 10.1097/INF.0000000000003043</dc:source>
   <dc:source>52. Tsankov BK, Allaire JM, Irvine MA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases. 2021 Feb;103:246-256. DOI: 10.1016/j.ijid.2020.11.163. PMID: 33227520; PMCID: PMC7679116.</dc:source>
   <dc:source>53. López-Medina E, Camacho-Moreno G, Brizuela ME, Dávalos DM, Torres JP, Ulloa-Gutierrez R, et al Factors Associated With Hospitalization or Intensive Care Admission in Children With COVID-19 in Latin America. Front Pediatr. 2022 Apr 14;10:868297. doi: 10.3389/fped.2022.868297. PMID: 35498776; PMCID: PMC9048675.</dc:source>
   <dc:source>54. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Características y resultados de los niños con infección por coronavirus 2019 (COVID-19) admitidos en unidades de cuidados intensivos pediátricos de EE. UU. y Canadá. JAMA Pediatría . 2020;174(9):868-873. doi:10.1001/jamapediatrics.2020.1948.</dc:source>
   <dc:source>55. Woodruff RC, Campbell AP, Taylor CA, et al. Risk Factors for Severe COVID-19 in Children. Pediatrics 2021.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/2679</identifier><datestamp>2021-06-03T00:46:35Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Estudio de correlación entre la PaO2/FiO2 y la SO2/FiO2 en niños en ventilación mecánica de la Fundación Cardioinfantil en Bogotá entre Abril y Junio de 2011</dc:title>
   <dc:creator>Murcia Sánchez, Hecmar Eduardo</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:subject>Síndrome de dificultad Respiratoria Aguda</dc:subject>
   <dc:subject>lesión pulmonar aguda</dc:subject>
   <dc:subject>Ventilación mecánica</dc:subject>
   <dc:subject>Saturación de oxígeno</dc:subject>
   <dc:subject>Presión arterial de oxígeno</dc:subject>
   <dcterms:abstract>Objectives: To determine if there is any correlation between SaFiO2 and PaFiO2 variables of patients with acute respiratory disease in the Pediatric Intensive Care Unit in Fundacion Cardioinfantil the city of Bogotá DC.&#xd;
Materials and methods: The quantitative variables were analyzed with measures of central tendency like average and measures of dispersion such as standard deviation.&#xd;
We used a confidence level of 95% and an estimated 80% power to test hypotheses of a proportion.&#xd;
We performed a correlation analysis to measure the strength of the relation between PaO2/FiO2 and SO2/FiO2 variables through the coefficient of correlation.&#xd;
Results: We included 12 patients and it took a total of 65 records of SO2/FiO2 and PaO2/FiO2 founding a positive relation between SaO2/FIO2 and PaO2/FIO2 variables, which is variable depending on the inspired fraction of oxygen to which is the patient.&#xd;
According to the observations, the SaO2/FIO2 variable is moderately correlated (r = 0.602) with PaO2/FIO2 variable, when FIO2 is between 0.35 and 0.55, one degree of acceptable correlation (r = 0.319), when the FIO2 is between 0.60 to 0.80 and 0.81 - 1 (r = 0.318).&#xd;
Conclusions: The noninvasive methods in the evaluation of oxygenation may be an alternative for clinical monitoring in children with acute lung injury or acute respiratory distress syndrome. It requires an analytical studies to provide a better scientific evidence which can be extrapolated to the children covered by this study.</dcterms:abstract>
   <dcterms:dateAccepted>2011-11-28T17:58:41Z</dcterms:dateAccepted>
   <dcterms:available>2011-11-28T17:58:41Z</dcterms:available>
   <dcterms:created>2011-11-28T17:58:41Z</dcterms:created>
   <dcterms:issued>2011</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_2679 </dc:identifier>
   <dc:identifier>TEME 0073 2011</dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/2679</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/47584</identifier><datestamp>2026-02-26T03:01:57Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Desenlaces en pacientes sépticos de una unidad de cuidado intensivo pediátrico con Programa de Optimización de Antimicrobianos (PROA). Clínica Colsubsidio Infantil 2021 - 2023</dc:title>
   <dc:creator>Romero Castro, Héctor Andrés</dc:creator>
   <dc:creator>Cardenas Muller, Adriana</dc:creator>
   <dc:contributor>Bejarano, Ana María</dc:contributor>
   <dc:contributor>Buitrago Medina, Daniel Alejandro</dc:contributor>
   <dc:contributor>Educación Médica y en Ciencias de la Salud</dc:contributor>
   <dc:subject>Sepsis</dc:subject>
   <dc:subject>Pediatria</dc:subject>
   <dc:subject>Cuidado intensivo pedaitrico</dc:subject>
   <dc:subject>Programa de optimización de antimicrobianos</dc:subject>
   <dc:subject>Resistencia bacteriana</dc:subject>
   <dcterms:abstract>A retrospective observational cohort study was conducted including 395 patients aged 0–18 years with a diagnosis of sepsis admitted to the PICU between 2021 and 2023. Sociodemographic and clinical characteristics, microbiological patterns, resistance mechanisms, antibiotic decisions within the PROA framework and clinical outcomes were described. This study provides a detailed description of pediatric sepsis in a high-complexity PICU operating within an institutional antimicrobial stewardship program and offers a local baseline on clinical and microbiological characteristics and outcomes, which may inform protocol refinement and the design of future analytical or implementation studies.</dcterms:abstract>
   <dcterms:dateAccepted>2026-02-25T15:06:06Z</dcterms:dateAccepted>
   <dcterms:available>2026-02-25T15:06:06Z</dcterms:available>
   <dcterms:created>2026-02-25T15:06:06Z</dcterms:created>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_47584</dc:identifier>
   <dc:identifier>https://repository.urosario.edu.co/handle/10336/47584</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud</dc:publisher>
   <dc:publisher>Especialización en Medicina Crítica y Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Aizawa, Y., Suwa, J., Higuchi, H., Tazumi, K., &amp; Takeuchi, M. (2018). Antimicrobial stewardship program in a pediatric intensive care unit of a tertiary care center in Japan. Journal of the Pediatric Infectious Diseases Society, 7(3), e156–e159.</dc:source>
   <dc:source>Antimicrobial Resistance Collaborators. (2023). The burden of antimicrobial resistance in the Americas in 2019: A cross-country systematic analysis. The Lancet Regional Health – Americas, 25, 100561.</dc:source>
   <dc:source>Berezin, E. N., &amp; Solórzano, F. (2014). Gram-negative infections in pediatric and neonatal intensive care units of Latin America. Journal of Infection in Developing Countries, 8(8), 942–953.</dc:source>
   <dc:source>Cornistein, W., Ferrero, F., Uez, O., Speranza, N., Ardiles, R., &amp; Ferraro, M. (2025). Prevalence and associated mortality of infections by multidrug-resistant organisms in children: A multicenter study in Latin America. Antibiotics, 14(5), 493</dc:source>
   <dc:source>Fernández-Polo, A., Melendo-Pérez, S., Larrosa, N., et al. (2024). Five-year evaluation of a pediatric antimicrobial stewardship program in a tertiary-care hospital. Antibiotics, 13(6), 511</dc:source>
   <dc:source>Fleischmann-Struzek, C., Goldfarb, D. M., Schlattmann, P., Schlapbach, L. J., Reinhart, K., &amp; Kissoon, N. (2018). The global burden of paediatric and neonatal sepsis: A systematic review. The Lancet Respiratory Medicine, 6(3), 223–230.</dc:source>
   <dc:source>Fonseca-Rivera, I. C., et al. (2025). Impact of an antimicrobial stewardship program on mortality and consumption of antibiotics in the intensive care units of a pediatric referral hospital in Peru. Antimicrobial Stewardship &amp; Healthcare Epidemiology, 5(1)</dc:source>
   <dc:source>Liberati, C., Brigadoi, G., et al. (2025). Antimicrobial stewardship programs in pediatric intensive care units: A systematic scoping review. Antibiotics, 14(2), 130.</dc:source>
   <dc:source>Massaud-Ribeiro, L., Martinez, E. E., &amp; Schlapbach, L. J. (2022). Pediatric sepsis research: Where are we and where are we headed? Frontiers in Pediatrics, 10, 829119.</dc:source>
   <dc:source>Ministerio de Salud y Protección Social. (2017). La resistencia a los antimicrobianos: Un reto para los sistemas de salud. Ministerio de Salud y Protección Social de Colombia.</dc:source>
   <dc:source>Renk, H., Regamey, N., Hitzler, M., et al. (2020). Antibiotic stewardship in the PICU: Impact of ward rounds led by pediatric infectious diseases specialists on antibiotic use. Scientific Reports, 10, 13717.</dc:source>
   <dc:source>Robledo, J., Maldonado, N., Robledo, C., et al. (2022). Changes in antimicrobial resistance and etiology of blood culture isolates: Results of a decade (2010–2019) of surveillance in a northern region of Colombia. Infection and Drug Resistance, 15, 6067–6079.</dc:source>
   <dc:source>Rudd, K. E., Johnson, S. C., Agesa, K. M., et al. (2020). Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. The Lancet, 395(10219), 200–211</dc:source>
   <dc:source>Sanchez-Pinto, L. N., Schlapbach, L. J., et al. (2024). International consensus criteria for pediatric sepsis and septic shock (Phoenix criteria). JAMA, 331</dc:source>
   <dc:source>Sick-Samuels, A. C., et al. (2022). Diagnostic stewardship in the pediatric intensive care unit. Current Treatment Options in Infectious Diseases, 14(1), 54–67</dc:source>
   <dc:source>Watson, R. S., Carrol, E. D., Carter, M. J., et al. (2024). The burden and contemporary epidemiology of sepsis in children. The Lancet Child &amp; Adolescent Health, 8(9), 670–681. https://doi.org/10.1016/S2352-4642(24)00135-9</dc:source>
   <dc:source>Weiss, S. L., Peters, M. J., Alhazzani, W., et al. (2020). Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Medicine, 46(Suppl 1), 10–67</dc:source>
   <dc:source>Willems, J., Hermans, E., Schelstraete, P., Depuydt, P., &amp; De Cock, P. (2021). Optimizing the use of antibiotic agents in the pediatric intensive care unit: A narrative review. Pediatric Drugs, 23(1), 39–53.</dc:source>
   <dc:source>Donà, D., Barbieri, E., Daverio, M., Lundin, R., Giaquinto, C., Zaoutis, T., &amp; Sharland, M. (2020). Implementation and impact of pediatric antimicrobial stewardship programs: A systematic scoping review. Antimicrobial Resistance &amp; Infection Control, 9, 3</dc:source>
   <dc:source>Gaies, M. G., Gurney, J. G., Yen, A. H., et al. (2010). Vasoactive-Inotropic Score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatric Critical Care Medicine, 11(2), 234–238</dc:source>
   <dc:source>Hersh, A. L., Beekmann, S. E., Polgreen, P. M., Zaoutis, T. E., &amp; Newland, J. G. (2013). Antimicrobial stewardship programs in pediatrics. Infectious Disease Clinics of North America, 27(1), 283–298</dc:source>
   <dc:source>Newland, J. G., &amp; Gerber, J. S. (2013). Pediatric antimicrobial stewardship programs. Infectious Disease Clinics of North America, 27(1), 91–116</dc:source>
   <dc:source>Selewski, D. T., Cornell, T. T., Heung, M., Troost, J. P., Ehrmann, B. J., Lombel, R. M., Shanley, T. P., et al. (2014). Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Medicine, 40(10), 1481–1488</dc:source>
   <dc:source>Shah, P., et al. (2022). Using aggregate vasoactive-inotrope scores to predict outcomes in pediatric sepsis. Frontiers in Pediatrics, 10, 778378</dc:source>
   <dc:source>Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., &amp; Clancy, C. J. (2021). IDSA guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance. Clinical Infectious Diseases, 72(7), e169–e183</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/12322</identifier><datestamp>2021-06-03T00:48:00Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Infección por virus sincitial respiratorio y su relación con valores de IGG en niños críticos</dc:title>
   <dc:creator>Bonilla González, Carolina</dc:creator>
   <dc:contributor>Ruiz, Diana Alejandra</dc:contributor>
   <dc:subject>Virus sincitial respiratorio</dc:subject>
   <dc:subject>inmunoglobulinas</dc:subject>
   <dc:subject>inmunodeficiencia</dc:subject>
   <dc:subject>hipogamaglobulineamia</dc:subject>
   <dc:subject>unidad de cuidado intensivo pediátrico</dc:subject>
   <dcterms:abstract>Background: Respiratory Syncytial Virus (RSV) infection represents a high morbidity and mortality, and in some cases management in pediatric intensive care units (PICU). The immune response directly influences the severity and prognosis of patients with respiratory infection. Methodology: A retrospective study of a cohort of patients with severe RSV respiratory infection and no history of immunodeficiency was conducted in the PICU of San Rafael University Hospital Clinic. Global descriptive analysis was performed and according to the categorization of IgG tests analysis. Results: Of 188 patients admitted to the PICU, 13% had RSV infection (24), with an average age of 7. 3 (SD = 3. 6) months; 79. 83% were male. Twelve point five percent had a low value of IgG, 58. 33% had a lower limit value and 29. 17% within the normal range for their age. In patients with low IgG was higher septic shock unresponsive to liquids (100 vs 92 vs 86%), median days of mechanical ventilation (8 vs 6 vs 5, respectively) and mortality (67 vs 7. 1 vs 0%). Conclusion: Our series found that patients with low levels or lower limit values of IgG had more systemic involvement, longer duration of mechanical ventilation and increased mortality. Prospective studies are needed that low levels of IgG relationships with severity and prognosis for these patients with severe RSV infection. </dcterms:abstract>
   <dcterms:dateAccepted>2016-08-30T21:16:37Z</dcterms:dateAccepted>
   <dcterms:available>2016-08-30T21:16:37Z</dcterms:available>
   <dcterms:created>2016-08-30T21:16:37Z</dcterms:created>
   <dcterms:issued>2016</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_12322 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/12322</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>1. Secretaría Distrital de Salud de Bogotá. Boletin II trimestre de 2014. Boletin enfermedad respiratoria aguda ERA [Internet]. 2014. [CItado 5 de julio de 2016]. Disponible en:http://www.saludcapital.gov.co/DSP/ERA/Bolet%C3%ADn%20ERA%20II%20Trimest re%202014.pdf</dc:source>
   <dc:source>2. Casto J RD. Caracterizaciòn del Virus Sincitial Respiratorio en la Unidad de Cuidados Intensivos Pediàtricos del Hospital Universitario Clìnica San Rafael de Bogotà en el Periodo de enero 1 a junio 30 de los años 2010 y 2011: Universidad Militar Nueva Granada 2012.</dc:source>
   <dc:source>3. K. M. Developments in respiratory syncytial virus (RSV) I: pathogenesis. Medwave. 2008;8(9):1713.</dc:source>
   <dc:source>4. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189(2):233-8.</dc:source>
   <dc:source>5. Fields BN, Knipe DM, Howley PM. Paramyxoviridae: Respiratory Syncytial Virus and Metapneumovirus. Fields' Virology. II: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; 2007. p. 3177.</dc:source>
   <dc:source>6. Johnson PR, Spriggs MK, Olmsted RA, Collins PL. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A. 1987;84(16):5625-9.</dc:source>
   <dc:source>7. Murphy BR. WR. Orthomyxoviruses. In: Knippe DM HP, editor. Fields BN. 3 ed. Nueva York: Lippincot-Raven 1996. p. 1397.</dc:source>
   <dc:source>8. Eiros JM, Ortiz de Lejarazu R, Tenorio A, Casas I, Pozo F, Ruiz G, et al. [Microbiological diagnosis of viral respiratory infections]. Enferm Infecc Microbiol Clin. 2009;27(3):168-77.</dc:source>
   <dc:source>9. Yamaguchi M, Sano Y, Dapat IC, Saito R, Suzuki Y, Kumaki A, et al. High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan. J Clin Microbiol. 2011;49(3):1034-40.</dc:source>
   <dc:source>10. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588-98.</dc:source>
   <dc:source>11. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282(15):1440-6.</dc:source>
   <dc:source>12. Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J. 2012;31(1):5-9.</dc:source>
   <dc:source>13. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545-55.</dc:source>
   <dc:source>14. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128.</dc:source>
   <dc:source>15. Moylett EH. PP. Respiratory syncytial virus infection: diagnosis, treatment and prevention. Hosp Med. 1999;35:10-7.</dc:source>
   <dc:source>16. Centers for Disease C, Prevention. Respiratory syncytial virus activity--United States, 1999-2000 season. MMWR Morb Mortal Wkly Rep. 2000;49(48):1091-3.</dc:source>
   <dc:source>17. Staat MA, Henrickson K, Elhefni H, Groothuis J, Makari D. Prevalence of respiratory syncytial virus-associated lower respiratory infection and apnea in infants presenting to the emergency department. Pediatr Infect Dis J. 2013;32(8):911-4.</dc:source>
   <dc:source>18. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol. 2007;20(1):108-19.</dc:source>
   <dc:source>19. Hoffman SJ, Laham FR, Polack FP. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect. 2004;6(8):767-72.</dc:source>
   <dc:source>20. Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, James PD, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child. 1994;71(5):428-32.</dc:source>
   <dc:source>21. Fishaut M, Tubergen D, McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr. 1980;96(2):179-86.</dc:source>
   <dc:source>22. Rohwedder A, Keminer O, Forster J, Schneider K, Schneider E, Werchau H. Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol. 1998;54(4):320-7.</dc:source>
   <dc:source>23. Welliver RC, Garofalo RP, Ogra PL. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J. 2002;21(5):457-61.</dc:source>
   <dc:source>24. Agarwal S, Cunningham-Rundles C. Assessment and clinical interpretation of reduced IgG values. Ann Allergy Asthma Immunol. 2007;99(3):281-3.</dc:source>
   <dc:source>25. Fisher RG, Gruber WC, Edwards KM, Reed GW, Tollefson SJ, Thompson JM, et al. Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics. 1997;99(2):E7.</dc:source>
   <dc:source>26. Jolliff CR, Cost KM, Stivrins PC, Grossman PP, Nolte CR, Franco SM, et al. Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin Chem. 1982;28(1):126-8.</dc:source>
   <dc:source>27. El Saleeby CM, Suzich J, Conley ME, DeVincenzo JP. Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation. Clin Infect Dis. 2004;39(2):e17-20</dc:source>
   <dc:source>28. Stagliano DR, Nylund CM, Eide MB, Eberly MD. Children with Down syndrome are high-risk for severe respiratory syncytial virus disease. J Pediatr. 2015;166(3):703-9 e2.</dc:source>
   <dc:source>29. Hoebee B, Rietveld E, Bont L, Oosten M, Hodemaekers HM, Nagelkerke NJ, et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis. 2003;187(1):2-11.</dc:source>
   <dc:source>30. Puthothu B, Krueger M, Forster J, Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis. 2006;193(3):438-41.</dc:source>
   <dc:source>31. Lofgren J, Ramet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis. 2002;185(3):283-9.</dc:source>
   <dc:source>32. Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis. 2004;189(11):2057-63.</dc:source>
   <dc:source>33. Amanatidou V, Sourvinos G, Apostolakis S, Tsilimigaki A, Spandidos DA. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 2006;25(5):410-4.</dc:source>
   <dc:source>34. Henderson FW, Collier AM, Clyde WA, Jr., Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979;300(10):530-4.</dc:source>
   <dc:source>35. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98(5):708-15.</dc:source>
   <dc:source>36. Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EA. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr. 2009;154(2):296-8.</dc:source>
   <dc:source>37. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543-6.</dc:source>
   <dc:source>38. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001;33(6):792-6.</dc:source>
   <dc:source>39. Lindgren C, Jing L, Graham B, Grogaard J, Sundell H. Respiratory syncytial virus infection reinforces reflex apnea in young lambs. Pediatr Res. 1992;31(4 Pt 1):381-5.</dc:source>
   <dc:source>40. Uren EC, Williams AL, Jack I, Rees JW. Association of respiratory virus infections with sudden infant death syndrome. Med J Aust. 1980;1(9):417-9.</dc:source>
   <dc:source>41. Levine DA, Platt SL, Dayan PS, Macias CG, Zorc JJ, Krief W, et al. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004;113(6):1728-34.</dc:source>
   <dc:source>42. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541-5.</dc:source>
   <dc:source>43. Regnier SA, Huels J. Association between respiratory syncytial virus hospitalizations in infants and respiratory sequelae: systematic review and meta-analysis. Pediatr Infect Dis J. 2013;32(8):820-6.</dc:source>
   <dc:source>44. Backman K, Piippo-Savolainen E, Ollikainen H, Koskela H, Korppi M. Adults face increased asthma risk after infant RSV bronchiolitis and reduced respiratory health-related quality of life after RSV pneumonia. Acta Paediatr. 2014;103(8):850-5.</dc:source>
   <dc:source>45. Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003;143(5 Suppl):S112-7.</dc:source>
   <dc:source>46. Giubergia V, Martinchuk G, Moreno N, Colombres G, Parra L, Viale D, et al. Gravedad de la infección por virus sincicial respiratorio en pacientes con factores de riesgo y sin ellos. Archivos argentinos de pediatría. 2004;102:330-4.</dc:source>
   <dc:source>47. Fodha I, Vabret A, Ghedira L, Seboui H, Chouchane S, Dewar J, et al. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol. 2007;79(12):1951-8.</dc:source>
   <dc:source>48. Palomino M. LM, Moraga J., Avendaño L., Luis F. Severidad clinica de la infecciòn respiratoria aguda baja primaria por virus respiratorio sincicial grupos A y B Rev chil pediatr [Internet]. 2004 feb 2016; 75:[18-24 pp.].</dc:source>
   <dc:source>49. Zhang Y, Yuan L, Zhang Y, Zhang X, Zheng M, Kyaw MH. Burden of respiratory syncytial virus infections in China: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020417.</dc:source>
   <dc:source>50. Kho N, Kerrigan JF, Tong T, Browne R, Knilans J. Respiratory syncytial virus infection and neurologic abnormalities: retrospective cohort study. J Child Neurol. 2004;19(11):859-64.</dc:source>
   <dc:source>51. Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol. 2005;32(5):307-10.</dc:source>
   <dc:source>52. Hirayama K, Sakazaki H, Murakami S, Yonezawa S, Fujimoto K, Seto T, et al. Sequential MRI, SPECT and PET in respiratory syncytial virus encephalitis. Pediatr Radiol. 1999;29(4):282-6.</dc:source>
   <dc:source>53. Hanna S, Tibby SM, Durward A, Murdoch IA. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr. 2003;92(4):430-4.</dc:source>
   <dc:source>54. van Steensel-Moll HA, Hazelzet JA, van der Voort E, Neijens HJ, Hackeng WH. Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus. Arch Dis Child. 1990;65(11):1237-9.</dc:source>
   <dc:source>55. Tasker RC, Roe MF, Bloxham DM, White DK, Ross-Russell RI, O'Donnell DR. The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy. Intensive Care Med. 2004;30(12):2257-62.</dc:source>
   <dc:source>56. Fujishima H, Okamoto Y, Saito I, Tsubota K. Respiratory syncytial virus and allergic conjunctivitis. J Allergy Clin Immunol. 1995;95(3):663-7.</dc:source>
   <dc:source>57. Englund JA, Piedra PA, Jewell A, Patel K, Baxter BB, Whimbey E. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol. 1996;34(7):1649-53.</dc:source>
   <dc:source>58. Chartrand C, Tremblay N, Renaud C, Papenburg J. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J Clin Microbiol. 2015;53(12):3738-49.</dc:source>
   <dc:source>59. Puppe W, Weigl JA, Aron G, Grondahl B, Schmitt HJ, Niesters HG, et al. Evaluation of a multiplex reverse transcriptase PCR ELISA for the detection of nine respiratory tract pathogens. J Clin Virol. 2004;30(2):165-74.</dc:source>
   <dc:source>60. Willson DF, Jiao JH, Hendley JO, Donowitz L. Invasive monitoring in infants with respiratory syncytial virus infection. J Pediatr. 1996;128(3):357-62.</dc:source>
   <dc:source>61. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344(25):1917-28.</dc:source>
   <dc:source>62. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review. Crit Care. 2006;10(4):R107.</dc:source>
   <dc:source>63. Reyes MA, Duque GA, Quevedo FL. Neumología Pediátrica. Infección, alergia y enfermedad respiratoria en el niño: Editorial Medica Panamericana Sa de; 2006.</dc:source>
   <dc:source>64. Salud OMdl. Plan de acciòn estratègico de la OMS para la gripe pandèmica. Ginebra2006.</dc:source>
   <dc:source>65. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. The Lancet. 2010;375(9725):1545-55.</dc:source>
   <dc:source>66. Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JP. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatric Critical Care Medicine. 2001;2(4):318-23.</dc:source>
   <dc:source>67. Straliotto SM, Siqueira MM, Machado V, Maia TMR. Respiratory viruses in the pediatric intensive care unit: prevalence and clinical aspects. Memórias do Instituto Oswaldo Cruz. 2004;99(8):883-7.</dc:source>
   <dc:source>68. Bello O, Langenhin M, Pujadas M, Mateo S, Chiparelli H. Infecciones graves por virus respiratorio sincicial en lactantes menores de tres meses: Incidencia en pacientes sin factores de riesgo clásicos. Archivos de Pediatría del Uruguay. 2001;72:S20-S5.</dc:source>
   <dc:source>69. Herrera-Rodríguez DH, De la Hoz F, Mariño C, Ramírez E. Virus Respiratorios en Menores de Diez Años con Infección Respiratoria en el Hospital Militar Central de Bogotá. Revista de Salud Pública. 2007;9(4):576-86.</dc:source>
   <dc:source>70. Welliver Sr RC. Temperature, humidity, and ultraviolet B radiation predict community respiratory syncytial virus activity. The Pediatric infectious disease journal. 2007;26(11):S29-S35.</dc:source>
   <dc:source>71. Secretaría Distrital de Salud de Bogotá. Boletín informativo distrital de impactos en la salud de los eventos climáticos extremos asociados a variabilidad climática. Bogotá, Colombia. [Internet]. 2015. [Citado 30 de junio de 2015]; 66:1-11 . Disponible en:http://biblioteca.saludcapital.gov.co/img_upload/57c59a889ca266ee6533c26f970cb14a/ Boletin Abr_15.pdf.</dc:source>
   <dc:source>72. Arruvito L, Raiden S, Geffner J. Host response to respiratory syncytial virus infection. Current opinion in infectious diseases. 2015;28(3):259-66.</dc:source>
   <dc:source>73. Lacroix-Desmazes S, Bayry J, Kaveri SV, Hayon-Sonsino D, Thorenoor N, Charpentier J, et al. High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(11):4109-13.</dc:source>
   <dc:source>74. Bermejo‐Martín JF, Rodriguez‐Fernandez A, Herrán‐Monge R, Andaluz‐Ojeda D, Muriel‐Bombín A, Merino P, et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. Journal of internal medicine. 2014;276(4):404-12.</dc:source>
   <dc:source>75. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandía F, et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care. 2011;15(5):R243.</dc:source>
   <dc:source>76. Tamayo E, Fernández A, Almansa R, Carrasco E, Goncalves L, Heredia M, et al. Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock. Journal of critical care. 2012;27(6):616-22.</dc:source>
   <dc:source>77. Taccone FS, Stordeur P, De Backer D, Creteur J, Vincent J-L. γ-globulin levels in patients with community-acquired septic shock. Shock. 2009;32(4):379-85.</dc:source>
   <dc:source>78. Venet F, Gebeile R, Bancel J, Guignant C, Poitevin-Later F, Malcus C, et al. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. International immunopharmacology. 2011;11(12):2086-90.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/1653</identifier><datestamp>2021-06-03T00:46:43Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Dosis ideal de relajación neuromuscular: evitar desacondicionamiento físico en niños críticamente enfermos</dc:title>
   <dc:creator>Olier Serra, Tatiana María</dc:creator>
   <dc:contributor>Restrepo Vélez, Nora</dc:contributor>
   <dc:contributor>Ochoa Silva, Cristina</dc:contributor>
   <dc:contributor>Beltrán Rodríguez, Johnny Adalber</dc:contributor>
   <dc:subject>Vecuronio</dc:subject>
   <dc:subject>Desacondicionamiento Físico</dc:subject>
   <dcterms:dateAccepted>2010-02-19T20:48:39Z</dcterms:dateAccepted>
   <dcterms:available>2010-02-19T20:48:39Z</dcterms:available>
   <dcterms:created>2010-02-19T20:48:39Z</dcterms:created>
   <dcterms:issued>2010</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_1653 </dc:identifier>
   <dc:identifier>TEME 0045 2009</dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/1653</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/14192</identifier><datestamp>2021-06-03T00:48:27Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Asociación LACHT con hipoplasia de la vía aérea superior. Caso clínico</dc:title>
   <dc:creator>Ardila Gomez, Iván Jose</dc:creator>
   <dc:contributor>Pardo Carrero, María Rosalba</dc:contributor>
   <dc:contributor>Ruiz Rodriguez, Diana Alejandra</dc:contributor>
   <dc:subject>Asociación Mardini-Nyhan</dc:subject>
   <dc:subject>Asociación LACTH</dc:subject>
   <dc:subject>Agenesia pulmonar</dc:subject>
   <dcterms:abstract>Introduction: The Mardini-Nyhan or LACHT association is a clinical condition of low prevalence that presents with pulmonary, cardiac and limb abnormalities, in which genetic etiology is not clearly documented to date. Objective: To describe the case of a 4-month-old child and the literature review of cases reported on this association, with the purpose of exposing the alterations found and thus guide the early diagnosis of this entity. Clinical case: 4 months old girl, who admitted to intensive care in mixed respiratory failure, with pulmonary, cardiac and limb disorders that meet criteria for LACHT association, additionally documents hypoplasia of the upper airway, which worsens the evolution, increases the difficulty in mechanical ventilation and favors the fatal outcome at 7 days of hospitalization. Conclusions: LACTH association is a rare pathology in which the clinical findings make it&#xd;
possible to suspect the diagnosis, this is the first case diagnosed in the Americas and the number 11 case in the world literature and brings as a new finding the association with hypoplasia of the upper airway.</dcterms:abstract>
   <dcterms:dateAccepted>2018-01-15T14:34:55Z</dcterms:dateAccepted>
   <dcterms:available>2018-01-15T14:34:55Z</dcterms:available>
   <dcterms:created>2018-01-15T14:34:55Z</dcterms:created>
   <dcterms:issued>2017</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_14192 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/14192</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. 
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. 
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.
--------------------------------------
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Atik T, Torun HO, Cogulu O, Ozkinay F. A new patient with LACHT syndrome (Mardini-Nyhan association). Am J Med Genet Part A. 2015;167(2):400-2. doi:10.1002/ajmg.a.36832.</dc:source>
   <dc:source>Jaiman S, Surampudi K, Gundabattula SR, Nalluri HB. Mardini-Nyhan association (LACHT syndrome) with intrauterine fetal demise. Clin Dysmorphol. 2016;25(1):27-30. doi:10.1097/ MCD.0000000000000103.</dc:source>
   <dc:source>Sawardekar KP. Is there a link between Holt-Oram Syndrome and “Mardini- Nyhan” association? – need for further research. Clin Genet. 2016:1-4. doi:10.1111/cge.12777.</dc:source>
   <dc:source>Hastings R, Harding D, Donaldson A, et al. Mardini-Nyhan Association (Lung Agenesis, Congenital Heart, and Thumb Anomalies): Three New Cases and Possible Recurrence in a Sib-Is There a Distinct Recessive Syndrome? Am J Med Genet. 2009;(November):2838-42. doi:10.1002/ajmg.a.33124.</dc:source>
   <dc:source>Mardini MNW. Agenesis of the lung: report of four patients with unusual anomalies. Chest. 1985;87(4):522-7. doi:10.1378/chest.87.4.522.</dc:source>
   <dc:source>Kayemba-kay S, Goua V, Podevin G. Case Report Unilateral Pulmonary Agenesis: A Report of Four Cases , Two Diagnosed Antenatally and Literature Review. Pediatr Pulmonol. 2014;102(October 2013):96- 102. doi:10.1002/ppul.22920</dc:source>
   <dc:source>Xie L, Zhao J, Shen J. Clinical diagnostic approach to congenital agenesis of right lung with dextrocardia: a case report with review of literature. Clin Respir J. 2015:1- 4. doi:10.1111/crj.12282.</dc:source>
   <dc:source>Tansir G, Sasmal G, Dixit J, Sahoo R. Left Pulmonary Agenesis with Right Lung Bronchiectasis in an Adult. J Clin Diagnostic Res. 2016;10(9):15-17. doi:10.7860/JCDR/2016/21623.8547.</dc:source>
   <dc:source>He H, Sun F, Ren W, Ph D, Wang Y, Xu S. Diagnostic Value of Echocardiography in Isolated Congenital Unilateral Lung Agenesis Combined with Different Anomalies: Two Rare Cases in Children. J Clin ultrasound. 2016;0(0):1- 4. doi:10.1002/jcu.22340</dc:source>
   <dc:source>Vanessa P, Dinamarco V, Cilento C. Pulmonary agenesis and respiratory failure in childhood. Autops Case Reports. 2015;5(1):29-32.</dc:source>
   <dc:source>De A. Agenesis of the Lung-a Rare Congenital Anomaly of the Lung. Acta Med Iran. 2012;51(Figure 2): 2011-4.</dc:source>
   <dc:source>Hentati A, Neifar C, Abid W, Sameh M. Case Report Left lung agenesis discovered by a spontaneous pneumothorax in a 20‑year‑old girl. Lung india. 2016:205-7. doi:10.4103/0970-2113.177443.</dc:source>
   <dc:source>Yu Y, Zhu C, Qian X, Gao Y, Zhang Z. Adult patient with pulmonary agenesis: focusing on one-lung ventilation during general anesthesia. J Thorac Dis. 2016;8(1):124-9. doi:10.3978/j.issn.2072- 1439.2016.01.23.</dc:source>
   <dc:source>Nandan D, Bhatt GC, Dewan V, Pongener I. Complete Right Lung Agenesis with Dextrocardia : An Unusual Cause of Respiratory Distress. J Clin Imaging Sci. 2016;2(4):6-8. doi:10.4103/2156- 7514.105140</dc:source>
   <dc:source>Nguyen LN, Parks WT. Bilateral Pulmonary Agenesis : A Rare and Unexpected Finding in a Newborn. Am J Perinatol Rep. 2016;1(212):246-9.</dc:source>
   <dc:source>Malcon MC, Malcon CM, Cavada MN, Eduardo P, Caruso M, Real LF. Agenesia pulmonar unilateral. Relato de Caso. J Bras Pneumol. 2012;38(4):526-9.</dc:source>
   <dc:source>Sumsam M, Khurram A, Rao SP, Vamshipriya A. Pulmonary agenesis : A case report with review of literature. Qatar Med J. 2013;2013:38-40.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/47598</identifier><datestamp>2026-03-04T03:03:04Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Uso de una herramienta de valoración sistemática de lectura de radiografía de tórax en estudiantes de último año de medicina de la Universidad de los Andes en rotación clínica en la  Fundación Santa Fe de Bogotá entre septiembre de 2024 y abril de 2025</dc:title>
   <dc:creator>Solano Rivera, Andrés Camilo</dc:creator>
   <dc:creator>Hernández Aranda, Jorge Mario</dc:creator>
   <dc:contributor>Yepes Velasco, Andrés Felipe</dc:contributor>
   <dc:contributor>Carrizosa, Jorge Armando</dc:contributor>
   <dc:subject>Radiografía de tórax</dc:subject>
   <dc:subject>Educación en cuidado crítico</dc:subject>
   <dc:subject>Enseñanza entre pares</dc:subject>
   <dc:subject>Estudiantes  de medicina</dc:subject>
   <dc:subject>Aprendizaje guiado por listas de verificación</dc:subject>
   <dc:subject>Habilidades de interpretación</dc:subject>
   <dcterms:abstract>Background: Chest radiography remains a cornerstone in the evaluation and daily management of critically ill patients. However, accurate interpretation continues to challenge trainees due to overlapping structures, variable image quality, and frequent perceptual errors. Near-peer teaching and structured checklists have shown potential to improve diagnostic accuracy, yet few randomized studies have evaluated their combined educational impact. Objective: To assess the effectiveness of a resident-led, checklist-guided educational intervention in improving systematic chest radiograph (CXR) interpretation among final-year medical students. Methods: A randomized educational trial was conducted between September 2024 and April 2025 at Universidad de los Andes (Bogotá, Colombia). All participants attended a standardized lecture on CXR interpretation led by intensive care residents. Students were then randomized into two groups: a control group (lecture-only) and an experimental group (lecture plus checklist-guided training). Performance was measured through a 16-item online test (8 interpretation, 8 diagnosis questions). Scores were compared using nonparametric tests, and internal consistency was assessed with Cronbach’s alpha. Results: Fifty students completed the study. The experimental group achieved significantly higher median scores across all domains: interpretation (6 vs. 3; p&lt;0.05), diagnosis (4 vs. 3; p&lt;0.05), and total score (10 vs. 6; p&lt;0.05). Strong correlations were observed between interpretation and total scores (ρ=0.78, p&lt;0.01) and between diagnosis and total scores (ρ=0.69, p&lt;0.01). Internal consistency was moderate (α=0.59). Nine items demonstrated excellent discrimination (D≥0.40). Conclusions: A brief, resident-led, checklist-guided intervention significantly enhanced CXR interpretation performance in senior medical students. This near-peer model provides a low-cost, feasible, and scalable approach to strengthen perceptual and analytical skills essential for critical care training. While interpretation improved markedly, diagnostic integration remained limited, suggesting the need for complementary strategies linking perceptual findings with clinical reasoning.</dcterms:abstract>
   <dcterms:dateAccepted>2026-03-03T22:38:09Z</dcterms:dateAccepted>
   <dcterms:available>2026-03-03T22:38:09Z</dcterms:available>
   <dcterms:created>2026-03-03T22:38:09Z</dcterms:created>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_47598</dc:identifier>
   <dc:identifier>https://repository.urosario.edu.co/handle/10336/47598</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud</dc:publisher>
   <dc:publisher>Especialización en Medicina Crítica y Cuidado Intensivo</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/20167</identifier><datestamp>2025-08-06T15:28:56Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Asociación entre uso de soluciones balanceadas y lesión renal durante la reanimación hídrica en niños con sepsis</dc:title>
   <dc:creator>Alcalá Lozano, Silvia Catalina</dc:creator>
   <dc:creator>Erazo Vargas, Sofia Camila</dc:creator>
   <dc:creator>Gómez Cortes, Laura Bibiana</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:contributor>Reyes Casas, Martha Cecilia</dc:contributor>
   <dc:subject>Sepsis severa</dc:subject>
   <dc:subject>Solución balanceada</dc:subject>
   <dc:subject>Aacidosis metabólica</dc:subject>
   <dc:subject>Hipercloremia</dc:subject>
   <dc:subject>Lesión renal</dc:subject>
   <dc:subject>Niños</dc:subject>
   <dcterms:abstract>Objective. To establish the association between the administration of balanced an unbalanced crystalloid with different results such as acute kidney injury, metabolic acidosis and hyperchloremia, in children with severe sepsis and septic shock hospitalized in the PICU and in the cardiovascular PICU of the Fundación CardioInfantil. Type of study. Retrospective observational cohort. Patients. A cohort of patients from 1 month to 17 years of age, with severe sepsis and septic shock, who are hospitalized in the PICU and in the C-PICU of the Fundación CardioInfantil, from April 1/2018 to April 30/2019, and that received balanced and unbalanced crystalloids for hemodynamic stabilization, was collected. The association between the crystalloid type (balanced and unbalanced) and different outcome (acute kidney injury metabolic acidosis and hyperchloremia) was evaluated. Interventions. None. Results. Of 1074 patients hospitalized in the PICU and the C-PICU in the observation period, were included 103 patients with severe sepsis and septic shock, with an average age of 15 months old and a greater percentage of males. The mean length of stay in the PICU was 7.5 days. The most frequent infections were the respiratory, and secondly, the gastrointestinal ones (54.4% and 24.3%, respectively). It was found that 47.2% of patients who received unbalanced crystalloids developed acute renal injury (p&lt;0.003), and of them, 16.7% required extracorporeal renal support (p&lt;0.002). The mortality to the day 28 was significantly lower (7.6% vs 25.7%; p=0.02 respectively). There were no differences in the development of metabolic acidosis (p=0.84) and hyperchloremia (p=0.12) between the groups. Conclusion. The administration of balanced crystalloids was associated with a lower rate of acute kidney injury in children with severe sepsis and septic shock, and secondly, with a lower need for extracorporeal renal support and mortality rate.</dcterms:abstract>
   <dcterms:dateAccepted>2019-08-27T12:26:26Z</dcterms:dateAccepted>
   <dcterms:available>2019-08-27T12:26:26Z</dcterms:available>
   <dcterms:created>2019-08-27T12:26:26Z</dcterms:created>
   <dcterms:issued>2018</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_20167 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/20167</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Prusakowski MK, Chen AP. Pediatric Sepsis. Emerg Med Clin North Am. 2017;35(1):123–38.</dc:source>
   <dc:source>Kawasaki T. Update on pediatric sepsis: A review. J Intensive Care. 2017;5(47):1–12.</dc:source>
   <dc:source>Guillén Cánovas AM, Esquijarosa Roque BM, Bejerano Pérez N, Álvarez Reinoso S, Gonzáles Ungo EL. Proyección hospitalaria a la comunidad: repercusión en la morbilidad y mortalidad por sepsis. Rev Ciencias Médicas Pinar del Río. 2013;17(6):15–25.</dc:source>
   <dc:source>Engel C, Brunkhorst FM, Bone H-G, Brunkhorst R, Gerlach H, Grond S, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007;33(4):606–18.</dc:source>
   <dc:source>Wang H, Coates MM, Coggeshall M, Dandona L, Fraser M, Fullman N, et al. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1725–74.</dc:source>
   <dc:source>Organización Mundial de la Salud. Estadísticas Sanitarias Mundiales 2011 [Internet] . Organización Mundial de la Salud; 2011. Disponible en: http://www.who.int/whosis/whostat/ES_WHS2011_Full.pdf.</dc:source>
   <dc:source>Organización Mundial de la Salud. Mejora de la prevención, el diagnóstico y la atención clínica de la septicemia [Internet]. Organización Mundial de la Salud; 2017. Disponible en: http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_12-sp.pdf</dc:source>
   <dc:source>Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006;34(2):344–53.</dc:source>
   <dc:source>Organización Panamericana de la Salud. Informe final sobre los Objetivos de Desarrollo del Milenio relacionados con la salud en la Región de las Américas [Internet]. Organización Panamericana de la Salud; 2017. Disponible en: http://iris.paho.org/xmlui/bitstream/handle/123456789/34114/9789275118782_spa.pdf?sequence=5&amp;isAllowed=y</dc:source>
   <dc:source>Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet. 2003;362(9379):192–7.</dc:source>
   <dc:source>Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147–57.</dc:source>
   <dc:source>Jaramillo-Bustamante JC, Marín-Agudelo A, Fernández-Laverde M, Bareño-Silva J. Epidemiology of sepsis in pediatric intensive care units: First Colombian Multicenter Study. Pediatr Crit Care Med. 2012;13(5):501–8.</dc:source>
   <dc:source>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; 43(3):304-377.</dc:source>
   <dc:source>Freitas ERFS. Profile and severity of the patients of intensive care units: prospective application of the APACHE II index. Rev Lat Am Enfermagem. 2010;18(3):317–23.</dc:source>
   <dc:source>Bahl R, Martines J, Ali N, Bhan MK, Carlo W, Chan KY, et al. Research priorities to reduce global mortality from newborn infections by 2015. Pediatr Infect Dis J. 2009;28(1):43–8.</dc:source>
   <dc:source>Emrath ET, Fortenberry JD, Travers C, McCracken CE, Hebbar KB. Resuscitation with Balanced Fluids Is Associated with Improved Survival in Pediatric Severe Sepsis. Crit Care Med. 2017;45(7):1177–83.</dc:source>
   <dc:source>Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695–701.</dc:source>
   <dc:source>Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1): 2-8.</dc:source>
   <dc:source>Remick DG. Pathophysiology of sepsis. Am J Pathol. 2007; 170(5):1435–44.</dc:source>
   <dc:source>Carcillo JA, Podd B, Aneja R, Weiss SL, Hall MW, Cornell TT, et al. Pathophysiology of pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med. 2017;18(3):32–45.</dc:source>
   <dc:source>Kissoon N, Uyeki TM. Sepsis and the Global Burden of Disease in Children. JAMA Pediatr. 2016; 170(2):107-8.</dc:source>
   <dc:source>Regueira T, Andresen M, Mercado M, Downey P. Physiopathology of acute renal failure during sepsis. Med Intensiva. 2011;35(7):424–32.</dc:source>
   <dc:source>Piton G, Belon F, Cypriani B, Regnard J, Puyraveau M, Manzon C, et al. Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality. Crit Care Med. 2013;41(9):2169–76.</dc:source>
   <dc:source>Vincent JL, Orbegozo Cortés D, Acheampong A. Current haemodynamic management of septic shock. Press Medicale. 2016;45(4):99–103.</dc:source>
   <dc:source>Silva JM, Oliveira AMRR, de Morais SZ, de Araújo LS, Victoria LGF, Marubayashi LY. Influence of central venous oxygen saturation on in-hospital mortality of surgical patients. Rev Bras Anestesiol. 2010;60(6):593–602, 329–34.</dc:source>
   <dc:source>Fernández-sarmiento J, Carcillo JA, Salinas CM, Galvis EF, López PA, Jagua-gualdrón A. Effect of a Sepsis Educational Intervention on Hospital Stay. 2018; 19(6):321-328.</dc:source>
   <dc:source>Hanna W, Wong HR. Pediatric Sepsis: Challenges and Adjunctive Therapies. Crit Care Clin. 2013;29(2):203–22.</dc:source>
   <dc:source>Hartmann AF, Senn MJ. Studies in the metabolism of sodium r-Lactate. Response of normal human subjects to the intravenous injection of sodium r-Lactate. J Clin Invest. 1932;11(2):327–335.</dc:source>
   <dc:source>Lee JA. Sydney Ringer (1834–1910) and Alexis Hartmann (1898–1964). Anaesthesia. 1981;36(12):1115–21.</dc:source>
   <dc:source>Chua HR, Venkatesh B, Stachowski E, Schneider AG, Perkins K, Ladanyi S, et al. Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care. 2012;27(2):138–45.</dc:source>
   <dc:source>Hoorn EJ. Intravenous fluids: balancing solutions. J Nephrol. 2017;30(4):485–92.</dc:source>
   <dc:source>Mendes PV, Zampieri FG, Park M. Is There a Role for Balanced Solutions in Septic Patients?. Shock. 2017;47(1):30–4.</dc:source>
   <dc:source>De Backer D, Cortés DO. Characteristics of fluids used for intravascular volume replacement. Best Pract Res Clin Anaesthesiol. 2012;26(4):441–51.</dc:source>
   <dc:source>Zampieri FG, Azevedo LCP, Corrêa TD, Falavigna M, Machado FR, De Assunção MSC, et al. Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): A factorial randomised trial. Crit Care Resusc. 2017;19(2):175–82.</dc:source>
   <dc:source>Song JW, Shim JK, Kim NY, Jang J, Kwak YL. The effect of 0.9% saline versus plasmalyte on coagulation in patients undergoing lumbar spinal surgery; a randomized controlled trial. Int J Surg. 2015;20:128–34.</dc:source>
   <dc:source>Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr. 2008;27(2):179–88.</dc:source>
   <dc:source>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill Adults. Jama. 2012;308(15):1566.</dc:source>
   <dc:source>Friedman JN, Beck CE, DeGroot J, Geary DF, Sklansky DJ, Freedman SB. Comparison of Isotonic and Hypotonic Intravenous Maintenance Fluids. JAMA Pediatr. 2015;169(5):445-51.</dc:source>
   <dc:source>Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth. 2008;101(2):141–50.</dc:source>
   <dc:source>González-Castro A, Peñasco Martin Y, Ortiz-Lasa M. Reanimación con fluidos: perspectiva actual. Med Clin (Barc). 2016;146(3):128–32.</dc:source>
   <dc:source>Miller DJ. Sydney Ringer; physiological saline, calcium and the contraction of the heart. J Physiol . 2004;555(3):585–7.</dc:source>
   <dc:source>Morgan TJ, Venkatesh B. Designing ‘ Balanced ’ Crystalloids. 2003;5(4):284-91.</dc:source>
   <dc:source>Kim SY, Huh KH, Lee JR, Kim SH, Jeong SH, Choi YS. Comparison of the effects of normal saline versus plasmalyte on acid-base balance during living donor kidney transplantation using the Stewart and base excess methods. Transplant Proc. 2013;45(6):2191–6.</dc:source>
   <dc:source>Weinberg L, Collins N, Mourik VK, Tan C, Bellomo R. Plasma-Lyte 148: A clinical review. World J Crit Care Med . 2016;5(4):235-50.</dc:source>
   <dc:source>Pfortmueller CA, Fleischmann E. Acetate-buffered crystalloid fluids: Current knowledge, a systematic review. J Crit Care. 2016;35:96–104.</dc:source>
   <dc:source>Aksu U, Bezemer R, Yavuz B, Kandil A, Demirci C, Ince C. Balanced vs unbalanced crystalloid resuscitation in a near-fatal model of hemorrhagic shock and the effects on renal oxygenation, oxidative stress, and inflammation. Resuscitation. 2012;83(6):767–73.</dc:source>
   <dc:source>Murthi SB, Wise RM, Weglicki WB, Komarov AM, Kramer JH. Mg-gluconate provides superior protection against postischemic dysfunction and oxidative injury compared to Mg-sulfate. Mol Cell Biochem. 2003;245(1–2):141–8.</dc:source>
   <dc:source>Rochwerg B, Alhazzani W, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, et al. Fluid resuscitation in sepsis: A systematic review and network meta-analysis. Ann Intern Med. 2014;161(5):347–55.</dc:source>
   <dc:source>Stewart PA. Independent and dependent variables of acid-base control. Respir Physiol. 1978;33(1):9–26.</dc:source>
   <dc:source>Fores-Novales B, Diez-Fores  P. Evaluación del equilibrio ácido-base. Aportaciones del método de Stewart. 2016;63(4):212-219.</dc:source>
   <dc:source>Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028–35.</dc:source>
   <dc:source>Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018;378(9):819–28.</dc:source>
   <dc:source>Zampieri FG, Ranzani OT, Azevedo LC, Martins ID, Kellum JA, Libório AB. Lactated Ringer Is Associated with Reduced Mortality and Less Acute Kidney Injury in Critically Ill Patients: A Retrospective Cohort Analysis. Crit Care Med. 2016;44(12):2163–70.</dc:source>
   <dc:source>Van Regenmortel N, Verbrugghe W, Van den Wyngaert T, Jorens PG. Impact of chloride and strong ion difference on ICU and hospital mortality in a mixed intensive care population. Ann Intensive Care. 2016;6:91.</dc:source>
   <dc:source>Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, et al. Balanced crystalloids versus saline in the intensive care unit: The SALT randomized trial. Am J Respir Crit Care Med. 2017;195(10):1362–72.</dc:source>
   <dc:source>Weiss SL, Keele L, Balamuth F, Vendetti N, Ross R, Fitzgerald JC, et al. Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study. J Pediatr . 2017;182:304-310.</dc:source>
   <dc:source>Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40(12):1897–905.</dc:source>
   <dc:source>Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: The SPLIT randomized clinical trial. JAMA . 2015;314(16):1701–10.</dc:source>
   <dc:source>Loflin R, Winters ME. Fluid Resuscitation in Severe Sepsis. Emerg Med Clin North Am . 2017;35(1):59–74.</dc:source>
   <dc:source>Russell JA, Rush B, Boyd J. Pathophysiology of Septic Shock. Crit Care Clin. 2018;34(1):43–61.</dc:source>
   <dc:source>Raghunathan K, Nailer P, Konoske R. What is the ideal crystalloid? Curr Opin Crit Care. 2015;21(4):309–14.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/8784</identifier><datestamp>2021-06-03T00:45:50Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Diferencia venoarterial de Pco2 como predictor de disfunción miocárdica en niños con sepsis severa y choque séptico.</dc:title>
   <dc:creator>Orozco Marun, Rafael Jose</dc:creator>
   <dc:creator>Fernández Sarmiento, Jaime</dc:creator>
   <dc:creator>Morón Duarte, Lina Sofía</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:subject>Sepsis</dc:subject>
   <dc:subject>Cardiomiopatía</dc:subject>
   <dc:subject>Diferencia venoarterial de pCO2</dc:subject>
   <dc:subject>Disfunción miocárdica</dc:subject>
   <dcterms:abstract>Introduction: Sepsis is a major cause of morbidity and mortality in the pediatric population worldwide. It is widely known that low cardiac output is one of the main factors associated with mortality in pediatric sepsis. It has been suggested venoarterial pCO2 difference as predictor of myocardial function in patients with sepsis, however, to date no studies in children have been done to asses it. Objective: The aim of this study was to determine the predictive capacity and operational characteristics of venoarterial pCO2 difference as predictor of myocardial dysfunction in pediatric patients with severe sepsis and septic shock. Methods: In order to achieve the objectives of the study, it was performed a prospective study of diagnostic tests. Echocardiogram and venoarterial pCO2 difference were done to each patient, then the operating characteristics of the venoarterial difference of pCO2 were calculated, to determine its usefulness. Results: 71 patients were included. The median venoarterial pCO2 difference was not significantly higher in patients who had cardiac dysfunction on echocardiography compared with those with no dysfunction. A statistically significant relationship of values from 1. 5 to 2. 1 mmHg, as a negative predictor of myocardial dysfunction with a sensitivity of 100% and a specificity of 88% was found. Conclusions: The difference venoarterial pCO2 is not yet a good predictor of myocardial dysfunction in pediatric patients with severe sepsis and septic shock, even when other biomarkers are within normal limits. More clinical essays are requerided </dcterms:abstract>
   <dcterms:dateAccepted>2014-08-12T13:19:17Z</dcterms:dateAccepted>
   <dcterms:available>2014-08-12T13:19:17Z</dcterms:available>
   <dcterms:created>2014-08-12T13:19:17Z</dcterms:created>
   <dcterms:issued>2014</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_8784 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/8784</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>1.	Moloney-Harmon P. Pediatric Sepsis: The Infection unto Death. Crit Care Nurs Clin N Am 2005; 17: 417 – 429</dc:source>
   <dc:source>2.	Dellinger RP, Levy MM, Carlet JM, Bion J, Parker M, Jaeschke R, Reinhart K, Angus DC, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2008; 36:296–327.</dc:source>
   <dc:source>3.	Carcillo J. Pediatric septic shock and multiple organ failure. Crit Care Clin 2003; 19, 413– 440.</dc:source>
   <dc:source>4.	Pediatric Advanced Life Support. Provider Manual. American Heart Association. 2006.</dc:source>
   <dc:source>5.	Vincent JL.  Intensive Care Medicine Annual Update. Springer. 2009.</dc:source>
   <dc:source>6.	West J. B. Best y Taylor. Bases Fisiológicas de la Práctica Médica. 12da Edición. Editorial Médica Panamericana. 1991</dc:source>
   <dc:source>7.	Gutierreza G, Wulf-Gutierrez M, Reines D. Monitoring oxygen transport and tissue oxygenation. Curr Opin Anaesthesiol 2004; 17:107–117.</dc:source>
   <dc:source>8.	Pinsky M. Hemodynamic monitoring in the intensive care unit.  Clin Chest Med 2003; 24,  549– 560.</dc:source>
   <dc:source>9.	Goldstein B, Giroir B, Randolph A and the Members of the International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2–8.</dc:source>
   <dc:source>10.	Valle´e F,  Vallet B,  Mathe O,  Parraguette J,  Mari A, Silva S, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med 2008; 34:2218–2225</dc:source>
   <dc:source>11.	Durkin R, Gergits MA, Reed JF 3rd, Fitzgibbons J. The Relationship Between the Arteriovenous Carbon Dioxide Gradient and Cardiac Index. J Crit Care. 1993, 8(4):217-21</dc:source>
   <dc:source>12.	Ho KM, Harding R, Chamberlain. A comparison of central venous-arterial and mixed venous-arterial carbon dioxide tension gradient in circulatory failure.  J.Anaesth Intensive Care. 2007; (5):695-701.</dc:source>
   <dc:source>13.	Furqan M, Hashmat F, Amanullah M, Khan M, Durani HK, Anwar-ul-Haque. Venoarterial PCO2 difference: a marker of postoperative cardiac output in children with congenital heart disease. J Coll Physicians Surg Pak. 2009; 19(10):640-3.</dc:source>
   <dc:source>14.	Carcillo J, Han K, Lin J, MD, Orr R. Goal-Directed Management of Pediatric Shock in the Emergency Department. Clin Ped Emerg Med 2007; (8)165-175.</dc:source>
   <dc:source>15.	Ortegón L, Fernández J. Impacto  de  la  antibioticoterapia   empirica  temprana  en pacientes pediatricos con sepsis  en la unidad de cuidado intensivo pediátrico de la Fundación Cardioinfantil. (Tesis de grado). Premio Arturo Aparicio al mejor trabajo de investigación. Universidad del Rosario; 2009.</dc:source>
   <dc:source>16.	Cuschieri J, Rivers E, Donnino M, Katilius M, Jacobsen G, Nguyen HB, Pamukov N,  Horst NM. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med 2005; (31) 818–822.</dc:source>
   <dc:source>17.	Bakker J, Vincent JL, Gris P, Leon M, Goffernils M, Kahn R. Veno –arterial Carbon Dioxide Gradient in Human Septic SOC. Chest 1992; (101) 509 – 15.</dc:source>
   <dc:source>18.	Nichols, D. Roger's Textbook of Pediatric Intensive Care, 4th Edition. Lippincott Williams &amp; Wilkins. 2008</dc:source>
   <dc:source>19.	Troskot R, Šimurina T, Žižak M, Majstorović K, Marinac I, Mrakovčić-Šutić I. Prognostic Value of Venoarterial Carbon Dioxide Gradient in Patients with Severe Sepsis and Septic Shock. Croat Med J. 2010; 51(6):501-8</dc:source>
   <dc:source>20.	Futiere E, Robin E, Jabaudon M, Guerin R, Petit A, Bazin JE, Constantin JM, Vallet B. Central venous O2 saturation and venous-to arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery. Critical Care 2010; 14 (5):R193</dc:source>
   <dc:source>21.	Silva JM, Ribas A, Lopes J, Ribeiro MH, Nacevicius C, Toledo D, Rezende E, Malbouisson L.  A large Venous-Arterial PCO2 Is Associated with Poor Outcomes in Surgical Patients. Anesthesiol Res Pract. 2011;2011:759792</dc:source>
   <dc:source>22.	Brierley J, Choong K, Cornell T, DeCaen A, Deymann A, Doctor A, Davis A, Duff J, et al. 2007 American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2009; 37:000–000</dc:source>
   <dc:source>23.	Casserly B, Read R, Levy M. Hemodynamic Monitoring in Sepsis. Crit Care Clin 2009; 25 : 803–823</dc:source>
   <dc:source>24.	Ruiz A, Morillo L. Epidemiología Clínica. Investigación Clínica Aplicada. Editorial Médica Panamericana. 2004</dc:source>
   <dc:source>25.	Allen, Hugh D.; Driscoll, David J.; Shaddy, Robert E.; Feltes, Timothy F. Moss and Adam’s Heart Disease in Infants, Children and Adolescents: Including the fetus and Young Adults. 7th Ed. Lippincott Williams &amp; Wilkins. 2008</dc:source>
   <dc:source>26.	Rivers E, Guyen R, Havstad S, Ressler J, Muzzin A,  Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy In The Treatment Of Severe Sepsis And Septic Shock. N Engl J Med 2001;345:1368-77</dc:source>
   <dc:source>27.	Maddirala S, Khan A. Optimizing Hemodynamic  Support in Septic Shock Using Centraland Mixed Venous Oxygen Saturation. Crit Care Clin 2010; 26: 323–333</dc:source>
   <dc:source>28.	Rivers EP, Ander DS, Powell D. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care 2001; 7(3):204-11</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/40754</identifier><datestamp>2023-08-26T03:02:38Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Cambios en la microcirculación asociados al uso de infusiones de Milrinona en niños con choque séptico</dc:title>
   <dc:creator>Sarta Mantilla, Carlos Mauricio</dc:creator>
   <dc:creator>Fernández-Sarmiento, Jaime</dc:creator>
   <dc:creator>Acevedo Sedano, Lorena</dc:creator>
   <dc:creator>Mulett Hoyos, Hernando</dc:creator>
   <dc:contributor>Fernandez-Sarmiento, Jaime</dc:contributor>
   <dc:subject>Choque séptico</dc:subject>
   <dc:subject>Sepsis</dc:subject>
   <dc:subject>Microcirculacion</dc:subject>
   <dc:subject>Milrinone</dc:subject>
   <dc:subject>Endotelio</dc:subject>
   <dcterms:abstract>Objectives:  To evaluate changes in microcirculation (capillary density - blood flow) and the endothelial glycocalyx associated with using milrinone in children with sepsis. Sublingual videomicroscopy was used to assess capillary density (DC4-6 microns and DC7-25 microns), microvascular flow index, and perfused blood region (perfusion boundary region (PBR), inverse parameter of glycocalyx thickness - abnormal > 2.0 microns). The primary outcome was the association between changes in microcirculation and the endothelial glycocalyx related to milrinone use. Design: Prospective cohort study from February 2021 - January 2022. Place: 12-bed pediatric intensive care unit (PICU) in a university hospital. Patients: Children with sepsis/septic shock with and without milrinone infusion. Intervention: None Methods and Main Results: 140 children with a mean age of 2 years (IQR 0.58-12.1) were included. Fifty-eight percent (81/140) of patients received milrinone infusion. The main focus of infection was respiratory (43/140;30.7%). After 24 hours of administering milrinone, it was observed that capillary density (4-6 microns) was maintained only in this group (p&lt;0.01). Children younger than two years who received milrinone had better DC4-6 than older ones (OR 0.33; CI 95% 0.12-0.89;p=0.02). In milrinone patients, capillary blood flow was more homogeneous and capillary recruitment capacity was maintained (p&lt;0.05). Additionally, these children had less endothelial glycocalyx degradation (aOR 0.34 CI 95% 0.11-0.99; p=0.04), which was maintained despite elevated ferritin and C-reactive protein (aOR 0.41; CI 95% 0.18-0.93;p=0.03). The group without milrinone had more organ failure associated with microcirculation dysfunction, glycocalyx degradation (p&lt;0.01) and a lower number of functional recruited capillaries (p&lt;0.01). Elevated PBR was associated with mortality in both groups (p=0.04). Conclusions: in this investigation of children with sepsis, we found that milrinone was associated with changes in microcirculation. We found persistence of capillary recruitment of 4-6 microns after 24 hours of its administration, and maintenance and less heterogeneity of capillary blood flow as well as less degradation of the glycocalyx, particularly in children under two years of age.</dcterms:abstract>
   <dcterms:dateAccepted>2023-08-25T12:29:10Z</dcterms:dateAccepted>
   <dcterms:available>2023-08-25T12:29:10Z</dcterms:available>
   <dcterms:created>2023-08-25T12:29:10Z</dcterms:created>
   <dc:type>bachelorThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_40754 </dc:identifier>
   <dc:identifier>https://repository.urosario.edu.co/handle/10336/40754</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/embargoedAccess</dc:rights>
   <dc:rights>Restringido (Temporalmente bloqueado)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights>
   <dc:rights>Attribution-NonCommercial-ShareAlike 4.0 International</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Weiss SL, Balamuth F, Hensley J, Fitzgerald JC, Bush J, Nadkarni VM, Thomas NJ, Hall M, Muszynski J. The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die. Pediatr Crit Care Med. 2017 Sep;18(9):823-830</dc:source>
   <dc:source>Weiss SL, Peters MJ, Agus MSD, Alhazzani W, Choong K, Flori HR, Inwald DP, Nadel S, Nunnally ME, Schlapbach LJ, Tasker RC, Tissieres P, Kissoon N; Children’s Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children Taskforce. Perspective of the Surviving Sepsis Campaign on the Management of Pediatric Sepsis in the Era of Coronavirus Disease 2019. Pediatr Crit Care Med. 2020 Nov;21(11):e1031-e1037.</dc:source>
   <dc:source>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018 Mar;6(3):223-230.</dc:source>
   <dc:source>De Backer D, Ricottilli F, Ospina-Tascón GA. Septic shock: a microcirculation disease. Curr Opin Anaesthesiol. 2021 Apr 1;34(2):85-91.</dc:source>
   <dc:source>Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019 Jan 17;23(1):16.</dc:source>
   <dc:source>Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016 Jul;280(1):97-113.</dc:source>
   <dc:source>Yajnik V, Maarouf R. Sepsis and the microcirculation: the impact on outcomes. Curr Opin Anaesthesiol. 2022 Apr 1;35(2):230-235.</dc:source>
   <dc:source>Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019 Feb;17(2):283-294</dc:source>
   <dc:source>Walley KR. Sepsis-induced myocardial dysfunction. Curr Opin Crit Care. 2018 Aug;24(4):292-299</dc:source>
   <dc:source>Gelinas JP, Russell JA. Vasopressors During Sepsis: Selection and Targets. Clin Chest Med. 2016 Jun;37(2):251-62</dc:source>
   <dc:source>Liet JM, Jacqueline C, Orsonneau JL, et al. The effects  of milrinone on hemodynamics in an experimental septic shock model. Pediatr Crit Care Med 2005;6:195-9</dc:source>
   <dc:source>Jain S. Sepsis: An Update on Current Practices in Diagnosis and Management. Am J Med Sci. 2018 Sep;356(3):277-286. doi: 10.1016/j.amjms.2018.06.012.</dc:source>
   <dc:source>Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, Singhi SC, Erickson S, Roy JA, Bush JL, Nadkarni VM, Thomas NJ; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57.</dc:source>
   <dc:source>Joffre J, Hellman J, Ince C, Ait-Oufella H. Endothelial Responses in Sepsis. Am J Respir Crit Care Med. 2020 Aug 1;202(3):361-370</dc:source>
   <dc:source>Fernández-Sarmiento J, Carcillo JA, Salinas CM, Galvis EF, López PA, Jagua-Gualdrón A. Effect of a Sepsis Educational Intervention on Hospital Stay. Pediatr Crit Care Med. 2018 Jun;19(6):e321-e328.</dc:source>
   <dc:source>Colbert JF, Schmidt EP. Endothelial and Microcirculatory Function and Dysfunction in Sepsis. Clin Chest Med. 2016 Jun;37(2):263-75. doi: 10.1016/j.ccm.2016.01.009.</dc:source>
   <dc:source>Chanani NK, Cowan DB, Takeuchi K, et al. Differential effects of amrinone and milrinone upon myocardial inflammatory signaling. Circulation 2002;106:I284-9</dc:source>
   <dc:source>Lin JC, Spinella PC, Fitzgerald JC, Tucci M, Bush JL, Nadkarni VM, Thomas NJ, Weiss SL; Sepsis Prevalence, Outcomes, and Therapy Study Investigators. New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality. Pediatr Crit Care Med. 2017 Jan;18(1):8-16.</dc:source>
   <dc:source>Beurskens DM, Bol ME, Delhaas T, van de Poll MC, Reutelingsperger CP, Nicolaes GA, Sels JE. Decreased endothelial glycocalyx thickness is an early predictor of mortality in sepsis. Anaesth Intensive Care. 2020 May;48(3):221-228.</dc:source>
   <dc:source>Rohlenova K, Veys K, Miranda-Santos I, De Bock K, Carmeliet P. Endothelial Cell Metabolism in Health and Disease. Trends Cell Biol. 2018 Mar;28(3):224-236.</dc:source>
   <dc:source>Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017 May;9(5):434-449.</dc:source>
   <dc:source>Büchele GL, Ospina-Tascon GA, De Backer D. How microcirculation data have changed my clinical practice. Curr Opin Crit Care. 2007 Jun;13(3):324-31.</dc:source>
   <dc:source>Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT. Endothelium structure and function in kidney health and disease. Nat Rev Nephrol. 2019 Feb;15(2):87-108.</dc:source>
   <dc:source>Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004 Jul;84(3):869-901.</dc:source>
   <dc:source>Petzelbauer P, Halama T, Gröger M. Endothelial adherens junctions. J Investig Dermatol Symp Proc. 2000 Dec;5(1):10-3.</dc:source>
   <dc:source>Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, Padilla J, Martinez-Lemus L. Endothelial Glycocalyx. Compr Physiol. 2022 Aug 23;12(4):3781-3811.</dc:source>
   <dc:source>Luft JH. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc.</dc:source>
   <dc:source>Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014 Jul;69(7):777-84.</dc:source>
   <dc:source>Jacob M, Chappell D. Reappraising Starling: the physiology of the microcirculation. Curr Opin Crit Care. 2013 Aug;19(4):282-9.</dc:source>
   <dc:source>Pillinger NL, Kam P. Endothelial glycocalyx: basic science and clinical implications. Anaesth Intensive Care. 2017 May;45(3):295-307</dc:source>
   <dc:source>Vink H., Duling B.R. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res 1996; 79: 581–589</dc:source>
   <dc:source>Nieuwdorp M., Meuwese M.C., Mooij H.L., Ince C., Broekhuizen L.N., Kastelein J.J. et al. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol 2008; 104: 845–852</dc:source>
   <dc:source>Reitsma S., Slaaf D.W., Vink H., van Zandvoort M.A., oude Egbrink M.G. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 2007; 454: 345–359</dc:source>
   <dc:source>Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007; 9: 121–167.</dc:source>
   <dc:source>Curry F.E., Adamson R.H. Endothelial glycocalyx: permeability barrier and mechanosensor. Ann Biomed Eng 2012; 40: 828–839.</dc:source>
   <dc:source>van Haaren PM, VanBavel E, Vink H, Spaan JA. Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2848-56.</dc:source>
   <dc:source>Han S, Lee S-J, Kim KE, Lee HS, Oh N, Park I, Ko E, Oh SJ, Lee Y-S, Kim D, Lee S, Lee DH, Lee K-H, Chae SY, Lee J-H, Kim S-J, Kim H-C, Kim S, Kim SH, Kim C, Nakaoka Y, He Y, Augustin HG, Hu J, Song PH, Kim Y-I, Kim P, Kim I, Koh GY. Amelioration of sepsis by TIE2 activation-induced vascular protection. Sci Transl Med. 2016;8:335ra55</dc:source>
   <dc:source>King J, Hamil T, Creighton J, Wu S, Bhat P, McDonald F, Stevens T. Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes. Microvasc Res. 2004 Mar;67(2):139-51.</dc:source>
   <dc:source>Mochizuki S, Takayama A, Sasaki T, Yada T, Endo K, Horike H, Kashihara N, Ogasawara Y, Kajiya F. Clear correlation of tetrahydrobiopterin with nitric oxide bioavailability in continuous ambulatory peritoneal dialysis. Blood Purif. 2010;30(2):96-7.</dc:source>
   <dc:source>Lupu F, Kinasewitz G, Dormer K. The role of endothelial shear stress on haemodynamics, inflammation, coagulation and glycocalyx during sepsis. J Cell Mol Med. 2020 Nov;24(21):12258-12271.</dc:source>
   <dc:source>Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010 Jul 15;87(2):198-210.</dc:source>
   <dc:source>Kudo S, Morigaki R, Saito J, Ikeda M, Oka K, Tanishita K. Shear-stress effect on mitochondrial membrane potential and albumin uptake in cultured endothelial cells. Biochem Biophys Res Commun. 2000 Apr 13;270(2):616-21</dc:source>
   <dc:source>Hellenthal KEM, Brabenec L, Wagner NM. Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation. Cells. 2022 Jun 15;11(12):1935.</dc:source>
   <dc:source>Suzuki A, Tomita H, Okada H. Form follows function: The endothelial glycocalyx. Transl Res. 2022 Sep;247:158-167. doi: 10.1016/j.trsl.2022.03.014.</dc:source>
   <dc:source>Zhao F, Wang R, Huang Y, Li L, Zhong L, Hu Y, Han Z, Fan J, Liu P, Zheng Y, Luo Y. Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke. Front Pharmacol. 2022 Jul 15;13:949290</dc:source>
   <dc:source>Richter RP, Payne GA, Ambalavanan N, Gaggar A, Richter JR. The endothelial glycocalyx in critical illness: A pediatric perspective. Matrix Biol Plus. 2022 Mar 9;14:100106.</dc:source>
   <dc:source>Goligorsky MS, Sun D. Glycocalyx in Endotoxemia and Sepsis. Am J Pathol. 2020 Apr;190(4):791-798</dc:source>
   <dc:source>Annecke T, Fischer J, Hartmann H, Tschoep J, Rehm M, Conzen P, Sommerhoff CP, Becker BF. Shedding of the coronary endothelial glycocalyx: effects of hypoxia/reoxygenation vs ischaemia/reperfusion. Br J Anaesth. 2011 Nov;107(5):679-86</dc:source>
   <dc:source>Suzuki K, Okada H, Sumi K, Tomita H, Kobayashi R, Ishihara T, Mizuno Y, Yamaji F, Kamidani R, Miura T, Yasuda R, Kitagawa Y, Fukuta T, Suzuki K, Miyake T, Kanda N, Doi T, Yoshida T, Yoshida S, Tetsuka N, Ogura S, Suzuki A. Syndecan-1 as a severity biomarker for patients with trauma. Front Med (Lausanne). 2022 Sep 27;9:985955</dc:source>
   <dc:source>Woods A, Couchman JR. Syndecan-4 and focal adhesion function. Curr Opin Cell Biol. 2001 Oct;13(5):578-83.</dc:source>
   <dc:source>Couchman JR, Woods A. Syndecan-4 and integrins: combinatorial signaling in cell adhesion. J Cell Sci. 1999 Oct;112 ( Pt 20):3415-20.</dc:source>
   <dc:source>Li JP, Kusche-Gullberg M. Heparan Sulfate: Biosynthesis, Structure, and Function. Int Rev Cell Mol Biol. 2016;325:215-73.</dc:source>
   <dc:source>Nelson A, Berkestedt I, Bodelsson M. Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol Scand. 2014 Jan;58(1):36-43.</dc:source>
   <dc:source>Fernández-Sarmiento J, Schlapbach LJ, Acevedo L, Santana CR, Acosta Y, Diana A, Monsalve M, Carcillo JA. Endothelial Damage in Sepsis: The Importance of Systems Biology. Front Pediatr. 2022 Mar 9;10:828968.</dc:source>
   <dc:source>Eickhoff MK, Winther SA, Hansen TW, Diaz LJ, Persson F, Rossing P, Frimodt-Møller M. Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions. PLoS One. 2020 Dec 23;15(12):e0243737</dc:source>
   <dc:source>Dubin A, Kanoore Edul VS, Caminos Eguillor JF, Ferrara G. Monitoring Microcirculation: Utility and Barriers - A Point-of-View Review. Vasc Health Risk Manag. 2020 Dec 31;16:577-589.</dc:source>
   <dc:source>Fernández-Sarmiento J, Salazar-Peláez LM, Acevedo L, Niño-Serna LF, Flórez S, Alarcón-Forero L, Mulett H, Gómez L, Villar JC. Endothelial and Glycocalyx Biomarkers in Children With Sepsis After One Bolus of Unbalanced or Balanced Crystalloids. Pediatr Crit Care Med. 2023 Mar 1;24(3):213-221</dc:source>
   <dc:source>Rovas A, Seidel LM, Vink H, Pohlkötter T, Pavenstädt H, Ertmer C, Hessler M, Kümpers P. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis. Crit Care. 2019 Jul 24;23(1):260.</dc:source>
   <dc:source>Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci. 2015 Jul;1347:45-51.</dc:source>
   <dc:source>Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006 Feb;12(2):235-9.</dc:source>
   <dc:source>Crowley LC, Marfell BJ, Scott AP, Waterhouse NJ. Quantitation of Apoptosis and Necrosis by Annexin V Binding, Propidium Iodide Uptake, and Flow Cytometry. Cold Spring Harb Protoc. 2016 Nov 1;2016(11).</dc:source>
   <dc:source>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644-55</dc:source>
   <dc:source>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005 Jan;6(1):2-8.</dc:source>
   <dc:source>Fernández-Sarmiento J, De Souza DC, Martinez A, Nieto V, López-Herce J, Soares Lanziotti V, Arias López MDP, De Carvalho WB, Oliveira CF, Jaramillo-Bustamante JC, Díaz F, Yock-Corrales A, Ruvinsky S, Munaico M, Pavlicich V, Iramain R, Márquez MP, González G, Yunge M, Tonial C, Cruces P, Palacio G, Grela C, Slöcker-Barrio M, Campos-Miño S, González-Dambrauskas S, Sánchez-Pinto NL, Celiny García P, Jabornisky R. Latin American Consensus on the Management of Sepsis in Children: Sociedad Latinoamericana de Cuidados Intensivos Pediátricos [Latin American Pediatric Intensive Care Society] (SLACIP) Task Force: Executive Summary. J Intensive Care Med. 2022 Jun;37(6):753-763</dc:source>
   <dc:source>Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106.</dc:source>
   <dc:source>Hilarius KWE, Skippen PW, Kissoon N. Early Recognition and Emergency Treatment of Sepsis and Septic Shock in Children. Pediatr Emerg Care. 2020 Feb;36(2):101-106</dc:source>
   <dc:source>Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016 May 23;353:i1585.</dc:source>
   <dc:source>Carcillo JA, Halstead ES, Hall MW, Nguyen TC, Reeder R, Aneja R, Shakoory B, Simon D; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network Investigators. Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome. Pediatr Crit Care Med. 2017 Jun;18(6):513-523.</dc:source>
   <dc:source>Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am. 2020 Jul;104(4):573-585</dc:source>
   <dc:source>van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017 Jul;17(7):407-420.</dc:source>
   <dc:source>Kudo D, Goto T, Uchimido R, Hayakawa M, Yamakawa K, Abe T, Shiraishi A, Kushimoto S. Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies. Crit Care. 2021 Mar 19;25(1):114</dc:source>
   <dc:source>Diehl JL, Borgel D. Sepsis and coagulation. Curr Opin Crit Care. 2005 Oct;11(5):454-60.</dc:source>
   <dc:source>Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. 1991 Sep 4;266(9):1242-5. PMID: 1870250</dc:source>
   <dc:source>Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011 Jun 30;364(26):2483-95</dc:source>
   <dc:source>Maitland K, Gibb DM, Babiker A; FEAST trial team. Secondary re-analysis of the FEAST trial. Lancet Respir Med. 2019 Oct;7(10):e29.</dc:source>
   <dc:source>Martin GS, Bassett P. Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: A systematic review and meta-analysis. J Crit Care. 2019 Apr;50:144-154.</dc:source>
   <dc:source>Sankar J, Ismail J, Sankar MJ, C P S, Meena RS. Fluid Bolus Over 15-20 Versus 5-10 Minutes Each in the First Hour of Resuscitation in Children With Septic Shock: A Randomized Controlled Trial. Pediatr Crit Care Med. 2017 Oct;18(10):e435-e445.</dc:source>
   <dc:source>Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier JM, Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Hervé F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P; SEPSISPAM Investigators. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014 Apr 24;370(17):1583-93</dc:source>
   <dc:source>De Backer D, Donadello K, Cortes DO. Monitoring the microcirculation. J Clin Monit Comput. 2012 Oct;26(5):361-6.</dc:source>
   <dc:source>Kara A, Akin S, Ince C. Monitoring microcirculation in critical illness. Curr Opin Crit Care. 2016 Oct;22(5):444-52.</dc:source>
   <dc:source>Koster G, Bekema HJ, Wetterslev J, Gluud C, Keus F, van der Horst IC. Milrinone for cardiac dysfunction in critically ill adult patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med. 2016 Sep;42(9):1322-35</dc:source>
   <dc:source>Kakihana Y, Ito T, Nakahara M, Yamaguchi K, Yasuda T. Sepsis-induced myocardial dysfunction: pathophysiology and management. J Intensive Care. 2016 Mar 23;4:22.</dc:source>
   <dc:source>Tomicic V; Zouein L; Iribarren G; Arenas A; Rol de la milrinona en el tratamiento del shock séptico; Rev Chil Med Intensiv 2021; 36(2): 61-71.</dc:source>
   <dc:source>Rich N, West N, McMaster P, Alexander J. Milrinone in meningococcal sepsis. Pediatr Crit Care Med. 2003 Jul;4(3):394-5.</dc:source>
   <dc:source>Meyer S, Gortner L, Brown K, Abdul-Khaliq H. The role of milrinone in children with cardiovascular compromise: review of the literature. Wien Med Wochenschr. 2011 Apr;161(7-8):184-91.</dc:source>
   <dc:source>Ospina-Tascón GA, Calderón-Tapia LE. Inodilators in septic shock: should these be used? Ann Transl Med. 2020 Jun;8(12):796.</dc:source>
   <dc:source>de Miranda ML, Pereira SJ, Santos AO, Villela NR, Kraemer-Aguiar LG, Bouskela E. Milrinone attenuates arteriolar vasoconstriction and capillary perfusion deficits on endotoxemic hamsters. PLoS One. 2015 Feb 3;10(2):e0117004</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/3744</identifier><datestamp>2021-06-03T00:46:56Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Correlación SO2/FiO2 con PaO2/FiO2 en niños en ventilación mecánica a grandes alturas : estudio multicéntrico</dc:title>
   <dc:creator>González Vélez, Claudia Liliana</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:subject>SDRA</dc:subject>
   <dc:subject>Índices de oxigenación</dc:subject>
   <dc:subject>SO/FiO2</dc:subject>
   <dc:subject>Pa/FiO2</dc:subject>
   <dc:subject>Pediatría</dc:subject>
   <dc:subject>Grandes alturas</dc:subject>
   <dcterms:abstract>Introduction: changes in the PaO2 correlate positively with changes in the SO2 allowing to determine the severity of hypoxemia. The search for a predictor, which in a noninvasive way detects patients with greater lung involvement has been gaining acceptance; establishing levels of moderate or severe hypoxemia as criteria for ALI and ARDS, based on the values of PaO2/FiO2 and its correlation with SO2/FiO2 in adults. The values of SO2/ FiO2 that identify the severity of the hypoxemia in Pediatrics are not known for heights over 2.500 m.a.s.l.&#xd;
Methodology: study of correlation and prediction in patients from one month to 18 years of age admitted to PICU, with mechanical ventilatory support and serial blood gas analysis in two referral hospitals. Analysis of linear relationship and determination of the SOFiO2 and POFiO2 correlation from 430 measurements.&#xd;
Results: the study showed a mean of 192,12 (DS 75.62) for PaO2/FiO2 and a mean of 208,61 (DS 62,79) for SO2/FiO2. The SO2/FiO2 and Pa2/FiO2 correlation was positive and moderately high (r = 0.702; p &lt; 0.01). From the linear regression between the variables was obtained the equation for determining PaO2/FiO2 = (0.92xSO2/FIO2) - 12, with a 76% sensitivity and specificity for detecting severe hypoxemia (SO2/FiO2 &lt;231), and 74% sensitivity and specificity of 71% for moderate hypoxemia (SO2/FiO2 &lt;340).&#xd;
Discussion: the findings obtained are very useful from a clinical point of view to quickly detect patients with moderate and severe hypoxemia, with a potential risk of deterioration, when there is no arterial line or arterial gases.</dcterms:abstract>
   <dcterms:dateAccepted>2012-08-21T18:46:04Z</dcterms:dateAccepted>
   <dcterms:available>2012-08-21T18:46:04Z</dcterms:available>
   <dcterms:created>2012-08-21T18:46:04Z</dcterms:created>
   <dcterms:issued>2012</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_3744 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/3744</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/closedAccess</dc:rights>
   <dc:rights>Bloqueado (Texto referencial)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Acevedo LE, Solarte I. Gasimetría arterial en adultos sanos a nivel de Bogotá. Acta Med Colomb. 1984; 9: 7-14.</dc:source>
   <dc:source>Bernard GR, Artigas A, Brigham, Carlet J, Falke K, Hudson L et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination; the Consensus Committee. Intensive Care Med. 1994; 20:225–32.</dc:source>
   <dc:source>Camargo JP, Gil. Comparación de la razón saturometría de pulso/fracción inspirada de oxígeno (SA/FIO2) y la razón presión arterial de oxígeno/fracción inspirada de oxígeno (PO2/FIO2) en pacientes con insuficiencia respiratoria aguda. Acta Colombiana de Cuidado Intensivo 2011; 11(2): 86-90.</dc:source>
   <dc:source>Donahoe M. Acute respiratory distress syndrome: A clinical review. Pulm Circ. 2011 Apr-Jun; 1(2): 192–211. Doi: 10.4103/2045-8932.83454 PMCID: PMC3198645.</dc:source>
   <dc:source>Fernández RO, Grilli MB, Arjona JC. Correlación saturometría de pulso / Fracción inspirada de oxígeno (SAFIO2) y razón presión arterial de oxígeno / fracción inspirada de oxígeno (PAFIO2) en una población general de pacientes críticos. Revista Hospital Español de Mendoza. Vol XII. No.1. ISSN 1668-9496.</dc:source>
   <dc:source>Freishtat RJ, Mojgani B, Mathison DJ and Chamberlain JM. Toward early identification of acute lung injury in the emergency department. J Investig Med. 2007 December; 55 (8): 423-429</dc:source>
   <dc:source>Fuhrman &amp; Zimmerman: Pediatric Critical Care, 3rd ed. Copyright 2006 Mosby, Inc. MOSBY ELSEVIER. Software medico.</dc:source>
   <dc:source>Guyton AC, Hall JE. Text Book of medical physiology. 11ed. Elsevier Saunders; 2006. P 471-480.</dc:source>
   <dc:source>Hammer J, Newth CJ. Infant lung function testing in the intensive care unit. Intensive care medicine. 1995 sep; 21(9):744-52.</dc:source>
   <dc:source>Hurtado JC, Salazar T, De la Peña M. Valores normales gases arteriales en Bogotá. Umbral científico Bogotá Colombia. 2007; Num10;93-101.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/4618</identifier><datestamp>2021-06-03T00:45:48Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Guía para el diagnóstico, atención integral y seguimiento de asma en niños y niñas</dc:title>
   <dc:creator>Godoy Collazos, Carol Yohanna</dc:creator>
   <dc:creator>Dueñas, Elida</dc:creator>
   <dc:contributor>Velez Van Meerbeke, Alberto Francisco</dc:contributor>
   <dc:subject>Asthma</dc:subject>
   <dc:subject>Bronchial Spasm</dc:subject>
   <dc:subject>Inhaled Corticosteroids</dc:subject>
   <dcterms:dateAccepted>2013-08-12T23:27:47Z</dcterms:dateAccepted>
   <dcterms:available>2013-08-12T23:27:47Z</dcterms:available>
   <dcterms:created>2013-08-12T23:27:47Z</dcterms:created>
   <dcterms:issued>2013</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_4618 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/4618</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Castro-Rodríguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162(4 Pt 1):1403-6.</dc:source>
   <dc:source>Galant SP, Crawford LJ, Morphew T, Jones CA, Bassin S. Predictive value of a cross-cultural asthma case-detection tool in an elementary school population. Pediatrics. 2004;114(3):e307-16.</dc:source>
   <dc:source>Gerald LB, Grad R, Turner-Henson A, Hains C, Tang S, Feinstein R, et al. Validation of a multistage asthma case-detection procedure for elementary school children. Pediatrics. 2004;114(4):e459-68</dc:source>
   <dc:source>Ly NP, Gold DR, Weiss ST, Celedón JC. Recurrent wheeze in early childhood and asthma among children at risk for atopy. Pediatrics. 2006;117(6):e1132-8</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/14419</identifier><datestamp>2021-06-03T00:48:09Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Adaptación transcultural y validación psicométrica de la escala de Sedacion Comfort (Comfort Scale)</dc:title>
   <dc:creator>Leonor Alexandra, Monroy Cordoba</dc:creator>
   <dc:contributor>Pardo Carrero, María Rosalba</dc:contributor>
   <dc:subject>Escala de Sedación</dc:subject>
   <dc:subject>COMFORT</dc:subject>
   <dc:subject>Traducción</dc:subject>
   <dc:subject>Equivalencia Lingüista</dc:subject>
   <dcterms:abstract>Approximately 2% of all children admitted to the hospital require management in the pediatric intensive care unit, and between 20 to 64% (1) requires the use of mechanical ventilation, therefore sedation is very important in order to provide them with well-being , relieve pain, reduce anxiety due to confinement and the presence of unknown persons, prevent discomfort caused by the high level of noise that can alter the sleep pattern and ensure adequate invasive monitoring. (2). In some circumstances, sedation and analgesia have therapeutic use. It should be remembered that high doses of sedation can increase morbidity and even affect the recovery of patients. The management of the critical patient focused on the disease cause of admission makes it tend to use multiple sedative drugs without considering the long-term consequences. This is why it is very important to objectively evaluate sedation goals in order to avoid excessive or deficient use of this, resulting in greater morbidity. The measurement is made by means of scales or instruments designed and validated to evaluate the sedation in intensive care units, based on the observation of clinical signs, allowing systematic sedation assessments, which must be interpreted in a similar way independently of the person of the team of health that uses it. There are multiple sedation scales, the COMFORT sedation scale is the most accepted due to its validity, reliability and ease of application (1); Ambuel and his collaborators (1990) developed the COMFORT Scale to assess the psychological distress of critically ill children; additionally, it was determined that the COMFORT scale is useful in determining whether a child is optimally sedated or not (3). This tool is considered a pain assessment instrument using the behavioral or physiological parameters often associated with pain. This was designed and validated in the United States (1994), has been translated and validated in Porto Alegre Brazil, (4); no validations were found for Spanish language in South America or Colombia. The purpose of this research is to perform the translation or linguistic equivalence of the scale from English to Spanish according to the international standards in force given by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and the validation of the scale in Spanish for Colombia.</dcterms:abstract>
   <dcterms:dateAccepted>2018-02-20T12:05:38Z</dcterms:dateAccepted>
   <dcterms:available>2018-02-20T12:05:38Z</dcterms:available>
   <dcterms:created>2018-02-20T12:05:38Z</dcterms:created>
   <dcterms:issued>2018</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_14419 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/14419</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>Atribución-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. 
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. 
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.
--------------------------------------
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Szumita, P. (2011). Evaluation of a local ICU sedation guideline on goal-directed administration of sedatives and analgesics. Journal of Pain Research, 127. http://doi.org/10.2147/JPR.S18161</dc:source>
   <dc:source>Vigg, A. (2011). Principles and Practice of Sedation in Intensive Care Unit (ICU). Apollo Medicine, 8(1), 13–23. http://doi.org/10.1016/S0976-0016(11)60044-6</dc:source>
   <dc:source>Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., &amp; Erikson, P. (2005). Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 8(2), 94–104. http://doi.org/10.1111/j.1524-4733.2005.04054.x</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/1657</identifier><datestamp>2021-06-03T00:46:57Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Suplementación de hormona tiroidea en pacientes pediátricos críticos con síndrome eutiroideo enfermo</dc:title>
   <dc:creator>Trigos Pallares, Paul Leonardo</dc:creator>
   <dc:contributor>Vega la Rotta, Gonzalo Gonzalo,</dc:contributor>
   <dc:contributor>Beltrán Rodríguez, Johnny Adalber</dc:contributor>
   <dc:subject>Síndrome eutiroideo enfermo</dc:subject>
   <dc:subject>Síndrome de t4 alto</dc:subject>
   <dc:subject>Síndrome de t3 bajo</dc:subject>
   <dcterms:abstract>Background: The Euthyroid Sick Syndrome,  and it has   been considered as predicting factor of poor outcome . And the supplementation of thyroid hormone (T3) improves the myocardial contractility, stimulate the production of pulmonary surfactant. Nevertheless the  hormone supplementation has been objet of  controversy because  the  risk  of secondary complications, lack of hemodynamic effects,   or  hospital stay. Objectives: determine the effect of the oral supplementation of thyroid hormones in critically ill patients with no  response  to  crystalloids reanimation  and need of two inotropic agents with respect to the arrhythmias, hemodynamic stability,  requirements of inotropics, stay in pediatric intensive care,  and mortality associated to the treatment. Methodology: descriptive,  retroprospective of   pediatric patients with refractory shock to cristaloides in the (PICU) Pediatric Intensive Care Unit.  At   Hospital Simon Bolivar of Bogota Colombia from 1 of January of the 2007 to 1 January of the 2009. Results: supplementation  of   thyroid hormone  in  euthyroid  sick  syndrome, is  related with a significative    decrease  in needs  of   adrenergic  agents: dopamine, epinephrine and norepinephrine with rangs of  [4,78-2.4], [3.92 - 2.98] and  [3.58- 2.24] (p &lt;0.001) respectively without difference  in   diuretic, inodilators   and  vasodilators. Conclusion: thyroid hormone administration had a beneficial effect and allowed   decrease   inotropic support   in patients   with   refractory   shock and euthyroid sick syndrome&#xd;
There is not relation between the presence of arrhythmias and the use of hormone thyroid.</dcterms:abstract>
   <dcterms:dateAccepted>2010-02-22T20:43:31Z</dcterms:dateAccepted>
   <dcterms:available>2010-02-22T20:43:31Z</dcterms:available>
   <dcterms:created>2010-02-22T20:43:31Z</dcterms:created>
   <dcterms:issued>2009</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_1657 </dc:identifier>
   <dc:identifier>TEME 0046 2009</dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/1657</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/19042</identifier><datestamp>2025-10-09T14:36:41Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Principales desenlaces clínicos en lactantes con insuficiencia respiratoria aguda tratados con cánula nasal de alto flujo</dc:title>
   <dc:creator>Piracoca Mejia, Jaime</dc:creator>
   <dc:contributor>Pardo, Rosalba</dc:contributor>
   <dc:contributor>Ruiz, Diana</dc:contributor>
   <dc:subject>Canula nasal alto flujo</dc:subject>
   <dc:subject>Oxigenoterapia</dc:subject>
   <dc:subject>Insuficiencia respiratoria aguda</dc:subject>
   <dc:subject>Bronquiolitis</dc:subject>
   <dc:subject>Niños</dc:subject>
   <dcterms:abstract>The High Flow Nasal Cannula (HFNC) is a non-invasive ventilatory modality that is increasingly used in the pediatric population in which benefits are described on oxygenation, ventilation and comfort of the patient through mechanisms of action that have been studied and described in the medical literature, however there is still little evidence regarding the efficacy and safety of the high-flow nasal cannula, so through this study we will generate scientific information and know what the main outcomes of infants are. One month and up to 23 months of age were treated with acute respiratory failure with high flow nasal cannula in the pediatric intensive care unit of the Colsubsidio Children's Clinic between 2016 -2017.</dcterms:abstract>
   <dcterms:dateAccepted>2019-02-12T13:37:01Z</dcterms:dateAccepted>
   <dcterms:available>2019-02-12T13:37:01Z</dcterms:available>
   <dcterms:created>2019-02-12T13:37:01Z</dcterms:created>
   <dcterms:issued>2019</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_19042 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/19042</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud </dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>1.	BE de Jongh. Work of breathing indices in infants with respiratory insufficiency receiving high-flow nasal cannula and nasal continuous positive airway pressure. J Perinatol. 34(1): 27–32. http://dx.doi.org/10.1038/jp.2013.120 (August 22, 2014).</dc:source>
   <dc:source>2.	Wegner A. A, et al. Cánula nasal de alto flujo en lactantes: experiencia en una unidad de paciente crítico. Revista Chilena de Pediatría. http://dx.doi.org/10.1016/j.rchipe.2015.06.003 (Febrero 11, 2015).</dc:source>
   <dc:source>3.	Schereiber, A. High flow nasal cannula oxygen therapy, work in progress in respiratory critical care. Minerva Medica 2016 December; 107(Suppl 1 to Nº  6): 14-20.</dc:source>
   <dc:source>4.	UNICEF. 2007. State of the World’s Children. New York: United Nations Children’s Fund</dc:source>
   <dc:source>5.	Principi, T. Complications of mechanical ventilation in the pediatric population.  Pediatric Pulmonology 2011;  46(5): 452-7. doi 10.1002/ppul.21389</dc:source>
   <dc:source>6.	Programa Nacional de Prevención Manejo y Control de la Infección Respiratoria Aguda. Dirección de Promoción y Prevención, Subdirección de Enfermedades Transmisibles, Ministerio de Salud y Protección Social. Bogotá, D.C. Colombia 2014.</dc:source>
   <dc:source>7.	Estadísticas y datos epidemiológicos de la Organización Mundial de la Salud (OMS). 2010 ISBN 978 92 4 356398 5.</dc:source>
   <dc:source>8.	Iram Haq, Saikiran Gopalakaje et al. The evidence for high flow nasal cannula devices in infants. Paediatric Respiratory Reviews 124–134. http://dx.doi.org/10.1016/j.prrv.2013.12.002 (June, 2014).</dc:source>
   <dc:source>9.	Mikalsen, et al. High flow nasal cannula in children: A literature review. Scandinavian Journal of trauma, Resuscitation and Emergency Medicine 2016, 24:93 DOI 10.1186/s13049-016-0278-4</dc:source>
   <dc:source>10.	Wing Robyn, Armsby Carrie C. Non-Invasive Ventilation in Pediatric Acute Respiratory Illness, Clinical Pediatric Emergency Medicine. http://dx.doi.org/10.1016/j.cpem.2015.07.004 (July 4, 2015).</dc:source>
   <dc:source>11.	 Frat, Jean Pierre, et al. High flow nasal oxygen therapy and non-invasive ventilation in the management of acute hypoxemic respiratory failure. Annals of translation Medicine 2017; 5(14):297 DOI 10.21037</dc:source>
   <dc:source>12.	Pham Tài. Mechanical Ventilation: State of the art. Mayo Clin Proc 2017;92(9): 1382-1400.</dc:source>
   <dc:source>13.	Nedel, Wagner. High flow nasal cannula in critically ill subjects with or at risk for respiratory failure. A systematic review and Meta analysis. Respir Care 2017 Jan; 62(1): 123-132 DOI 10.4187/respcare.04831</dc:source>
   <dc:source>Christine McKiernan et al. High Flow Nasal Cannula Therapy in Infants with Bronchiolitis; 156:634-8.  http://dx.doi.org/10.1016/j.jpeds.2009.10.039. (December 29, 2009).</dc:source>
   <dc:source>15.	 Abboud PA et al. “Predictors of failure in infants with viral bronchiolitis treated with high-flow, high-humidity nasal cannula therapy”. Pediatr Crit Care Med. https://www.ncbi.nlm.nih.gov/pubmed/22805160. 343-349. (Noviembre 2013).</dc:source>
   <dc:source>Masclans, J.R. Papel de la oxigenoterapia de alto flujo en la insufiencia respiratoria aguda. Med Intensiva. 2015;39(8):505-515.</dc:source>
   <dc:source>Christophe Milési. High flows nasal cannula: recommendations for daily practice in pediatrics. Annals of Intensive Care 4:29. http://dx.doi.org/10.1186/s13613-014-0029-5 (September 30, 2014)</dc:source>
   <dc:source>A. García Figueruelo et al.  “Utilización de cánulas nasales de alto flujo para la ventilación no invasiva en niños”. Anales de pediatría (Barc). http://www.analesdepediatria.org/es/utilizacion-canulas-nasales-alto-flujo/articulo.  182-17. (Septiembre 2011).</dc:source>
   <dc:source>Randolph AG. “Management of acute lung injury and acute respiratory distress syndrome in children”. Crit. Care Med.  https://www.ncbi.nlm.nih.gov/pubmed/19531940.  2448-54. (Agosto 2009).</dc:source>
   <dc:source>Khemani RG, Patel NR, Bart RD, Newth CJ. “Comparison of the Pulse Oximetric Saturation/Fraction of Inspired Oxygen Ratio and the PaO2/Fraction of Inspired Oxygen Ratio in Children”. Chest. https://www.ncbi.nlm.nih.gov/pubmed/19029434. 662-668. (Marzo 2009).</dc:source>
   <dc:source>K.K. Kattelmann, M. Hise, M. Russell, P. Charney, M. Stokes, C. Compher. “Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients J Am Diet Assoc”.  https://www.ncbi.nlm.nih.gov/pubmed/16863719. 1226-1241. (Agosto 2006).</dc:source>
   <dc:source>Amir Kugelman, Karine Raibin, Husein Dabbah, Irina Chistyakov, Isaac Srugo, Lea Even, Nurit Bzezinsky, Arieh Riskin. “Intravenous Fluids versus Gastric-Tube feeding  in Hospitalized Infants with Viral Bronchiolitis: A Randomized, Prospective Pilot Study” The Journal of Pediatrics.  http://www.jpeds.com/article/S0022-347. 640-642.(Marzo 2013)</dc:source>
   <dc:source>Pallás, Argimon, and Jiménez Villa. 2013. “Estudios de Cohortes Tipos de esTudios de cohortes.” Métodos de investigación clínica y epidemiológica: 64–73. http://paginas.facmed.unam.mx/deptos/sp/wp-content/uploads/2013/12/Anexo-1B.-Argimon-PJ.-Estudios-de-cohortes.pdf (June 12, 2017).</dc:source>
   <dc:source>24.	Beggs S et al. High-flow nasal cannula therapy for infants with bronchiolitis (Review). The Cochrane Collaboration. http://dx.doi.org/10.1002/14651858.CD009609.pub2.  (May 13, 2013).</dc:source>
   <dc:source>25.	 Masaji Nishimura et al. “High-flow nasal cannula oxygen therapy in adults”. Journal of Intensive Care. 3 – 15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393594, (Marzo 2015).</dc:source>
   <dc:source>Pons Òdena M,Cambra Lasaosa FJ. “Ventilación mecánica en pediatría (III). Retirada de la ventilación, complicaciones y otros tipos de ventilación”. Ventilación no invasiva, An Pediatr (Barc), http://www.analesdepediatria.org/es/aplicacion-ventilacion-no-invasiva-una/articulo/13070175/. 165-72. (Enero 2005).</dc:source>
   <dc:source>M. Gómez-Garrido, E. Martínez González. “Enteral feeding of critical patients Rev Esp Anestesiol Reanim”. http://www.elsevier.es/es-revista-revista-espanola-anestesiologia-reanimacion-344-articulo. 31-42. (Enero 2009).</dc:source>
   <dc:source>Velásquez J, García M, Moya G. “Valores de referencia de saturación arterial de oxígeno mediante pulso-oximetría en niños sanos de Bucaramanga”. Med UNAB. 63-69. (Febrero 2003)</dc:source>
   <dc:source>Ruiz J, Álvaro, Carlos Gómez - Restrepo. 2015. Epidemiología Clínica - Investigación Clínica Aplicada. Segunda ed. Bogotá.</dc:source>
   <dc:source>30.	Coletti, Kristen D et al. 2017. “High-Flow Nasal Cannula Utilization in Pediatric Critical Care.” Respiratory Care: respcare.05153. http://www.ncbi.nlm.nih.gov/pubmed/28588119 (June 12, 2017).</dc:source>
   <dc:source>31.	Ibrahim, Joseph E et al. 2017. “Premature Deaths of Nursing Home Residents: An Epidemiological Analysis.” The Medical journal of Australia 206(10): 442–47. http://www.ncbi.nlm.nih.gov/pubmed/28566062 (June 12, 2017).</dc:source>
   <dc:source>32.	Kashef, Mohammad Amin et al. 2017. “Quality of Care of Hospitalized Infective Endocarditis Patients: Report from a Tertiary Medical Center.” Journal of Hospital Medicine 12(6): 414–20. http://www.ncbi.nlm.nih.gov/pubmed/28574530 (June 12, 2017).</dc:source>
   <dc:source>33.	Wright, Eric A et al. 2017. “Medication Burden in Patients with Acute Coronary Syndromes.” The American journal of managed care 23(4): e106–12. http://www.ncbi.nlm.nih.gov/pubmed/28554213 (June 12, 2017).</dc:source>
   <dc:source>34.	Carlos Lobete MD, Alberto Medina MD, Corsino Rey MD,Juan Mayordomo-Colunga MD, Andrés Concha MD, Sergio Menéndez MD. Correlation of oxygen saturation as measured by pulse oximetry/ fraction of inspired oxygen ratio with PaO2/fraction of inspired oxygen ratio in a heterogeneous sample of critically ill children. Elsevier 2013</dc:source>
   <dc:source>Lasso Javier. Interpretación de los gases arteriales en Bogotá (2.640 msnm) basada en el nomograma de Siggaard-Andersen.Una propuesta para facilitar y unificar la lectura. Revista Colombiana de Neumología Vol 26 N° 1 | 2014</dc:source>
   <dc:source>Grupo de  vigilancia de la IRA. Subdireccion de vigilancia y control en salud publica y Subdireccion red nacional de laboratorios INS. Datos a semana 52 de  2012.</dc:source>
   <dc:source>Aristizabal G. Analisis y formulacion de conjunto de prestacion de atencion para enfermedades respiratorias de carácter epidemico. Informe. Bogota: OPS; 2007</dc:source>
   <dc:source>Kramer A. Conceptos, metodos, modelos y salud publica. In Alexander K. Epidemiologia de las enfermedades infecciosos modernas; 2010.</dc:source>
   <dc:source>Rudan, I., Tomaskovic, L., Boschi-Pinto, C., Campbell, H. 2004. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull. World Health Organ. 82:895-903.</dc:source>
   <dc:source>Lee J, Rehder K, Willifor L, Cheifetz I, Turner D. Use of high flow nasal cannula in critically ill infants, children and adults: A critical review of literature. Int Care Med. 2013;39:247</dc:source>
   <dc:source>Ward J. High flow oxygen administration by nasal cannula for adults and perinatal patients. Respir Care. 2013;58:98-122.</dc:source>
   <dc:source>Dysart K, Miller T, Wolfson M, Shaffer T. Research in high flow therapy: Mechanism of action. Resp Med. 2009;103:1400-5.</dc:source>
   <dc:source>Wettstein R, Shelley D, Peters J. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Resp Care. 2005;50:604-9</dc:source>
   <dc:source>44.	Declaracion de Hensinky de la Asociacion Medica Mundial. Principios éticos para las investigaciones medicas en seres humanos. 59ª Asamblea General, Seul, Corea, octubre 2008.</dc:source>
   <dc:source>45.	Ministerio de Salud. Resolucion número 8430 de 1993. Normas científicas, técnicas y administrativas para la investigación en salud.</dc:source>
   <dc:source>Evelio PJ. Humanitas Humanidades medicas. (Online); 2006 (cited 2013 Enero 4). Disponible: www.fundacionmhm.org/www_es_numero2/papel.pdf</dc:source>
   <dc:source>Indicadores Basicos 2010, Situacion de Salud en Colombia. Organización Panamericana de la Salud, Instituto Nacional de Salud y Ministerio de la Proteccion Social</dc:source>
   <dc:source>INS – Vigilancia y Control en Salud Publica. Instituto Nacional de Salud de Colombia. 2013. www.ins.gov.co/Paginas/inicio.aspx.</dc:source>
   <dc:source>49.	Benguiqui Y, Lopez FJ, Schumunis G, Yunes J. Infecciones respiratorias en niños. Washington D.C. Organización Panamericana de la Salud; 1999. </dc:source>
   <dc:source>Boletin ERA 67. Secretaria de Salud Distrital, Julio 2011.</dc:source>
   <dc:source>Hutchings FA, Hilliard TN, Davis PJ. Heated humidified high-flow nasal cannula therapy in children. Arch Dis Child 2015;100(6): 571–575</dc:source>
   <dc:source>Mardegan, V., Priante, E., Lolli, E., Lago, P. Heated humidified High-flow Nasal Cannulae as a form of Noninvasive Respiratory Support for Preterm Infants and Children with Acute Respiratory Failure. American Journal of Perinatatology 2016, 33(11), 1058-1061.</dc:source>
   <dc:source>53.	Bressan S, Balzani M, Krauss B, Pettenazzo A, Zanconato S, Baraldi E. High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study. Eur J Pediatr 2013;172(12):1649–1656.</dc:source>
   <dc:source>Bueno Campaña M, Olivares Ortiz J, Notario Muñoz C, et al. High flow therapy versus hypertonic saline in bronchiolitis: random- ised controlled trial. Arch Dis Child 2014;99(6):511–515.</dc:source>
   <dc:source>Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med  2001;163:1723–9</dc:source>
   <dc:source>Polin R, Sahni R. Continuous positive airway pressure: old questions and new controversies. J Neonatal Perinat Med 2008;1:1–10.</dc:source>
   <dc:source>Greenspan JS, Wolfson MR, Shaffer TH. Airway responsiveness to low inspired gas temperature in preterm neonates. J Pediatr 1991;118(3):443–5</dc:source>
   <dc:source>Roehr, C. C., Yoder, B. A., Davis, P. G., &amp; Ives, K. (2016). Evidence Support and Guidelines for Using Heated, Humidified, High-Flow Nasal Cannulae in Neonatology. Clinics in Perinatology, 43(4), 693–705.doi:10.1016/j.clp.2016.07.006</dc:source>
   <dc:source>Yoder BA, Stoddard RA, Li M, et al. Heated, humidified high-flow nasal cannula  versus nasal CPAP for respiratory support in neonates. Pediatrics 2013;131:  e1482–90.</dc:source>
   <dc:source>Collins CL, Holberton JR, Barfield C, et al. A randomized controlled trial to  compare heated humidified high-flow nasal cannulae with nasal continuous pos- itive airway pressure postextubation in premature infants. J Pediatr 2013;162: 949–54.e1.</dc:source>
   <dc:source>61.	Manley BJ, Owen LS, Doyle LW, et al. High-flow nasal cannulae in very preterm infants after extubation. N Engl J Med 2013;369:1425–33.  </dc:source>
   <dc:source>Kugelman A, Riskin A, Said W, et al. A randomized pilot study comparing heated humidified high-flow nasal cannulae with NIPPV for RDS. Pediatr Pulmonol 2015; 50:576–83.</dc:source>
   <dc:source>63.	Woodhead DD, Lambert DK, Clark JM, et al. Comparing two methods of delivering high-flow gas therapy by nasal cannula following endotracheal extubation: a prospective, randomized, masked, crossover trial. J Perinatol 2006;26(8): 481–5.</dc:source>
   <dc:source>Negus VE. Humidification of the air passages. Acta Otolaryngol 2009;41:74–83.</dc:source>
   <dc:source>Holleman-Duray D, Kaupie D, Weiss MG. Heated humidified high-flow nasal can- nula: use and a neonatal early extubation protocol. J Perinatol 2007;27(12): 776–81.</dc:source>
   <dc:source>Harrison VC, Heese Hde V, Klein M. The significance of grunting in hyaline  membrane disease. Pediatrics   1968;41(3):549–59.</dc:source>
   <dc:source>67.	Frizzola M, Miller TL, Rodriguez ME, et al. High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model. Pediatr Pulmonol 2011; 46:67 – 74 .</dc:source>
   <dc:source>Móller W, Celik G, Feng S, et al. Nasal high flow clears anatomical dead space  in upper airway models. J Appl Physiol 2015; 118:.  Physiology study using infrared spectroscopy and labeled gas imaging to measure gas clearance from on a basic and complex model of the upper airway constructed from segmented computed tomography scan images</dc:source>
   <dc:source>69.	Saslow JG, Aghai ZH, Nakhla TA, et al. Work of breathing using high-flow nasal cannula in preterm infants. J Perinatol 2006; 26:476 – 480.  </dc:source>
   <dc:source>70.	Fontanari P, Burnet H, Zattara-Hartmann MC, Jammes Y. Changes in airway resistance induced by nasal inhalation of cold dry, dry, or moist air in normal individuals. J Appl Physiol 1996; 81:1739 – 1743.</dc:source>
   <dc:source>71.	SchiblerA, Pham TM, Dunster KR, etal. Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med 2011; 37:847–852. </dc:source>
   <dc:source>72.	Riese J, Fierce J, Riese A, Alverson BK. Effect of a hospital-wide high-flow  nasal cannula protocol on clinical outcomes and resource utilization of  bronchiolitis patients admitted to the PICU. Hosp Pediatr 2015; 5:613 – 618.</dc:source>
   <dc:source>73.	Pierce HC, Mansbach JM, Fisher ES, et al. Variability of intensive care management for children with bronchiolitis. Hosp Pediatr 2015; 5:175–184.</dc:source>
   <dc:source>74.	Wraight TI, Ganu SS. High-flow nasal cannula use in a paediatric intensive  care unit over 3 years. Crit Care Resusc 2015; 17:197 – 201. </dc:source>
   <dc:source>75.	Mayfield S, Bogossian F, O’Malley L, Schibler A. High-flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study. J Paediatr Child Heal 2014; 50:373 – 378. </dc:source>
   <dc:source>76.	Wing R, James C, Maranda LS, Armsby CC. Use of high-flow nasal cannula  support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency. Pediatr Emerg Care 2012; 28:1117–1123. Retrospective emergency department-based study showing reduction in intubation rates with the introduction and protocolization of HFNC</dc:source>
   <dc:source>77.	Milani GP, Plebani AM, Arturi E, et al. Using a high-flow nasal cannula provided superior results to low-flow oxygen delivery in moderate to severe bronchiolitis. Acta Paediatr 2016; 105:e368 – 372</dc:source>
   <dc:source>78.	McKiernan C, Chua LC, Visintainer PF, Allen H. High flow nasal cannulae &amp; therapy in infants with bronchiolitis. J Pediatr 2010; 156:634–638. A retrospective analysis showing a decrease in intubation rates for children with bronchiolitis after implementation of HFNC. </dc:source>
   <dc:source>79.	McGinley B, Halbower A, Schwartz AR, et al. Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children. Pediatrics 2009; 124:179 – 188.</dc:source>
   <dc:source>80.	Joseph L, Goldberg S, Shitrit M, Picard E. High-flow nasal cannula therapy for  obstructive sleep apnea in children. J Clin Sleep Med 2015; 11:1007 – 1010.</dc:source>
   <dc:source>81.	Spentzas T, Minarik M, Patters AB, et al. Children with respiratory distress  treated with high-flow nasal cannula. J Intensive Care Med 2009; 24:323– 328. </dc:source>
   <dc:source>82.	ten Brink F, Duke T, Evans J. High-flow nasal prong oxygen therapy or  nasopharyngeal continuous positive airway pressure for children with moderate to severe respiratory distress? Pediatr Crit Care Med 2013; 14:e326– e331.</dc:source>
   <dc:source>83.	Frat J-P, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372:2185– 2196</dc:source>
   <dc:source>84.	Lee M Jr, Nagler J. High-flow nasal cannula therapy beyond the perinatal period. Curr Opin Pediatr 2017 Jun; 29(3):291-296.</dc:source>
   <dc:source>85.	Kate A Hodgson, Peter G Davis et al. Nasal high flow therapy for neonates: Current evidence and future directions. Journal of Paediatrics and Chikd Health 2019 Jan 7.</dc:source>
   <dc:source>Jilei Lin et al. High-flow nasal cannula therapy for children with bronchiolitis: A systematic review and meta-analysis. Arch Dis Child 2019;0:1-13</dc:source>
   <dc:source>Spence KL, Murphy D, Kilian C, et al. High-flow nasal cannula as a device to  provide continuous positive airway pressure in infants. J Perinatol 2007; 27:772 – 775. </dc:source>
   <dc:source>88.	Hegde S, Prodhan P. Serious air leak syndrome complicating high-flow nasal cannula therapy: a report of 3 cases. Pediatrics 2013; 131:e939 – e944.</dc:source>
   <dc:source>89.	Jasin LR, Kern S, Thompson S, et al. Subcutaneous scalp emphysema, pneumo-orbitis and pneumocephalus in a neonate on high humidity high flow nasal cannula. J Perinatol 2008; 28:779 – 781.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/44937</identifier><datestamp>2025-10-09T09:27:22Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Caracterización del estado nutricional y evaluación del soporte nutricional en pacientes pediátricos críticamente enfermos en una UCI pediátrica de alta complejidad en Bogotá, Colombia</dc:title>
   <dc:creator>Vargas Morán, Carmen Helena</dc:creator>
   <dc:creator>Bejarano Quintero,  Ana María </dc:creator>
   <dc:creator>Lamprea Pineda, Shirley Vanessa </dc:creator>
   <dc:creator>Cárdenas, Adriana </dc:creator>
   <dc:creator>Medina, Leonor</dc:creator>
   <dc:creator>Bernal, Marcela</dc:creator>
   <dc:creator>Baquero, Olga</dc:creator>
   <dc:creator>Rojas, Sofia</dc:creator>
   <dc:contributor>Bejarano Quintero, Ana María</dc:contributor>
   <dc:contributor>Rodríguez Hernández, Andrea Esperanza</dc:contributor>
   <dc:subject>Malnutrición hospitalaria</dc:subject>
   <dc:subject>Pacientes pediátricos</dc:subject>
   <dc:subject>Unidad de cuidado intensivo pediátrico</dc:subject>
   <dc:subject>Soporte nutricional</dc:subject>
   <dcterms:abstract>Background: Hospital malnutrition was common among critically ill pediatric patients, with a negative impact on morbidity and mortality. Clínica Infantil Colsubsidio implemented a nutritional support team to address this issue. Objective: To describe patient demographics, nutritional status at the beginning and end of the intervention, nutrition-associated complications, type and route of nutrition administration used, and to evaluate significant variations in discharge weight and nutritional classification according to WHO criteria. Methodology: A retrospective cohort observational study was conducted on patients under 18 years of age admitted to the UCIP at Clínica Infantil Colsubsidio between January and December 2023. Patients receiving interventions from the nutritional support team were included, while cases with unreliable anthropometric data, short stays, deaths, or transfers were excluded. Results: This retrospective cohort study analyzed the intervention of the nutritional support team in pediatric patients, demonstrating a positive impact with improved nutritional status. An increase was observed in the proportion of patients classified as eutrophic and a decrease in patients with acute malnutrition and thinness, contrasting with international literature that often reports high rates of hospital malnutrition in critically ill patients. Conclusions: Structured nutritional intervention and continuous monitoring by a multidisciplinary team effectively prevented hospital malnutrition in critically ill patients. The results underscored the importance of implementing personalized nutritional support protocols tailored to each patient's needs, contributing to improved clinical outcomes and reduced nutritional risks in this population.</dcterms:abstract>
   <dcterms:dateAccepted>2025-02-06T15:39:58Z</dcterms:dateAccepted>
   <dcterms:available>2025-02-06T15:39:58Z</dcterms:available>
   <dcterms:created>2025-02-06T15:39:58Z</dcterms:created>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_44937</dc:identifier>
   <dc:identifier>https://repository.urosario.edu.co/handle/10336/44937</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights>
   <dc:rights>Attribution-NonCommercial-ShareAlike 4.0 International</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud</dc:publisher>
   <dc:publisher>Especialización en Medicina Crítica y Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Ma, Shuai; Evans, Roger G.; Iguchi, Naoya; Tare, Marianne; Parkington, Helena C.; Bellomo, Rinaldo; May, Clive N.; Lankadeva, Yugeesh R. (2019) Sepsis-induced acute kidney injury: A disease of the microcirculation. En: Microcirculation. Vol. 26; No. 2; pp. e12483 10739688; Consultado en: 2023/04/11/09:24:28. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/micc.12483. Disponible en: 10.1111/micc.12483.</dc:source>
   <dc:source>Bellomo, Rinaldo; Kellum, John A; Ronco, Claudio (2012) Acute kidney injury. En: The Lancet. Vol. 380; No. 9843; pp. 756 - 766; 01406736; Consultado en: 2023/02/17/19:58:49. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0140673611614542. Disponible en: 10.1016/S0140-6736(11)61454-2.</dc:source>
   <dc:source>Gómez, Hernando; Kellum, John A. (2019) Sepsis-Induced Acute Kidney Injury. En: Critical Care Nephrology. pp. 524 - 533.e3; Elsevier; 978-0-323-44942-7; Consultado en: 2023/05/01/23:49:51. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/B978032344942700090X.</dc:source>
   <dc:source>Gordon, Anthony C.; Mason, Alexina J.; Thirunavukkarasu, Neeraja; Perkins, Gavin D.; Cecconi, Maurizio; Cepkova, Magda; Pogson, David G.; Aya, Hollmann D.; Anjum, Aisha; Frazier, Gregory J.; Santhakumaran, Shalini; Ashby, Deborah; Brett, Stephen J.; for the VANISH Investigators (2016) Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. En: JAMA. Vol. 316; No. 5; pp. 509 0098-7484; Consultado en: 2023/05/01/23:49:53. Disponible en: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.10485. Disponible en: 10.1001/jama.2016.10485.</dc:source>
   <dc:source>Montomoli, Jonathan; Donati, Abele; Ince, Can (2019) Acute Kidney Injury and Fluid Resuscitation in Septic Patients: Are We Protecting the Kidney?. En: Nephron. Vol. 143; No. 3; pp. 170 - 173; 1660-8151, 2235-3186; Consultado en: 2023/05/01/23:49:56. Disponible en: https://www.karger.com/Article/FullText/501748. Disponible en: 10.1159/000501748.</dc:source>
   <dc:source>Fani, Filippo; Regolisti, Giuseppe; Delsante, Marco; Cantaluppi, Vincenzo; Castellano, Giuseppe; Gesualdo, Loreto; Villa, Gianluca; Fiaccadori, Enrico (2018) Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury. En: Journal of Nephrology. Vol. 31; No. 3; pp. 351 - 359; 1121-8428, 1724-6059; Consultado en: 2023/05/01/23:49:58. Disponible en: http://link.springer.com/10.1007/s40620-017-0452-4. Disponible en: 10.1007/s40620-017-0452-4.</dc:source>
   <dc:source>Song, Jong Wook; Zullo, Joseph; Lipphardt, Mark; Dragovich, Matthew; Zhang, Frank X; Fu, Bingmei; Goligorsky, Michael S (2018) Endothelial glycocalyx—the battleground for complications of sepsis and kidney injury. En: Nephrology Dialysis Transplantation. Vol. 33; No. 2; pp. 203 - 211; 0931-0509, 1460-2385; Consultado en: 2023/05/01/23:50:01. Disponible en: https://academic.oup.com/ndt/article/33/2/203/3849377. Disponible en: 10.1093/ndt/gfx076.</dc:source>
   <dc:source>Gomez, Hernando; Ince, Can; De Backer, Daniel; Pickkers, Peter; Payen, Didier; Hotchkiss, John; Kellum, John A. (2014) A Unified Theory of Sepsis-Induced Acute Kidney Injury: Inflammation, Microcirculatory Dysfunction, Bioenergetics, and the Tubular Cell Adaptation to Injury. En: Shock. Vol. 41; No. 1; pp. 3 - 11; 1073-2322; Consultado en: 2023/05/01/23:50:04. Disponible en: https://journals.lww.com/00024382-201401000-00003. Disponible en: 10.1097/SHK.0000000000000052.</dc:source>
   <dc:source>Gómez, Hernando; Kellum, John A. (2016) Sepsis-induced acute kidney injury:. En: Current Opinion in Critical Care. Vol. 22; No. 6; pp. 546 - 553; 1070-5295; Consultado en: 2023/05/01/23:50:07. Disponible en: http://journals.lww.com/00075198-201612000-00007. Disponible en: 10.1097/MCC.0000000000000356.</dc:source>
   <dc:source>Gordon, Anthony C.; Mason, Alexina J.; Thirunavukkarasu, Neeraja; Perkins, Gavin D.; Cecconi, Maurizio; Cepkova, Magda; Pogson, David G.; Aya, Hollmann D.; Anjum, Aisha; Frazier, Gregory J.; Santhakumaran, Shalini; Ashby, Deborah; Brett, Stephen J.; for the VANISH Investigators (2016) Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. En: JAMA. Vol. 316; No. 5; pp. 509 0098-7484; Consultado en: 2023/05/01/23:50:09. Disponible en: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.10485. Disponible en: 10.1001/jama.2016.10485.</dc:source>
   <dc:source>Guerci, Philippe; Ergin, Bulent; Ince, Can (2017) The macro- and microcirculation of the kidney. En: Best Practice &amp; Research Clinical Anaesthesiology. Vol. 31; No. 3; pp. 315 - 329; 15216896; Consultado en: 2023/05/01/23:50:11. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1521689617300757. Disponible en: 10.1016/j.bpa.2017.10.002.</dc:source>
   <dc:source>Harris, Pamela L.; Umberger, Reba A. (2020) Long-term Renal Outcomes in Adults With Sepsis-Induced Acute Kidney Injury: A Systematic Review. En: Dimensions of Critical Care Nursing. Vol. 39; No. 5; pp. 259 - 268; 1538-8646, 0730-4625; Consultado en: 2023/05/01/23:50:13. Disponible en: https://journals.lww.com/10.1097/DCC.0000000000000432. Disponible en: 10.1097/DCC.0000000000000432.</dc:source>
   <dc:source>Post, Emiel Hendrik; Kellum, John A.; Bellomo, Rinaldo; Vincent, Jean-Louis (2017) Renal perfusion in sepsis: from macro- to microcirculation. En: Kidney International. Vol. 91; No. 1; pp. 45 - 60; 00852538; Consultado en: 2023/05/01/23:50:15. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0085253816304173. Disponible en: 10.1016/j.kint.2016.07.032.</dc:source>
   <dc:source>Joannidis, M.; Druml, W.; Forni, L. G.; Groeneveld, A. B. J.; Honore, P. M.; Hoste, E.; Ostermann, M.; Oudemans-van Straaten, H. M.; Schetz, M. (2017) Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine. En: Intensive Care Medicine. Vol. 43; No. 6; pp. 730 - 749; 0342-4642, 1432-1238; Consultado en: 2023/05/01/23:50:17. Disponible en: http://link.springer.com/10.1007/s00134-017-4832-y. Disponible en: 10.1007/s00134-017-4832-y.</dc:source>
   <dc:source>Lankadeva, Yugeesh R.; Okazaki, Nobuki; Evans, Roger G.; Bellomo, Rinaldo; May, Clive N. (2019) Renal Medullary Hypoxia: A New Therapeutic Target for Septic Acute Kidney Injury?. En: Seminars in Nephrology. Vol. 39; No. 6; pp. 543 - 553; 02709295; Consultado en: 2023/05/01/23:50:19. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0270929519300890. Disponible en: 10.1016/j.semnephrol.2019.10.004.</dc:source>
   <dc:source>Marengo, Marita; Dellepiane, Sergio; Cantaluppi, Vincenzo; La Manna, G.; Ronco, C. (2017) Extracorporeal Treatments in Patients with Acute Kidney Injury and Sepsis. En: Contributions to Nephrology. Vol. 190; pp. 1 - 18; S. Karger AG; 978-3-318-06060-7 978-3-318-06061-4; Consultado en: 2023/05/01/23:50:21. Disponible en: https://www.karger.com/Article/FullText/468912.</dc:source>
   <dc:source>Poston, Jason T; Koyner, Jay L (2019) Sepsis associated acute kidney injury. En: BMJ. pp. k4891 0959-8138, 1756-1833; Consultado en: 2023/05/01/23:50:24. Disponible en: https://www.bmj.com/lookup/doi/10.1136/bmj.k4891. Disponible en: 10.1136/bmj.k4891.</dc:source>
   <dc:source>Romagnoli, Stefano; Ricci, Zaccaria; Ronco, Claudio (2018) CRRT for sepsis-induced acute kidney injury:. En: Current Opinion in Critical Care. Vol. 24; No. 6; pp. 483 - 492; 1070-5295; Consultado en: 2023/05/01/23:50:27. Disponible en: http://journals.lww.com/00075198-201812000-00010. Disponible en: 10.1097/MCC.0000000000000544.</dc:source>
   <dc:source>Zarbock, Alexander; Gomez, Hernando; Kellum, John A. (2014) Sepsis-induced acute kidney injury revisited: pathophysiology, prevention and future therapies. En: Current Opinion in Critical Care. Vol. 20; No. 6; pp. 588 - 595; 1070-5295; Consultado en: 2023/05/01/23:50:29. Disponible en: http://journals.lww.com/00075198-201412000-00003. Disponible en: 10.1097/MCC.0000000000000153.</dc:source>
   <dc:source>Ergin, B.; Kapucu, A.; Demirci-Tansel, C.; Ince, C. (2015) The renal microcirculation in sepsis. En: Nephrology Dialysis Transplantation. Vol. 30; No. 2; pp. 169 - 177; 0931-0509, 1460-2385; Consultado en: 2023/05/01/23:50:31. Disponible en: https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfu105. Disponible en: 10.1093/ndt/gfu105.</dc:source>
   <dc:source>Mårtensson, Johan; Bellomo, Rinaldo (2015) Sepsis-Induced Acute Kidney Injury. En: Critical Care Clinics. Vol. 31; No. 4; pp. 649 - 660; 07490704; Consultado en: 2023/05/01/23:50:34. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0749070415000457. Disponible en: 10.1016/j.ccc.2015.06.003.</dc:source>
   <dc:source>Ostermann, Marlies; Liu, Kathleen (2017) Pathophysiology of AKI. En: Best Practice &amp; Research Clinical Anaesthesiology. Vol. 31; No. 3; pp. 305 - 314; 15216896; Consultado en: 2023/05/01/23:50:37. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S1521689617300575. Disponible en: 10.1016/j.bpa.2017.09.001.</dc:source>
   <dc:source>Calzavacca, P.; May, C. N.; Bellomo, R. (2014) Glomerular haemodynamics, the renal sympathetic nervous system and sepsis-induced acute kidney injury. En: Nephrology Dialysis Transplantation. Vol. 29; No. 12; pp. 2178 - 2184; 0931-0509, 1460-2385; Consultado en: 2023/05/01/23:50:39. Disponible en: https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfu052. Disponible en: 10.1093/ndt/gfu052.</dc:source>
   <dc:source>Prowle, John R.; Bellomo, Rinaldo (2015) Sepsis-Associated Acute Kidney Injury: Macrohemodynamic and Microhemodynamic Alterations in the Renal Circulation. En: Seminars in Nephrology. Vol. 35; No. 1; pp. 64 - 74; 02709295; Consultado en: 2023/05/01/23:50:41. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S027092951500008X. Disponible en: 10.1016/j.semnephrol.2015.01.007.</dc:source>
   <dc:source>Regueira, T.; Andresen, M.; Mercado, M.; Downey, P. (2011) Fisiopatología de la insuficiencia renal aguda durante la sepsis. En: Medicina Intensiva. Vol. 35; No. 7; pp. 424 - 432; 02105691; Consultado en: 2023/05/01/23:50:44. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S021056911100088X. Disponible en: 10.1016/j.medin.2011.03.011.</dc:source>
   <dc:source>Bellomo, Rinaldo; Kellum, John A.; Ronco, Claudio; Wald, Ron; Martensson, Johan; Maiden, Matthew; Bagshaw, Sean M.; Glassford, Neil J.; Lankadeva, Yugeesh; Vaara, Suvi T.; Schneider, Antoine (2017) Acute kidney injury in sepsis. En: Intensive Care Medicine. Vol. 43; No. 6; pp. 816 - 828; 0342-4642, 1432-1238; Consultado en: 2023/05/01/23:50:46. Disponible en: http://link.springer.com/10.1007/s00134-017-4755-7. Disponible en: 10.1007/s00134-017-4755-7.</dc:source>
   <dc:source>Boron, Walter F.; Boulpaep, Emile L. (2017) Fisiología médica. pp. 1901 : Elsevier Health Sciences; 978-84-9113-126-7;</dc:source>
   <dc:source>Bruce, Koeppen; Bruce, Stanton (2019) Structure and Function of the Kidneys. En: Renal Physiology. Consultado en: 2023/05/13/20:59:44. Disponible en: https://www-clinicalkey-es.ez.urosario.edu.co/#!/content/book/3-s2.0-B9780323595681000020.</dc:source>
   <dc:source>Bruce, Koeppen; Bruce, Stanton (2019) Glomerular Filtration and Renal Blood Flow. En: Renal Physiology. pp. 25 - 40; Consultado en: 2023/05/19/23:07:48. Disponible en: https://www-clinicalkey-es.ez.urosario.edu.co/#!/content/book/3-s2.0-B9780323595681000032.</dc:source>
   <dc:source>Wu, Liping; Tiwari, Manish M.; Messer, Kurt J.; Holthoff, Joseph H.; Gokden, Neriman; Brock, Robert W.; Mayeux, Philip R. (2007) Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. En: American Journal of Physiology-Renal Physiology. Vol. 292; No. 1; pp. F261 - F268; 1931-857X; Consultado en: 2023/05/20/00:49:08. Disponible en: https://journals.physiology.org/doi/full/10.1152/ajprenal.00263.2006. Disponible en: 10.1152/ajprenal.00263.2006.</dc:source>
   <dc:source>Pérez-Manjarrez, Aldo; García-Cruz, Edgar; Gopar-Nieto, Rodrigo; Jiménez-Rodríguez, Gian Manuel; Lazcano-Díaz, Emmanuel; Rojas-Velasco, Gustavo; Manzur-Sandoval, Daniel (2023) Usefulness of the velocity–time integral of the left ventricular outflow tract variability index to predict fluid responsiveness in patients undergoing cardiac surgery. En: Echo Research and Practice. Vol. 10; Consultado en: 2023/08/02/23:26:02. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308625/. Disponible en: 10.1186/s44156-023-00022-z.</dc:source>
   <dc:source>Azamfirei, Razvan; Mennie, Colleen; Dinglas, Victor D.; Fatima, Arooj; Colantuoni, Elizabeth; Gurses, Ayse P.; Balas, Michele C.; Needham, Dale M.; Kudchadkar, Sapna R.; on behalf of the PICU Up! ﻿Investigators (2023) Impact of a multifaceted early mobility intervention for critically ill children. En: Trials. Vol. 24; No. 1; pp. 191 1745-6215; Disponible en: 10.1186/s13063-023-07206-2.</dc:source>
   <dc:source>Patel, Ruchit V.; Redivo, Juliana; Nelliot, Archana; Eakin, Michelle N.; Wieczorek, Beth; Quinn, Julie; Gurses, Ayse P.; Balas, Michele C.; Needham, Dale M.; Kudchadkar, Sapna R. (2021) Early Mobilization in a PICU: A Qualitative Sustainability Analysis of PICU Up!. En: Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Vol. 22; No. 4; pp. e233 - e242; 1529-7535; Disponible en: 10.1097/PCC.0000000000002619.</dc:source>
   <dc:source>Zheng, Katina; Sarti, Aimee; Boles, Sama; Cameron, Saoirse; Carlisi, Robert; Clark, Heather; Khawaji, Adeeb; Awladthani, Saif; Al-Harbi, Samah; Choong, Karen (2018) Impressions of Early Mobilization of Critically Ill Children-Clinician, Patient, and Family Perspectives. En: Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Vol. 19; No. 7; pp. e350 - e357; 1529-7535; Disponible en: 10.1097/PCC.0000000000001547.</dc:source>
   <dc:source>Morrow, Brenda M. (2021) Quality Improvement Versus Evidence-Based Practice in Early Mobilization Programs-Must We Choose?. En: Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Vol. 22; No. 4; pp. 439 - 442; 1529-7535; Disponible en: 10.1097/PCC.0000000000002646.</dc:source>
   <dc:source>Wieczorek, Beth; Ascenzi, Judith; Kim, Yun; Lenker, Hallie; Potter, Caroline; Shata, Nehal J.; Mitchell, Lauren; Haut, Catherine; Berkowitz, Ivor; Pidcock, Frank; Hoch, Jeannine; Malamed, Connie; Kravitz, Tamara; Kudchadkar, Sapna R. (2016) PICU Up!: Impact of a Quality Improvement Intervention to Promote Early Mobilization in Critically Ill Children. En: Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Vol. 17; No. 12; pp. e559 - e566; 1529-7535; Disponible en: 10.1097/PCC.0000000000000983.</dc:source>
   <dc:source>Morrow, Brenda M. (2021) Building a culture of early mobilization in the pediatric intensive care unit-a nuts and bolts approach. En: Translational Pediatrics. Vol. 10; No. 10; pp. 2845 - 2857; 2224-4344; Disponible en: 10.21037/tp-20-324.</dc:source>
   <dc:source>Dubb, Rolf; Nydahl, Peter; Hermes, Carsten; Schwabbauer, Norbert; Toonstra, Amy; Parker, Ann M.; Kaltwasser, Arnold; Needham, Dale M. (2016) Barriers and Strategies for Early Mobilization of Patients in Intensive Care Units. En: Annals of the American Thoracic Society. Vol. 13; No. 5; pp. 724 - 730; 2325-6621; Disponible en: 10.1513/AnnalsATS.201509-586CME.</dc:source>
   <dc:source>Hanna, Eriny S.; Zhao, Shilin; Shannon, Chevis N.; Betters, Kristina A. (2020) Changes in Provider Perceptions Regarding Early Mobility in the PICU. En: Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Vol. 21; No. 1; pp. e30 - e38; 1529-7535; Disponible en: 10.1097/PCC.0000000000002177.</dc:source>
   <dc:source> Estado nutricional y estrategias de soporte nutricional en cuidado intensivo pediátrico Cali-Colombia. Consultado en: 2023/10/02/00:48:47. Disponible en: https://scielo.isciii.es/scielo.php?pid=S1695-61412023000100007&amp;script=sci_arttext.</dc:source>
   <dc:source>Núñez-Barrera, Isela; Osorio-Lechuga, Citlali; Torres-González, Karina; Chávez-López, Adrián (2022) Condición y abordaje nutricional del paciente crítico pediátrico: primeros días de hospitalización. En: Latin American Journal of Pediatric Gastroenterology and Nutrition. Vol. 1; No. 1; pp. 8470 2696-9971; Consultado en: 2023/10/02/00:53:32. Disponible en: https://www.lajpgn.com/frame_esp.php?id=31. Disponible en: 10.24875/LAJPGN.M22000001.</dc:source>
   <dc:source>Guillén Cánovas, Ana Mercedes; Cabrera Urra, Claudia; Echevarría Martínez, Luis Enrique; Esquijarosa Roque, Bárbara María; Bazabe Márquez, María Isabel; Guillén Cánovas, Ana Mercedes; Cabrera Urra, Claudia; Echevarría Martínez, Luis Enrique; Esquijarosa Roque, Bárbara María; Bazabe Márquez, María Isabel (2021) Caracterización del estado y soporte nutricional en pacientes pediátricos graves. En: Revista de Ciencias Médicas de Pinar del Río. Vol. 25; No. 2; 1561-3194; Consultado en: 2023/10/02/00:55:25. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1561-31942021000200008&amp;lng=es&amp;nrm=iso&amp;tlng=en.</dc:source>
   <dc:source>Llontop Pérez, Samantha Catherine; Ñique Dávila, Paulo César (2020) Eficacia del soporte nutricional oral en pacientes pediátricos quemados del Hospital Regional Docente las Mercedes. Enero – Diciembre 2019. Consultado en: 2023/10/02/01:05:11. Disponible en: http://repositorio.unprg.edu.pe/handle/20.500.12893/8501.</dc:source>
   <dc:source> Evaluación y apoyo nutricional en el paciente pediátrico críticamente enfermo: Revisión de la literatura. Consultado en: 2023/10/02/01:06:03. Disponible en: https://www.scielo.cl/scielo.php?pid=S0717-75182021000100095&amp;script=sci_arttext.</dc:source>
   <dc:source>de León, María; Dotti, María; Duarte, Matías; Hoffman, María; López, María; Encuesta sobre prácticas nutricionales en pacientes críticos pediátricos en Uruguay durante julio de 2020. </dc:source>
   <dc:source>Tantaleán-da Fieno, José Alberto Javier; Palomo-Luck, Olga Patricia; León-Paredes, Rosa Josefina; Tantaleán-da Fieno, José Alberto Javier; Palomo-Luck, Olga Patricia; León-Paredes, Rosa Josefina (2022) Prácticas de soporte nutricional en unidad de cuidados intensivos pediátrica. En: Revista Cubana de Pediatría. Vol. 94; No. 1; 0034-7531; Consultado en: 2023/10/02/01:10:40. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0034-75312022000100002&amp;lng=es&amp;nrm=iso&amp;tlng=es.</dc:source>
   <dc:source>Pérez, Dra Susana Pineda; Miranda, Dra Vivian Mena; Acosta, Yeniset Fumero; Soporte nutricional en el paciente pediá trico crí tico. </dc:source>
   <dc:source> Enteral Nutrition in the Critically Ill Child: Comparison of Standard and Protein-Enriched Diets. Consultado en: 2023/10/07/13:35:15. Disponible en: https://www-clinicalkey-es.ez.urosario.edu.co/#!/content/playContent/1-s2.0-S0022347611001454?returnurl=null&amp;referrer=null.</dc:source>
   <dc:source>Campos-Miño, Santiago; Figueiredo-Delgado, Artur; Zárate, Patricia; Zamberlan, Patricia; Muñoz-Benavides, Eliana; Coss-Bu, Jorge A.; Nutrition Committee, Latin American Society of Pediatric Intensive Care (SLACIP) (2023) Malnutrition and Nutrition Support in Latin American PICUs: The Nutrition in PICU (NutriPIC) Study. En: Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 1529-7535; Disponible en: 10.1097/PCC.0000000000003337.</dc:source>
   <dc:source> Pasado, presente y futuro. Consultado en: 2023/10/07/14:03:51. Disponible en: https://scholar.googleusercontent.com/scholar?q=cache:sZ43u_-PVmIJ:scholar.google.com/+Pasado,+presente+y+futuro.+Diana+Cardenas&amp;hl=es&amp;as_sdt=0,5.</dc:source>
   <dc:source>Joosten, Koen F. M.; Hulst, Jessie M. (2014) Nutritional screening tools for hospitalized children: Methodological considerations. En: Clinical Nutrition. Vol. 33; No. 1; pp. 1 - 5; 0261-5614; Consultado en: 2023/10/07/14:20:27. Disponible en: https://www.sciencedirect.com/science/article/pii/S0261561413002070. Disponible en: 10.1016/j.clnu.2013.08.002.</dc:source>
   <dc:source>Mehta, Nilesh M.; Skillman, Heather E.; Irving, Sharon Y.; Coss-Bu, Jorge A.; Vermilyea, Sarah; Farrington, Elizabeth Anne; McKeever, Liam; Hall, Amber M.; Goday, Praveen S.; Braunschweig, Carol (2017) Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. En: Journal of Parenteral and Enteral Nutrition. Vol. 41; No. 5; pp. 706 - 742; 1941-2444; Consultado en: 2023/10/07/14:31:21. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1177/0148607117711387. Disponible en: 10.1177/0148607117711387.</dc:source>
   <dc:source>Haney, Amanda; Burritt, Emily; Babbitt, Christopher J. (2018) The impact of early enteral nutrition on pediatric acute respiratory failure. En: Clinical nutrition ESPEN. Vol. 26; pp. 42 - 46; 2405-4577; Disponible en: 10.1016/j.clnesp.2018.04.017.</dc:source>
   <dc:source>Irving, Sharon Y.; Guenter, Peggi; Mehta, Nilesh M. (2019) Incorporating the latest pediatric nutrition support guidelines into clinical practice. En: Nursing. Vol. 49; No. 2; pp. 38 - 44; 1538-8689; Disponible en: 10.1097/01.NURSE.0000552699.27631.88.</dc:source>
   <dc:source>Ocete Hita, E. (2011) Hacia el futuro en cuidados intensivos pediátricos. En: Medicina Intensiva. Vol. 35; No. 6; pp. 328 - 330; 02105691; Consultado en: 2023/10/07/14:46:33. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0210569111001434. Disponible en: 10.1016/j.medin.2011.05.002.</dc:source>
   <dc:source>Pedrón Giner, Consuelo; Cuervas-Mons Vendrell, Margarita; Galera Martínez, Rafael; Gómez López, Lilianne; Gomis Muñoz, Pilar; Irastorza Terradillos, Iñaki; Martínez Costa, Cecilia; Moreno Villares, José Manuel; Pérez-Portabella Maristany, Cleofé; Pozas Del Río, M.ª Teresa; Redecillas Ferreiro, Susana E.; Prieto Bozano, Gerardo; Grupo De Estandarización De La Senpe, Senpe (2017) Guía de práctica clínica SENPE/SEGHNP/SEFH sobre nutrición parenteral pediátrica. En: Nutrición Hospitalaria. Vol. 34; No. 3; pp. 745 1699-5198, 0212-1611; Consultado en: 2023/10/07/14:57:31. Disponible en: http://revista.nutricionhospitalaria.net/index.php/nh/article/view/1116. Disponible en: 10.20960/nh.1116.</dc:source>
   <dc:source>Martínez Costa, Cecilia; Pedrón Giner, Consuelo (2017) Requerimientos en nutrición parenteral pediátrica. En: Nutrición Hospitalaria. Vol. 34; No. 3; 1699-5198, 0212-1611; Consultado en: 2023/10/07/14:57:38. Disponible en: http://revista.nutricionhospitalaria.net/index.php/nh/article/view/1376. Disponible en: 10.20960/nh.1376.</dc:source>
   <dc:source>Agudelo, G. M.; Giraldo, N. A.; Aguilar, N.; Barbosa, J.; Castaño, E.; Gamboa, S.; Martínez, M. I.; Alzate, S.; Vanegas, M.; Restrepo, B.; Román, J.; Serna, A.; Hoyos, M. (2011) [Incidence of nutritional support complications in critical patients: multicenter study]. En: Nutricion Hospitalaria. Vol. 26; No. 3; pp. 537 - 545; 1699-5198; Disponible en: 10.1590/S0212-16112011000300016.</dc:source>
   <dc:source>Galeano, Fernando; Sanabria-Báez, Gabriela (2018) DESCRIPTION OF THE COMPLICATIONS ASSOCIATED WITH PARENTERAL NUTRITION IN NEONATES OF HOSPITAL OF CLINICS OF SAN LORENZO. En: Revista del Instituto de Medicina Tropical. Vol. 13; No. 2; pp. 3 - 9; 19963696; Consultado en: 2023/10/07/15:02:15. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S1996-36962018000200003&amp;lng=es&amp;nrm=iso&amp;tlng=es. Disponible en: 10.18004/imt/20181323-9.</dc:source>
   <dc:source>Bechard, Lori J.; Duggan, Christopher; Touger-Decker, Riva; Parrott, J. Scott; Rothpletz-Puglia, Pamela; Byham-Gray, Laura; Heyland, Daren; Mehta, Nilesh M. (2016) Nutritional status based on Body Mass Index is associated with morbidity and mortality in mechanically ventilated critically ill children in the PICU. En: Critical care medicine. Vol. 44; No. 8; pp. 1530 - 1537; 0090-3493; Consultado en: 2023/10/07/16:21:45. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949117/. Disponible en: 10.1097/CCM.0000000000001713.</dc:source>
   <dc:source> Nutrition Therapy in a Pediatric Intensive Care Unit. Consultado en: 2023/10/07/16:43:43. Disponible en: https://aspenjournals-onlinelibrary-wiley-com.ez.urosario.edu.co/doi/epdf/10.1177/0148607110386610.</dc:source>
   <dc:source>Bechard, Lori J.; Rothpletz-Puglia, Pamela; Touger-Decker, Riva; Duggan, Christopher; Mehta, Nilesh M. (2013) Influence of Obesity on Clinical Outcomes in Hospitalized Children. En: JAMA pediatrics. Vol. 167; No. 5; pp. 476 - 482; 2168-6203; Consultado en: 2023/10/07/16:46:56. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743026/. Disponible en: 10.1001/jamapediatrics.2013.13.</dc:source>
   <dc:source>Mehta, Nilesh M; Bechard, Lori J; Zurakowski, David; Duggan, Christopher P; Heyland, Daren K (2015) Adequate enteral protein intake is inversely associated with 60-d mortality in critically ill children: a multicenter, prospective, cohort study1. En: The American Journal of Clinical Nutrition. Vol. 102; No. 1; pp. 199 - 206; 0002-9165; Consultado en: 2023/10/07/16:50:11. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480666/. Disponible en: 10.3945/ajcn.114.104893.</dc:source>
   <dc:source>Kuczmarski, R. J.; Ogden, C. L.; Grummer-Strawn, L. M.; Flegal, K. M.; Guo, S. S.; Wei, R.; Mei, Z.; Curtin, L. R.; Roche, A. F.; Johnson, C. L. (2000) CDC growth charts: United States. En: Advance Data. No. 314; pp. 1 - 27; 0147-3956;</dc:source>
   <dc:source> (2022) Growth Charts. Consultado en: 2023/10/07/17:09:39. Disponible en: https://www.cdc.gov/growthcharts/clinical_charts.htm.</dc:source>
   <dc:source> Consensus Statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: Indicators Recommended for the Identification and Documentation of Pediatric Malnutrition (Undernutrition). Consultado en: 2023/10/07/17:18:39. Disponible en: https://www-clinicalkey-es.ez.urosario.edu.co/#!/content/playContent/1-s2.0-S2212267214013598?returnurl=null&amp;referrer=null.</dc:source>
   <dc:source>Becker, Patricia; Carney, Liesje Nieman; Corkins, Mark R.; Monczka, Jessica; Smith, Elizabeth; Smith, Susan E.; Spear, Bonnie A.; White, Jane V.; Academy of Nutrition and Dietetics; American Society for Parenteral and Enteral Nutrition (2015) Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: indicators recommended for the identification and documentation of pediatric malnutrition (undernutrition). En: Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition. Vol. 30; No. 1; pp. 147 - 161; 1941-2452; Disponible en: 10.1177/0884533614557642.</dc:source>
   <dc:source>de Onis, Mercedes; Onyango, Adelheid W; Borghi, Elaine; Siyam, Amani; Nishida, Chizuru; Siekmann, Jonathan (2007) Development of a WHO growth reference for school-aged children and adolescents. En: Bulletin of the World Health Organization. Vol. 85; No. 9; pp. 660 - 667; 0042-9686; Consultado en: 2023/10/07/17:28:23. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636412/. Disponible en: 10.2471/BLT.07.043497.</dc:source>
   <dc:source>Schofield, W. N. (1985) Predicting basal metabolic rate, new standards and review of previous work. En: Human Nutrition. Clinical Nutrition. Vol. 39 Suppl 1; pp. 5 - 41; 0263-8290;</dc:source>
   <dc:source> Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. Consultado en: 2023/10/07/17:59:48. Disponible en: https://aspenjournals-onlinelibrary-wiley-com.ez.urosario.edu.co/doi/epdf/10.1177/0148607117711387.</dc:source>
   <dc:source>Tume, Lyvonne N.; Valla, Frederic V.; Joosten, Koen; Jotterand Chaparro, Corinne; Latten, Lynne; Marino, Luise V.; Macleod, Isobel; Moullet, Clémence; Pathan, Nazima; Rooze, Shancy; van Rosmalen, Joost; Verbruggen, Sascha C. A. T. (2020) Nutritional support for children during critical illness: European Society of Pediatric and Neonatal Intensive Care (ESPNIC) metabolism, endocrine and nutrition section position statement and clinical recommendations. En: Intensive Care Medicine. Vol. 46; No. 3; pp. 411 - 425; 0342-4642; Consultado en: 2023/10/07/18:05:04. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067708/. Disponible en: 10.1007/s00134-019-05922-5.</dc:source>
   <dc:source>Albadi, Maram S.; Bookari, Khlood (2022) Is Undernutrition Associated With Deterioration of Outcomes in the Pediatric Intensive Care Unit (PICU): Systematic and Meta-Analysis Review. En: Frontiers in Pediatrics. Vol. 10; pp. 769401 2296-2360; Consultado en: 2023/10/07/18:05:22. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114497/. Disponible en: 10.3389/fped.2022.769401.</dc:source>
   <dc:source>Jacquot, Aurélien; Valla, Frédéric Victor; Mura, Thibault; Tume, Lyvonne Nicole; Bertet, Héléna; Ford-Chessel, Carole; Milesi, Christophe; Cambonie, Gilles; De Luca, Arnaud; Gaillard-Le Roux, Bénédicte (2019) NUTRI-REAPED study: nutritional assessment of French critically ill children and nutrition practice survey in French-speaking pediatric intensive care units. En: Annals of Intensive Care. Vol. 9; pp. 15 2110-5820; Consultado en: 2023/10/07/18:07:00. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342745/. Disponible en: 10.1186/s13613-019-0493-z.</dc:source>
   <dc:source>Srinivasan, Vijay; Seiple, Stephanie; Nagle, Monica; Falk, Shiela; Kubis, Sherri; Lee, Henry M.; Sisko, Martha; Mascarenhas, Maria; Irving, Sharon Y. (2017) Improving the Performance of Anthropometry Measurements in the Pediatric Intensive Care Unit. En: Pediatric Quality &amp; Safety. Vol. 2; No. 3; pp. e022 2472-0054; Consultado en: 2023/10/07/18:09:01. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132458/. Disponible en: 10.1097/pq9.0000000000000022.</dc:source>
   <dc:source>Irving, Sharon Y.; Seiple, Stephanie; Nagle, Monica; Falk, Shiela; Mascarenhas, Maria; Srinivasan, Vijay (2015) Perceived barriers to anthropometric measurements in critically ill children. En: American Journal of Critical Care: An Official Publication, American Association of Critical-Care Nurses. Vol. 24; No. 6; pp. e99 - e107; 1937-710X; Disponible en: 10.4037/ajcc2015807.</dc:source>
   <dc:source>Stephens, Karen; Orlick, Meike; Beattie, Shannon; Snell, Audrey; Munsterman, Kim; Oladitan, Leah; Abdel-Rahman, Susan (2020) Examining Mid-Upper Arm Circumference Malnutrition z-Score Thresholds. En: Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition. Vol. 35; No. 2; pp. 344 - 352; 1941-2452; Disponible en: 10.1002/ncp.10324.</dc:source>
   <dc:source>Rasmussen, J.; Andersen, A.; Fisker, A. B.; Ravn, H.; Sodemann, M.; Rodrigues, A.; Benn, C. S.; Aaby, P. (2012) Mid-upper-arm-circumference and mid-upper-arm circumference z-score: the best predictor of mortality?. En: European Journal of Clinical Nutrition. Vol. 66; No. 9; pp. 998 - 1003; 1476-5640; Disponible en: 10.1038/ejcn.2012.95.</dc:source>
   <dc:source>Haque, Md Ahshanul; Choudhury, Nuzhat; Ahmed, S. M. Tanvir; Farzana, Fahmida Dil; Ali, Mohammad; Naz, Farina; Raihan, Mohammad Jyoti; Rahman, Sheikh Shahed; Siddiqua, Towfida Jahan; Faruque, Abu Syed Golam; Ahmed, Tahmeed (2022) Does a child's mid‐upper arm circumference‐for‐age z‐score represent another nutritional indicator of childhood malnutrition status?. En: Maternal &amp; Child Nutrition. Vol. 18; No. 4; pp. e13404 1740-8695; Consultado en: 2023/10/07/19:01:12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480943/. Disponible en: 10.1111/mcn.13404.</dc:source>
   <dc:source>de Castro, Georgina Toussaint-Martínez; Kaufer-Horwitz, Martha; Carrillo-López, Héctor Antonio; Klünder-Klünder, Miguel; Jarillo-Quijada, Alberto; García-Hernández, Héctor Rodrigo (2013) Estado nutricional de niños en condiciones críticas de ingreso a las unidades de terapia intensiva pediátrica. En: Bol Med Hosp Infant Mex. Vol. 70;</dc:source>
   <dc:source>Peterson, Laura S.; Suárez, Cecilia Gállego; Segaloff, Hannah E.; Griffin, Cameron; Martin, Emily T.; Odetola, Folafoluwa O.; Singer, Kanakadurga (2020) Outcomes and Resource Use Among Overweight and Obese Children With Sepsis in the Pediatric Intensive Care Unit. En: Journal of intensive care medicine. Vol. 35; No. 5; pp. 472 - 477; 0885-0666; Consultado en: 2023/10/07/22:27:46. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027613/. Disponible en: 10.1177/0885066618760541.</dc:source>
   <dc:source>Campos-Miño, Santiago; López-Herce Cid, Jesús; Figueiredo Delgado, Artur; Muñoz Benavides, Eliana; Coss-Bu, Jorge A.; Nutrition Committee, Latin American Society of Pediatric Intensive Care (SLACIP) (2019) The Latin American and Spanish Survey on Nutrition in Pediatric Intensive Care (ELAN-CIP2). En: Pediatric Critical Care Medicine: A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. Vol. 20; No. 1; pp. e23 - e29; 1529-7535; Disponible en: 10.1097/PCC.0000000000001761.</dc:source>
   <dc:source>Fivez, Tom; Kerklaan, Dorian; Mesotten, Dieter; Verbruggen, Sascha; Wouters, Pieter J.; Vanhorebeek, Ilse; Debaveye, Yves; Vlasselaers, Dirk; Desmet, Lars; Casaer, Michael P.; Garcia Guerra, Gonzalo; Hanot, Jan; Joffe, Ari; Tibboel, Dick; Joosten, Koen; Van Den Berghe, Greet (2016) Early versus Late Parenteral Nutrition in Critically Ill Children. En: New England Journal of Medicine. Vol. 374; No. 12; pp. 1111 - 1122; 0028-4793, 1533-4406; Consultado en: 2023/10/07/22:35:58. Disponible en: http://www.nejm.org/doi/10.1056/NEJMoa1514762. Disponible en: 10.1056/NEJMoa1514762.</dc:source>
   <dc:source> How much protein and energy are needed to equilibrate nitrogen and energy balances in ventilated critically ill children?. Consultado en: 2023/10/07/22:41:20. Disponible en: https://www-clinicalkey-es.ez.urosario.edu.co/#!/content/playContent/1-s2.0-S0261561415000904?returnurl=null&amp;referrer=null.</dc:source>
   <dc:source>Ministerio de Salud y Protección Social de la República de Colombia (2015) Encuesta Nacional de la Situación Nutricional ENSIN 2015. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/presentacion-lanzamiento-ensin-2015.pdf.</dc:source>
   <dc:source> Normatividad_Nuevo. Consultado en: 2023/11/03/05:41:37. Disponible en: https://www.minsalud.gov.co/Normatividad_Nuevo/Forms/DispForm.aspx?ID=4909.</dc:source>
   <dc:source> Fact sheets. Consultado en: 2023/11/18/18:10:22. Disponible en: https://www.who.int/news-room/fact-sheets/detail/malnutrition.</dc:source>
   <dc:source>Bechard, Lori J.; Staffa, Steven J.; Zurakowski, David; Mehta, Nilesh M. (2021) Time to achieve delivery of nutrition targets is associated with clinical outcomes in critically ill children. En: The American Journal of Clinical Nutrition. Vol. 114; No. 5; pp. 1859 - 1867; 1938-3207; Disponible en: 10.1093/ajcn/nqab244.</dc:source>
   <dc:source> (2015) Objetivo 2: Hambre Cero. En: Sustainable Development Goals Fund. Consultado en: 2024/03/10/02:32:20. Disponible en: https://www.sdgfund.org/es/objetivo-2-hambre-cero.</dc:source>
   <dc:source>Rodríguez-Mañas, Leocadio; Murray, Robert; Glencorse, Carole; Sulo, Suela (2022) Good nutrition across the lifespan is foundational for healthy aging and sustainable development. En: Frontiers in Nutrition. Vol. 9; pp. 1113060 2296-861X; Disponible en: 10.3389/fnut.2022.1113060.</dc:source>
   <dc:source>Solana, María José; Manrique, Gema; Fernández, Reyes; Slocker, María; García, Miriam; Redondo, Silvia; Yun, Cristina; Gil, Raquel; Balaguer, Mónica; Rodríguez, Eva; González-Posada, Aranzazu; Santiago, Carmen; Martín, Carmen María; Miñambres, María; Sánchez, María; Goñi, Concepción; López, Jorge; López-Herce, Jesus (2021) Nutritional status and nutrition support in critically ill children in Spain: Results of a multicentric study. En: Nutrition (Burbank, Los Angeles County, Calif.). Vol. 84; pp. 110993 1873-1244; Disponible en: 10.1016/j.nut.2020.110993.</dc:source>
   <dc:source>Zamberlan, Patrícia; Delgado, Artur Figueiredo; Leone, Cláudio; Feferbaum, Rubens; Okay, Thelma Suely (2011) Nutrition therapy in a pediatric intensive care unit: indications, monitoring, and complications. En: JPEN. Journal of parenteral and enteral nutrition. Vol. 35; No. 4; pp. 523 - 529; 1941-2444; Disponible en: 10.1177/0148607110386610.</dc:source>
   <dc:source> WMA. Consultado en: 2024/03/10/03:20:55. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/.</dc:source>
   <dc:source>SAS, Redjurista; Resolución 8430 de 1993. En: www.redjurista.com. Consultado en: 2024/03/10/03:32:11. Disponible en: https://www.redjurista.com/Documents/resolucion_8430_de_1993.aspx.</dc:source>
   <dc:source>Fieno, José Alberto Javier Tantaleán-da; Palomo-Luck, Olga Patricia; León-Paredes, Rosa Josefina (2022) Prácticas de soporte nutricional en unidad de cuidados intensivos pediátrica. En: Revista Cubana de Pediatría. Vol. 94; No. 1; pp. 1 - 13; 1561-3119; Consultado en: 2024/10/21/04:01:43. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=114621.</dc:source>
   <dc:source>de León, María; Dotti, María; Duarte, Matías; Hoffman, María; López, María; Encuesta sobre prácticas nutricionales en pacientes críticos pediátricos en Uruguay durante julio de 2020. </dc:source>
   <dc:source>Barrera, Isela; Osorio-Lechuga, Citlali; Torres-González, Karina; Chávez-López, Adrián (2022) Condición y abordaje nutricional del paciente crítico pediátrico: primeros días de hospitalización. En: Latin American Journal of Pediatric Gastroenterology and Nutrition. Vol. 1; Disponible en: 10.24875/LAJPGN.M22000001.</dc:source>
   <dc:source>Etchegaray-Armijo, Karina; Bustos-Arriagada, Edson (2021) Evaluación y apoyo nutricional en el paciente pediátrico críticamente enfermo: Revisión de la literatura. En: Revista chilena de nutrición. Vol. 48; pp. 95 - 102; Disponible en: 10.4067/S0717-75182021000100095.</dc:source>
   <dc:source>Galeano, Fernando; Sanabria-Báez, Gabriela (2018) DESCRIPTION OF THE COMPLICATIONS ASSOCIATED WITH PARENTERAL NUTRITION IN NEONATES OF HOSPITAL OF CLINICS OF SAN LORENZO. En: Revista del Instituto de Medicina Tropical. Vol. 13; No. 2; pp. 3 - 9; 19963696; Consultado en: 2024/10/21/17:06:57. Disponible en: http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S1996-36962018000200003&amp;lng=es&amp;nrm=iso&amp;tlng=es. Disponible en: 10.18004/imt/20181323-9.</dc:source>
   <dc:source>Martínez-Costa, Cecilia; Giner, Consuelo (2017) Requerimientos en nutrición parenteral pediátrica. En: Nutrición Hospitalaria. Vol. 34; Disponible en: 10.20960/nh.1376.</dc:source>
   <dc:source>Naing, Lin; Nordin, Rusli; Abdul Rahman, Hanif; Naing, Yuwadi (2022) Sample size calculation for prevalence studies using Scalex and ScalaR calculators. En: BMC Medical Research Methodology. Vol. 22; Disponible en: 10.1186/s12874-022-01694-7.</dc:source>
   <dc:source>Theodoridis, Xenophon; Chrysoula, Lydia; Evripidou, Kleo; Kalaitzopoulou, Ioustini; Chourdakis, Michail (2023) Continuous versus Intermittent Enteral Feeding in Critically Ill Children: A Systematic Review. En: Nutrients. Vol. 15; pp. 288 Disponible en: 10.3390/nu15020288.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/3618</identifier><datestamp>2021-06-03T00:47:17Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Efectos de la ventilación mecánica con heliox en niños y adolescentes con patología bronquial obstructiva</dc:title>
   <dc:creator>Angarita Daza, Deicy</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:contributor>Godoy, Javier</dc:contributor>
   <dc:contributor>Mullet, Hernando</dc:contributor>
   <dc:subject>Heliox</dc:subject>
   <dc:subject>Ventilación mecánica</dc:subject>
   <dc:subject>Falla respiratoria</dc:subject>
   <dc:subject>Niños</dc:subject>
   <dcterms:abstract>Objective: To evaluate if the Heliox reduces the resistance in the airway in children and adolescents with obstructive bronchial pathology and mechanical ventilation.  &#xd;
Materials and Methods: An observational prospective descriptive study was made in children and adolescents with obstructive bronchial pathology and mechanical ventilation with Fi02 ≤ 0,5.  Different variables were measured: resistance, pressure peak, mean airway pressure, pressure plateau, tidal volume, AutoPEEP, compliance, PetCO2, dead space ventilation, before heliox and after 30 minutes, 2, 4, 6, 12, 18 and 24 hours, and daily until heliox suspension by extubation or FiO2  > 0,5. &#xd;
Results: This study with partial results included 9 patients finding significant reduction of expiratory resistance to 30 minutes (51.2 versus 32,3; p=0,0008), 2 hours (51.2 versus 33,4; p=0,0019) and 4 hours (51.2 versus 30,7; p=0,0012) as well as of the inspiratory resistance to hour 2 (48.6 versus 36,2; p = 0.013) and hour 4 (48.6 versus 30; p=0,004).  PetCO2 no significant decreasing tendency was observed (52.3 versus 34,3: p=0,06). No changes in variables; autoPEEP, pressure peak, mean airway pressure, compliance, dead space, pressure plateau and tidal volume, before or after the Heliox were observed.&#xd;
Conclusion: Mechanical ventilation with Heliox in Children with bronchial obstructive pathology appears to be that it reduce in a significant way the resistance of the airway, with tendency to the reduction of the PetC02. Prospective studies are needed at least observational analytic that corroborate these findings.</dcterms:abstract>
   <dcterms:dateAccepted>2012-07-23T14:04:30Z</dcterms:dateAccepted>
   <dcterms:available>2012-07-23T14:04:30Z</dcterms:available>
   <dcterms:created>2012-07-23T14:04:30Z</dcterms:created>
   <dcterms:issued>2012</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_3618 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/3618</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Philippe Jolliet, Christine Watremez, Comparative effects of helium-oxygen and external positive end-expiratory pressure on respiratory mechanics, gas exchange, and ventilation-perfusion relationships in mechanically ventilated patients with chronic obstructive pulmonary disease Intensive Care Med (2003) 29:1442–1450</dc:source>
   <dc:source>Claudio Migliori, The Effects of Helium/Oxygen Mixture (Heliox) Before and After Extubation in Long-term Mechanically Ventilated Very Low Birth Weight Infants Pediatrics 2009;123: 1524–1528</dc:source>
   <dc:source>Fernández Jaime, Estrategias de ventilación mecánica y terapia coadyuvante en enfermedades pulmonares severas, El niño en estado crítico, 2 ed, 2011; 82-86</dc:source>
   <dc:source>Matthew F Gross, Robert M Spear, Helium–oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis, Crit Care 2000, 4:188–192</dc:source>
   <dc:source>Martin CJ Kneyber, Marc van Heerde, Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure, Critical Care 2009</dc:source>
   <dc:source>Abd-Allah SA, Rogers MS, Terry M, et al. Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatr Crit Care Med 2003;4(3):353-7.</dc:source>
   <dc:source>Martin C. J. Kneyber Mechanical ventilation with heliox decreases respiratory system resistance and facilitates CO2 removal in obstructive airway disease Intensive Care Med (2006) 32:1676–167</dc:source>
   <dc:source>Tobias JD: Heliox in children with airway obstruction. Pediatr Emerg Care 1997; 13: 29–32</dc:source>
   <dc:source>Kass JE, Castriotta RJ: Heliox therapy in acute severe asthma. Chest 1995; 107: 757–760</dc:source>
   <dc:source>Wolfson MR, Bhutani VK, Shaffer TH, et al: Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984; 104: 752–757</dc:source>
   <dc:source>Macklem PT: The physiology of the small airway. Am J Respir Crit Care Med 1998; 157: 2181–2183</dc:source>
   <dc:source>Martinon F. Heliox: Teorías y Prácticas pediátricas. En Manual de Cuidados Intensivos Pediátricos 3ra Ed. Ruza. 2001: 532-557</dc:source>
   <dc:source>Martinon-Torres F. Current treatment for acute viral bronchiolitis in infants. Expert Opin Pharmacother. 2003 Aug;4(8):1355-71</dc:source>
   <dc:source>Barach AL: The use of helium in the treatment of asthma and obstructive lesions in the larynx and trachea. Ann Intern Med 1935; 9: 739–765</dc:source>
   <dc:source>Stein R, Canny GJ, Bohn DJ, et al: Severe acute asthma in a pediatric intensive care unit: Six years’ experience. Pediatrics 1989; 83: 1023–1028</dc:source>
   <dc:source>Osundwa VM, Dawod S: Four-year experience with bronchial asthma in a pediatric intensive care unit. Ann Allergy 1992; 69: 518–520</dc:source>
   <dc:source>Shugg AW, Kerr S, Butt WW: Mechanical ventilation of paediatric patients with asthma: Short and long term outcome. J Paediatr Child Health 1990; 26: 343–346</dc:source>
   <dc:source>DeNicola LK, Monem GF, Gayle MO, et al: Treatment of critical status asthmaticus in children. Pediatr Clin North Am 1994; 41: 1293–1324</dc:source>
   <dc:source>Schnitzler, Eduardo MD; Minces, Pablo MD. Is helium a better vehicle for aerosol therapy?. Ped Crit Care 2002;3;86-87</dc:source>
   <dc:source>Paret G, Kornecki A, Szeinberg A, et al: Severe acute asthma in a community hospital pediatric intensive care unit: A ten years’ experience. Ann Allergy Asthma Immunol 1998; 80: 339–344</dc:source>
   <dc:source>Dworkin G, Katton M: Mechanical ventilation for status asthmaticus in children. J Pediatr 1989; 114: 545–549</dc:source>
   <dc:source>Shiue ST, Gluck EH: The use of helium-oxygen mixtures in the support of patients with status asthmaticus and respiratory acidosis. J Asthma 1989; 26: 177–180</dc:source>
   <dc:source>Manthous CA, Morgan S, Pohlman A, et al: Heliox in the treatment of airflow obstruction: A critical review of the literature. Respir Care 1997; 42: 1034–1042</dc:source>
   <dc:source>Gluck EH, Onorato DJ, Castriotta R: Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98: 693–698</dc:source>
   <dc:source>Austan F: Heliox inhalation in status asthmaticus anrespiratory acidemia: A brief report. Heart Lung 1996; 25: 155–157</dc:source>
   <dc:source>Duncan PG: Efficacy of helium-oxygen mixtures in the management of severe viral and postintubation croup. Can Anaesth Soc J 1979; 26: 206–212</dc:source>
   <dc:source>Kemper KJ, Ritz RH, Benson MS, et al: Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991; 19: 356</dc:source>
   <dc:source>Kemper KJ, Izenberg S, Marvin JA, et al: Treatment of postextubation stridor in a pediatric patient with burns: The role of heliox. J Burn Care Rehabil 1990; 11: 337–339</dc:source>
   <dc:source>Weber JE, Chudnofsky CR, Younger JG, et al: A randomized comparison of helium-oxygen mixture (heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001; 107: e96</dc:source>
   <dc:source>Piva JP, Menna Barreto S, Zelmanovitz F, et al: Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002; 3: 6–10</dc:source>
   <dc:source>Polaner DM: The use of heliox and the laryngeal mask airway in a child with an anterior mediastinal mass. Anesth Analg 1996; 82: 208–210</dc:source>
   <dc:source>Rodrigo G, Pollack C, Rodrigo C, Rowe B. Cochrane Database Syst Rev. 2003;4 Y Chest. 2003 Mar;123(3):891-6</dc:source>
   <dc:source>Ho Anthony y cols. Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma. Meta-análysis. Chest 2003:123;882-890</dc:source>
   <dc:source>Manthous CA, Hall JB, Melmed A, et al: Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med 1995; 151: 310–314</dc:source>
   <dc:source>Kass J. Heliox redux. Chest 2003;123:673-4</dc:source>
   <dc:source>Paret G, Dekel B, Vardi A, et al: Heliox in respiratory failure secondary to bronchiolitis: A new therapy. Pediatr Pulmonol 1996; 22: 322–323</dc:source>
   <dc:source>Hollman G, Shen G, Zeng L, et al: Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis. Crit Care Med 1998; 26: 1731–1736</dc:source>
   <dc:source>Martinon F y cols. Heliox therapy in infants with acute bronchiolitis. Pediatrics 2002;109:68-73</dc:source>
   <dc:source>Pizov R, Oppenheim A, Eidelman LA, et al: Helium versus oxygen for tracheal gas insufflation during mechanical ventilation. Crit Care Med 1998; 26: 290–295</dc:source>
   <dc:source>Tsuno K, Prato P, Kolobow T: Acute lung injury from mechanical ventilation at moderately high airway pressures. J Appl Physiol 1990; 69: 956–961</dc:source>
   <dc:source>Sauder RA, Rafferty JF, Bilenki AL, et al: Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant. South Med J 1991; 84: 646–648</dc:source>
   <dc:source>Habib DM, Garner SS, Brandeburg S: Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy 1999; 19: 143–149</dc:source>
   <dc:source>Fernández Jaime, Ventilación mecánica con Heliox, Acta Colombiana de Cuidado Intensivo 2009; 9(4): 355-358</dc:source>
   <dc:source>Tassaux D, Jolliet P, Thouret J, et al: Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures. Am J Respir Crit Care Med 1999; 160: 22–32</dc:source>
   <dc:source>Berkenbosch, John W. MD; Grueber, Ryan E. Effect of helium-oxygen (heliox) gas mixtures on the function of four pediatric ventilators. Crit Care Med 2003;31:2052-58</dc:source>
   <dc:source>Anderson M, Svartengren M, Gunnar B, et al: Deposition in asthmatics of particles inhaled in air or in helium-oxygen. Am Rev Respir Dis 1993; 147: 524–528</dc:source>
   <dc:source>Michael JG, Blockage T, Tobias JD: Helium administration during mechanical ventilation in children with respiratory failure. J Intensive Care Med 1999; 14: 140–147</dc:source>
   <dc:source>Svartengren M, Skogward P, Nerbrink O, et al: Regional deposition of inhaled Evans blue dye in mechanically ventilated rabbits with air or helium oxygen mixture. Exp Lung Res 1998; 24: 159–172</dc:source>
   <dc:source>Ruben A, Harris A. Heliox for asthma in the emergency departament: a review of the literature. Emerg Med J 2004:21;131-135</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/1262</identifier><datestamp>2021-06-03T00:47:03Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Factores de riesgo para mortalidad quirúrgica en menores de un año con cardiopatía congénita</dc:title>
   <dc:creator>Mojica Walteros, Carlos Manuel</dc:creator>
   <dc:contributor>Guerra Romero, Alberto Rafael</dc:contributor>
   <dc:subject>Cardiopatías congénitas</dc:subject>
   <dc:subject>Complicaciones</dc:subject>
   <dc:subject>Factores de riesgo</dc:subject>
   <dc:subject>Mortalidad</dc:subject>
   <dcterms:abstract>OBJECTIVES Identify factors associated with mortality in patients under 1 year of age operated on for congenital heart disease at the Foundation Cardioinfantil IC, in a period from August 2004 to December 31, 2007. METHODS Descriptive analytical observational study of cases and controls in the period indicated. We reviewed 290 patients of which 60 were cases and 230 controls. A bivariate analysis with the risk ratio (Odds Ratio - OR) and confidence intervals 95% and subsequently performed unconditional logistic regression (multivariate) analysis of factors associated together.</dcterms:abstract>
   <dcterms:dateAccepted>2009-07-08T15:31:35Z</dcterms:dateAccepted>
   <dcterms:available>2009-07-08T15:31:35Z</dcterms:available>
   <dcterms:created>2009-07-08T15:31:35Z</dcterms:created>
   <dcterms:issued>2009</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_1262 </dc:identifier>
   <dc:identifier>TEME 0006 2009</dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/1262</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
&#xd;
PARÁGRAFO: En caso de presentarse cualquier reclamación o acción &#xd;
por parte de un tercero en cuanto a los derechos de autor sobre &#xd;
la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe.  &#xd;
&#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/45864</identifier><datestamp>2025-10-09T09:26:25Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Association Between Hyperprocalcitonemia and Endothelial and Microcirculatory Dysfunction and Outcomes in Children with Sepsis and Septic Shock</dc:title>
   <dc:creator>Beltrán Hernández, Briam</dc:creator>
   <dc:creator>Fernandez-Sarmiento, Jaime</dc:creator>
   <dc:creator>Cardenas, Carolina</dc:creator>
   <dc:creator>Mulett Hoyos, Hernando</dc:creator>
   <dc:creator>Sarta Mantilla, Mauricio</dc:creator>
   <dc:contributor>Fernández Sarmiento, Jaime</dc:contributor>
   <dc:subject>Sepsis</dc:subject>
   <dc:subject>Choque séptico</dc:subject>
   <dc:subject>Endotelio</dc:subject>
   <dc:subject>Matriz extracelular</dc:subject>
   <dc:subject>Glicocálix</dc:subject>
   <dc:subject>Permeabilidad vascular</dc:subject>
   <dc:subject>Proteoglicanos</dc:subject>
   <dc:subject>Resultados clínicos</dc:subject>
   <dcterms:abstract>OBJECTIVES: To evaluate the association between hyperprocalcitonemia and endothelial and microcirculatory dysfunction in children with sepsis and septic shock, along with clinical outcomes. DESIGN: A prospective observational cohort study. SETTING: A tertiary care pediatric intensive care unit (PICU) with 15 medical-surgical beds in a university hospital. PATIENTS: We included children with sepsis and/or septic shock who had serum procalcitonin (PCT) measured at admission, 24 hours, and 48 hours, with simultaneous microcirculatory assessment using sublingual videomicroscopy and evaluation of endothelial injury biomarkers (syndecan-1, angiopoietin-2, [Ang-2] and endocan). Hyperprocalcitonemia (H-PCT) was defined as procalcitonin > 2 ng/mL. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the 230 included patients, 43.9% (101/230) had H-PCT at PICU admission. After adjusting for confounders, children with H-PCT showed a greater reduction in capillary blood flow at 24 hours (aOR, 1.35 [95% CI, 1.08–1.72]) and 48 hours (aOR, 1.14 [95% CI, 1.04–1.24]) after admission, compared with patients with normal PCT. Children with H-PCT and elevated serum lactate had higher odds of glycocalyx damage (aOR, 1.31 [95% CI, 1.09–1.68]; p = 0.041). At 24 hours, children with H-PCT had higher syndecan-1 levels (125.87 [IQR, 49.56–224.30] vs. 107.71 [IQR, 62.82–156.55] ng/mL, respectively; p &lt; 0.01) and higher odds of Ang-2 elevation (aOR, 2.28 [95% CI, 1.08–5.17]; p = 0.042). Hyperprocalcitonemia with severe endothelial/microcirculatory dysfunction was associated with >10% fluid overload (aOR, 2.01 [95% CI, 1.06–3.80]; p = 0.033), multiple organ dysfunction (aOR, 1.87 [95% CI, 1.01–3.57]; p = 0.041), and mortality (aOR, 1.66 [95% CI, 1.06–2.61]; p = 0.022). CONCLUSIONS: Hyperprocalcitonemia in children with sepsis and septic shock represents a phenotype characterized by endothelial and microvascular dysfunction, and is associated with worse clinical outcomes. Our study suggests that preserving microvascular integrity may be a therapeutic target to reduce microcirculatory damage and  improve outcomes.</dcterms:abstract>
   <dcterms:dateAccepted>2025-07-14T15:00:44Z</dcterms:dateAccepted>
   <dcterms:available>2025-07-14T15:00:44Z</dcterms:available>
   <dcterms:created>2025-07-14T15:00:44Z</dcterms:created>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_45864</dc:identifier>
   <dc:identifier>https://repository.urosario.edu.co/handle/10336/45864</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto Completo)</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Escuela de Medicina y Ciencias de la Salud</dc:publisher>
   <dc:publisher>Especialización en Medicina Crítica y Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>Dahabreh, Issa J.; Bibbins-Domingo, Kirsten (2024) Causal Inference About the Effects of Interventions From Observational Studies in Medical Journals. En: JAMA. Vol. 331; No. 21; pp. 1845 - 1845; Disponible en: 10.1001/jama.2024.7741.</dc:source>
   <dc:source>Aldewereld, Zachary; Horvat, Christopher; Clermont, Gilles (2025) Pediatric Sepsis Phenotype in a Single-Center Cohort Covering 2010–2020: Evolution in Day 1–Day 3 Trajectory and Potential Prognostic Value. En: Pediatric Critical Care Medicine. Vol. 26; No. 7; pp. e909 - e914; Disponible en: 10.1097/PCC.0000000000003708.</dc:source>
   <dc:source>Stanski, Natalja L.; Zhang, Bin; Cvijanovich, Natalie Z.; Fitzgerald, Julie C.; Bigham, Michael T.; Jain, Parag N.; Schwarz, Adam J.; Lutfi, Riad; Allen, Geoffrey L.; Thomas, Neal J.; Baines, Torrey; Haileselassie, Bereketeab; Weiss, Scott L.; Atreya, Mihir R.; Lautz, Andrew J.; Zingarelli, Basilia; Standage, Stephen W.; Kaplan, Jennifer; Goldstein, Stuart L. (2024) Diagnostic Validation of the Updated Pediatric Sepsis Biomarker Risk II for Acute Kidney Injury Prediction Model in Pediatric Septic Shock*. En: Pediatric Critical Care Medicine. Vol. 25; No. 11; pp. 1005 - 1016; Disponible en: 10.1097/PCC.0000000000003589.</dc:source>
   <dc:source>Atreya, Mihir R.; Bennett, Tellen D.; Geva, Alon; Faustino, E. Vincent S.; Rogerson, Colin M.; Lutfi, Riad; Cvijanovich, Natalie Z.; Bigham, Michael T.; Nowak, Jeffrey; Schwarz, Adam J.; Baines, Torrey; Haileselassie, Bereketeab; Thomas, Neal J.; Luo, Yuan; Sanchez-Pinto, L. Nelson (2024) Biomarker Assessment of a High-Risk, Data-Driven Pediatric Sepsis Phenotype Characterized by Persistent Hypoxemia, Encephalopathy, and Shock. En: Pediatric Critical Care Medicine. Vol. 25; No. 6; pp. 512 - 517; Disponible en: 10.1097/PCC.0000000000003499.</dc:source>
   <dc:source>Sanchez-Pinto, L. Nelson; Bennett, Tellen D.; Stroup, Emily K.; Luo, Yuan; Atreya, Mihir; Bubeck Wardenburg, Juliane; Chong, Grace; Geva, Alon; Faustino, E. Vincent S.; Farris, Reid W.; Hall, Mark W.; Rogerson, Colin; Shah, Sareen S.; Weiss, Scott L.; Khemani, Robinder G. (2023) Derivation, Validation, and Clinical Relevance of a Pediatric Sepsis Phenotype With Persistent Hypoxemia, Encephalopathy, and Shock*. En: Pediatric Critical Care Medicine. Vol. 24; No. 10; pp. 795 - 806; Disponible en: 10.1097/PCC.0000000000003292.</dc:source>
   <dc:source>Branco, Ricardo G. (2023) Balancing Fluid Resuscitation in Pediatric Sepsis*. En: Pediatric Critical Care Medicine. Vol. 24; No. 3; pp. 257 - 259; Disponible en: 10.1097/PCC.0000000000003172.</dc:source>
   <dc:source>Nylen, Eric S.; Whang, Kevin T.; Snider, Richard H.; Steinwald, Paul M.; White, Jon C.; Becker, Kenneth L. (1998) Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. En: Critical Care Medicine. Vol. 26; No. 6; pp. 1001 - 1006; Disponible en: 10.1097/00003246-199806000-00015.</dc:source>
   <dc:source>Duranteau, J.; De Backer, D.; Donadello, K.; Shapiro, N. I.; Hutchings, S. D.; Rovas, A.; Legrand, M.; Harrois, A.; Ince, C. (2023) The future of intensive care: the study of the microcirculation will help to guide our therapies. En: Critical Care. Vol. 27; No. 1; pp. 190 - 190; Disponible en: 10.1186/s13054-023-04474-x.</dc:source>
   <dc:source>Piotti, Arianna; Novelli, Deborah; Meessen, Jennifer Marie Theresia Anna; Ferlicca, Daniela; Coppolecchia, Sara; Marino, Antonella; Salati, Giovanni; Savioli, Monica; Grasselli, Giacomo; Bellani, Giacomo; Pesenti, Antonio; Masson, Serge; Caironi, Pietro; Gattinoni, Luciano; Gobbi, Marco; Fracasso, Claudia; Latini, Roberto; Bruzzone, Paola; Pagan, Francesca; Russo, Riccarda; Confalonieri, Andrea; Abbruzzese, Chiara; Vergnano, Beatrice; Faenza, Stefano; Siniscalchi, Antonio; Pierucci, Elisabetta; Noto, Andrea; Pezzi, Angelo; Spanu, Paolo; Parrini, Vieri; Oggioni, Roberto; Pasetti, Giovanni Stefano; Casadio, Maria Cinzia; Buontempo, Rosa; Carrer, Sara; Piccoli, Francesca; Rizzi, Tatiana; Caricato, Anselmo; La Sala, Monica; Antonaci, Alessandra; Fassini, Paola; Paganini, Silvia; Porta, Virginia; Moise, Gabriella; Marell, Silvia; Furia, Mirella; Urbano, Maria Cristina; Carobbi, Roberta; Poleni, Simona; Kandil, Hassan; Ballotta, Andrea; Bettini, Fabrizio; Sanseverino, Manlio; Gatta, Alessandro; Cecchini, Francesca; Guatteri, Luca; Ciceri, Gabriella; Raimondi, Ferdinando; Colombo, Roberto; Ferraris, Sandra; Borelli, Massimo; Bellato, Valentina; Cancellieri, Franco; Senni, Silvia; Bertocchi, Ester; Ferri, Paola; Moioli, Gianpietro; Fedele, Andrea; Molin, Alexandra; Salati, Giovanni; Salsi, Pierpaolo; Brunori, Emanuela; Elisei, Daniele; Maggio, Giuseppe; Nicola, Federico Guardia; Cavana, Marco; Morelli, Giacomo; Guarino, Arturo; Isetta, Michele; Tulli, Giorgio; Mangani, Valerio; Rossi, Nicola; Ferrari, Marta; Bona, Francesco; Vay, Monica; Bartoli, Teresa; Gallo, Mauro; Vettoretto, Katiuscia; Morte, Mauro Della; Boselli, Enrico; Puscio, Daniela; Bovo, Monia; Galzerano, Antonio; Carli, Manuela; Zagara, Giovanni (2021) Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS. En: Critical Care. Vol. 25; No. 1; pp. 113 - 113; Disponible en: 10.1186/s13054-021-03545-1.</dc:source>
   <dc:source>Ince, Can (2015) Hemodynamic coherence and the rationale for monitoring the microcirculation. En: Critical Care. Vol. 19; No. S3; pp. S8 - S8; Disponible en: 10.1186/cc14726.</dc:source>
   <dc:source>Baranowsky, Anke; Appelt, Jessika; Kleber, Christian; Lange, Tobias; Ludewig, Peter; Jahn, Denise; Pandey, Puja; Keller, Daniela; Rose, Thomas; Schetler, Daniela; Braumüller, Sonja; Huber-Lang, Markus; Tsitsilonis, Serafeim; Yorgan, Timur; Frosch, Karl-Heinz; Amling, Michael; Schinke, Thorsten; Keller, Johannes (2021) Procalcitonin Exerts a Mediator Role in Septic Shock Through the Calcitonin Gene-Related Peptide Receptor. En: Critical Care Medicine. Vol. 49; No. 1; pp. e41 - e52; Disponible en: 10.1097/CCM.0000000000004731.</dc:source>
   <dc:source>Opal, S. M.; van der Poll, T. (2015) Endothelial barrier dysfunction in septic shock. En: Journal of Internal Medicine. Vol. 277; No. 3; pp. 277 - 293; Disponible en: 10.1111/joim.12331.</dc:source>
   <dc:source>Hellenthal, Katharina E. M.; Brabenec, Laura; Wagner, Nana-Maria (2022) Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation. En: Cells. Vol. 11; No. 12; pp. 1935 - 1935; Disponible en: 10.3390/cells11121935.</dc:source>
   <dc:source>Østergaard, Leif (2020) Blood flow, capillary transit times, and tissue oxygenation: the centennial of capillary recruitment. En: Journal of Applied Physiology. Vol. 129; No. 6; pp. 1413 - 1421; Disponible en: 10.1152/japplphysiol.00537.2020.</dc:source>
   <dc:source>Gupta, Shefali; Jaswani, Pradeep; Sharma, Raj K.; Agrawal, Suraksha; Prasad, Narayan; Sahu, Chinmoy; Gupta, Amit; Prasad, Kashi N. (2019) Procalcitonin as a diagnostic biomarker of sepsis: A tertiary care centre experience. En: Journal of Infection and Public Health. Vol. 12; No. 3; pp. 323 - 329; Disponible en: 10.1016/j.jiph.2018.11.004.</dc:source>
   <dc:source>Becker, Kenneth L.; Snider, Richard; Nylen, Eric S. (2010) Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. En: British Journal of Pharmacology. Vol. 159; No. 2; pp. 253 - 264; Disponible en: 10.1111/j.1476-5381.2009.00433.x.</dc:source>
   <dc:source>Sinha, Mahua; Desai, Seemanthini; Mantri, Sumant; Kulkarni, Anuja (2011) Procalcitonin as an adjunctive biomarker in sepsis. En: Indian Journal of Anaesthesia. Vol. 55; No. 3; pp. 266 - 266; Disponible en: 10.4103/0019-5049.82676.</dc:source>
   <dc:source>Rovas, Alexandros; Sackarnd, Jan; Rossaint, Jan; Kampmeier, Stefanie; Pavenstädt, Hermann; Vink, Hans; Kümpers, Philipp (2021) Identification of novel sublingual parameters to analyze and diagnose microvascular dysfunction in sepsis: the NOSTRADAMUS study. En: Critical Care. Vol. 25; No. 1; pp. 112 - 112; Disponible en: 10.1186/s13054-021-03520-w.</dc:source>
   <dc:source>Rovas, Alexandros; Lukasz, Alexander-Henrik; Vink, Hans; Urban, Marc; Sackarnd, Jan; Pavenstädt, Hermann; Kümpers, Philipp (2018) Bedside analysis of the sublingual microvascular glycocalyx in the emergency room and intensive care unit – the GlycoNurse study. En: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. Vol. 26; No. 1; pp. 16 - 16; Disponible en: 10.1186/s13049-018-0483-4.</dc:source>
   <dc:source>Ince, Can; Boerma, E. Christiaan; Cecconi, Maurizio; De Backer, Daniel; Shapiro, Nathan I.; Duranteau, Jacques; Pinsky, Michael R.; Artigas, Antonio; Teboul, Jean-Louis; Reiss, Irwin K. M.; Aldecoa, Cesar; Hutchings, Sam D.; Donati, Abele; Maggiorini, Marco; Taccone, Fabio S.; Hernandez, Glenn; Payen, Didier; Tibboel, Dick; Martin, Daniel S.; Zarbock, Alexander; Monnet, Xavier; Dubin, Arnaldo; Bakker, Jan; Vincent, Jean-Louis; Scheeren, Thomas W. L. (2018) Second consensus on the assessment of sublingual microcirculation in critically ill patients: results from a task force of the European Society of Intensive Care Medicine. En: Intensive Care Medicine. Vol. 44; No. 3; pp. 281 - 299; Disponible en: 10.1007/s00134-018-5070-7.</dc:source>
   <dc:source>Becker, Bernhard F.; Jacob, Matthias; Leipert, Stephanie; Salmon, Andrew H. J.; Chappell, Daniel (2015) Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. En: British Journal of Clinical Pharmacology. Vol. 80; No. 3; pp. 389 - 402; Disponible en: 10.1111/bcp.12629.</dc:source>
   <dc:source>Hou, Peter C.; Filbin, Michael R.; Wang, Henry; Ngo, Long; Huang, David T.; Aird, William C.; Yealy, Donald M.; Angus, Derek C.; Kellum, John A.; Shapiro, Nathan I. (2017) Endothelial Permeability and Hemostasis in Septic Shock. En: Chest. Vol. 152; No. 1; pp. 22 - 31; Disponible en: 10.1016/j.chest.2017.01.010.</dc:source>
   <dc:source>Shapiro, Nathan I; Schuetz, Philipp; Yano, Kiichiro; Sorasaki, Midori; Parikh, Samir M; Jones, Alan E; Trzeciak, Stephen; Ngo, Long; Aird, William C (2010) The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. En: Critical Care. Vol. 14; No. 5; pp. R182 - R182; Disponible en: 10.1186/cc9290.</dc:source>
   <dc:source>Edul, Vanina S. Kanoore; Ince, Can; Vazquez, Alejandro Risso; Rubatto, Paolo N.; Espinoza, Emilio D. Valenzuela; Welsh, Sebastián; Enrico, Carolina; Dubin, Arnaldo (2016) Similar Microcirculatory Alterations in Patients with Normodynamic and Hyperdynamic Septic Shock. En: Annals of the American Thoracic Society. Vol. 13; No. 2; pp. 240 - 247; Disponible en: 10.1513/AnnalsATS.201509-606OC.</dc:source>
   <dc:source>Poole, David C.; Pittman, Roland N.; Musch, Timothy I.; Østergaard, Leif (2020) August Krogh's theory of muscle microvascular control and oxygen delivery: a paradigm shift based on new data. En: The Journal of Physiology. Vol. 598; No. 20; pp. 4473 - 4507; Disponible en: 10.1113/JP279223.</dc:source>
   <dc:source>De Backer, Daniel; Orbegozo Cortes, Diego; Donadello, Katia (2014) Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. En: Virulence. Vol. 5; No. 1; pp. 73 - 79; Disponible en: 10.4161/viru.26482.</dc:source>
   <dc:source>Schlapbach, Luregn J.; Watson, R. Scott; Sorce, Lauren R.; Argent, Andrew C.; Menon, Kusum; Hall, Mark W.; Akech, Samuel; Albers, David J.; Alpern, Elizabeth R.; Balamuth, Fran; Bembea, Melania; Biban, Paolo; Carrol, Enitan D.; Chiotos, Kathleen; Chisti, Mohammod Jobayer; Dewitt, Peter E.; Evans, Idris; Flauzino De Oliveira, Cláudio; Horvat, Christopher M.; Inwald, David; Ishimine, Paul; Jaramillo-Bustamante, Juan Camilo; Levin, Michael; Lodha, Rakesh; Martin, Blake; Nadel, Simon; Nakagawa, Satoshi; Peters, Mark J.; Randolph, Adrienne G.; Ranjit, Suchitra; Rebull, Margaret N.; Russell, Seth; Scott, Halden F.; De Souza, Daniela Carla; Tissieres, Pierre; Weiss, Scott L.; Wiens, Matthew O.; Wynn, James L.; Kissoon, Niranjan; Zimmerman, Jerry J.; Sanchez-Pinto, L. Nelson; Bennett, Tellen D. (2024) International Consensus Criteria for Pediatric Sepsis and Septic Shock. En: JAMA.: American Medical Association; Disponible en: 10.1001/jama.2024.0179.</dc:source>
   <dc:source>Downes, Kevin J.; Fitzgerald, Julie C.; Weiss, Scott L. (2020) Utility of Procalcitonin as a Biomarker for Sepsis in Children. En: Journal of Clinical Microbiology. Vol. 58; No. 7; American Society for Microbiology; Disponible en: 10.1128/JCM.01851-19.</dc:source>
   <dc:source>Fernández-Sarmiento, Jaime; Lamprea, Shirley; Barrera, Sofia; Acevedo, Lorena; Duque, Catalina; Trujillo, Manuela; Aguirre, Valeria; Jimenez, Carolina (2024) The association between prolonged capillary refill time and microcirculation changes in children with sepsis. En: BMC Pediatrics. Vol. 24; No. 1; pp. 68 - 68; Disponible en: https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-024-04524-5. Disponible en: 10.1186/s12887-024-04524-5.</dc:source>
   <dc:source>Fernández-Sarmiento, Jaime; Salazar-Peláez, Lina María; Carcillo, Joseph A. (2020) The Endothelial Glycocalyx: A Fundamental Determinant of Vascular Permeability in Sepsis. En: Pediatric Critical Care Medicine. Vol. 21; No. 5; pp. E291 - E300; Lippincott Williams and Wilkins; Disponible en: 10.1097/PCC.0000000000002266.</dc:source>
   <dc:source>Weiss, Scott L.; Peters, Mark J.; Alhazzani, Waleed; Agus, Michael S.D.; Flori, Heidi R.; Inwald, David P.; Nadel, Simon; Schlapbach, Luregn J.; Tasker, Robert C.; Argent, Andrew C.; Brierley, Joe; Carcillo, Joseph; Carrol, Enitan D.; Carroll, Christopher L.; Cheifetz, Ira M.; Choong, Karen; Cies, Jeffry J.; Cruz, Andrea T.; De Luca, Daniele; Deep, Akash; Faust, Saul N.; De Oliveira, Claudio Flauzino; Hall, Mark W.; Ishimine, Paul; Javouhey, Etienne; Joosten, Koen F.M.; Joshi, Poonam; Karam, Oliver; Kneyber, Martin C.J.; Lemson, Joris; MacLaren, Graeme; Mehta, Nilesh M.; Møller, Morten Hylander; Newth, Christopher J.L.; Nguyen, Trung C.; Nishisaki, Akira; Nunnally, Mark E.; Parker, Margaret M.; Paul, Raina M.; Randolph, Adrienne G.; Ranjit, Suchitra; Romer, Lewis H.; Scott, Halden F.; Tume, Lyvonne N.; Verger, Judy T.; Williams, Eric A.; Wolf, Joshua; Wong, Hector R.; Zimmerman, Jerry J.; Kissoon, Niranjan; Tissieres, Pierre (2020) Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. En: Intensive Care Medicine. Vol. 46; pp. 10 - 67; Springer; Disponible en: 10.1007/s00134-019-05878-6.</dc:source>
   <dc:source>Fernández-Sarmiento, Jaime; Salazar-Peláez, Lina María; Acevedo, Lorena; Niño-Serna, Laura Fernanda; Flórez, Steffanie; Alarcón-Forero, Laura; Mulett, Hernando; Gómez, Laura; Villar, Juan Carlos (2023) Endothelial and Glycocalyx Biomarkers in Children With Sepsis After One Bolus of Unbalanced or Balanced Crystalloids*. En: Pediatric Critical Care Medicine. Vol. 24; No. 3; pp. 213 - 221; Lippincott Williams and Wilkins; Disponible en: 10.1097/PCC.0000000000003123.</dc:source>
   <dc:source>Wagner, Nana Maria; Van Aken, Caroline; Butschkau, Antje; Bierhansl, Laura; Kellner, Patrick; Schleusener, Viola; Seggewiss, Jochen; Vollmar, Brigitte; Nöldge-Schomburg, Gabriele; Roesner, Jan Patrick (2017) Procalcitonin Impairs Endothelial Cell Function and Viability. En: Anesthesia and Analgesia. Vol. 124; No. 3; pp. 836 - 845; Lippincott Williams and Wilkins; Disponible en: 10.1213/ANE.0000000000001574.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record><record><header><identifier>oai:repository.urosario.edu.co:10336/8852</identifier><datestamp>2021-06-03T00:45:32Z</datestamp><setSpec>com_10336_925</setSpec><setSpec>com_10336_562</setSpec><setSpec>col_10336_926</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Morbimortalidad asociada a transfusiones de glóbulos rojos en una unidad de cuidados intensivos pediátricos de Bogotá</dc:title>
   <dc:creator>Alvarado Villarreal, Manuel Antonio</dc:creator>
   <dc:creator>Tello Barceló, Montserrat Cristina</dc:creator>
   <dc:contributor>Pardo, Rosalba</dc:contributor>
   <dc:contributor>Cárdenas Müller, Adriana</dc:contributor>
   <dc:contributor>Morón Duarte, Lina Sofía</dc:contributor>
   <dc:subject>transfusión sanguínea</dc:subject>
   <dc:subject>mortalidad</dc:subject>
   <dc:subject>insuficiencia multiorgánica</dc:subject>
   <dc:subject>tiempo de internación</dc:subject>
   <dc:subject>respiración artificial</dc:subject>
   <dcterms:abstract>MORBIMORTALITY ASSOCIATED WITH RED BLOOD CELLS TRANSFUSION IN A PEDIATRIC CRITICAL CARE UNIT (PICU) IN BOGOTÁ. Objective: To determine if red blood cell transfusions in children hospitalized in a critical care unit are associated with an increase in morbimortality. Materials and Methods: An observational cohort analytical study including children with anemia from 1 month to 18 years that were admitted in PICU in a period of ten months. Results: 134 children with anemia were included. In 51. 5 % the anemia developed after admission. 66 children received a red blood cell transfusion and the median pretransfusion hemoglobin was 7. 5 g/dl. 6 % of the transfused patients had an adverse Reaction. Between transfused vs not trasfused children a significant difference exist in the admission hemoglobin, volumen of blood loss by extraction and age in the bivariate analysis. The transfused patients had major mortality than the not transfused ones (15. 2 % vs. 2. 9 %, p =0. 013). The development of multiorganic failure also was more frequent in the group transfused (62. 1 % vs. 16. 2 %, p 0. 001). The median of the days of stay in the PICU and time in mechanical ventilation was major in the transfused children than in the not transfused (8 vs 4 days p&amp;lt; 0. 001 and 6 vs 3 days p=0. 001 respectively). A mutivariate analysis showed association between red blood cell transfusions with mortality and multiorganic failure. Conclusion: Red blood cells transfusions are associated with an increase in the Mortality and in the development of Multiorganic Failure. The stay in the PICU and the time of Mechanical Ventilation was major in the children who received transfusion. </dcterms:abstract>
   <dcterms:dateAccepted>2014-09-02T21:06:16Z</dcterms:dateAccepted>
   <dcterms:available>2014-09-02T21:06:16Z</dcterms:available>
   <dcterms:created>2014-09-02T21:06:16Z</dcterms:created>
   <dcterms:issued>2014</dcterms:issued>
   <dc:type>masterThesis</dc:type>
   <dc:identifier>https://doi.org/10.48713/10336_8852 </dc:identifier>
   <dc:identifier>http://repository.urosario.edu.co/handle/10336/8852</dc:identifier>
   <dc:language>spa</dc:language>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:rights>Abierto (Texto completo)</dc:rights>
   <dc:rights>Atribución-NoComercial-SinDerivadas 2.5 Colombia</dc:rights>
   <dc:rights>EL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. &#xd;
PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. &#xd;
EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO,  para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia,  utilice y use la obra objeto de la presente autorización.&#xd;
--------------------------------------&#xd;
 POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO  para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data  cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación  podré solicitar la consulta, corrección y supresión de mis datos.</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.5/co/</dc:rights>
   <dc:publisher>Universidad del Rosario</dc:publisher>
   <dc:publisher>Facultad de medicina</dc:publisher>
   <dc:publisher>Especialización en Cuidado Intensivo Pediátrico</dc:publisher>
   <dc:source>1.	Bateman S, Lacroix J, Boven K, Forbes P, et al.  Anemia, Blood Loss, and Blood Transfusions in North American Children in the Intensive Care Unit.  Am J respire Crit Care Med 2008;178:26-33.</dc:source>
   <dc:source>2.	Lacroix J, Luban N, Wong E.  Blood products in the PICU. En  Roger´s Textbook of Pediatric Intensive Care. 4ª Ed. 2008. pág 584.</dc:source>
   <dc:source>3.	Morris KP, Naqvi n, Davies P, et al.  A new formula for blood transfusion volumen in the critically ill.  Arch Dis Child 2005;90:724-8.</dc:source>
   <dc:source>4.	Nishiyama T, Hanakoa K.  Hemolysis in stored red blood cell concentrates: Modulation by haptoglobin or ulinastatin, a protease inhibitor.  Crit Care Med 2001;1979-82.</dc:source>
   <dc:source>5.	Lacroix, J., Hébert, P.,  Hutchinson, J., Hume, H.  Transfusion Strategies for Patients in Pediatric Intensive Care Units. N Engl J Med 2007; 356;16:1609-19.</dc:source>
   <dc:source>6.	White M, Barron J, Gornbein J, Lin J.  Are red blood cell transfusions associated with nosocomial infections in pediatric intensive care units?  Pediatr Crit Care Med 2010;11;4:464-68.</dc:source>
   <dc:source>7.	Istaphanous G, Wheeler D, Lisco S, Shander A.  Red blood cell transfusion in critically ill children:  A narrative review.  Pediatr Crit Care Med 2011; 12;2:174-183.</dc:source>
   <dc:source>8.	Kneyber, M., Hersi, M., Twisk, J., Markhost, D.  Red blood cell transfusion in critically ill children is independently associated with increased mortality.  Intensive Care Med 2007;  33:1414-1422.</dc:source>
   <dc:source>9.	Sayah, D.,  Looney, M.,  Toy, P.  Transfusion Reactions:  Newer concepts on the pathophysiology, incidence, treatment and prevention of transfusion-related acute lung injury.  Crit Care Clin 2012; 28: 363-72.</dc:source>
   <dc:source>Toy P.,  Popovsky MA.,  Abraham E., et al.  Transfusion-related acute lung injury:  definition and review.  Crit Care Med  2005; 33 (4):721-26.</dc:source>
   <dc:source>11.	Gauvin F., Spinella P.,  Lacroix J.,  Choker G., et al.  Association between lenght of storage of transfused red blood cells and multiple organ dysfunction syndrome in pediatric intensive care patients.   Transfusion 2010; 50:1902-13.</dc:source>
   <dc:source>12.	Organización Mundial de la Salud [Internet].   Concentraciones de hemoglobina para diagnosticar la anemia y evaluar su gravedad.   Ginebra, Organización Mundial de la Salud, 2011 (WHO/NMH/NHD/MNM/11.1). [ consultado: 7 de octubre de 2012].  Dispobible en:  (http://www.who.int/vmnis/indicators/haemoglobin_es.pdf).</dc:source>
   <dc:source>13.	Forero J.  Síndrome de Disfunción orgánica múltiple, en López-Herce Cid J. y colaboradores.  Manual de Cuidados Intensivos Pediátricos.  3ª Ed. 2009: 365-69.</dc:source>
   <dc:source>14.	Slater A., Shann F., Pearson G.  A revised version of the paediatric index of mortality.  Intensive Care Med 2003; 29:278-85.</dc:source>
   <dc:source>15.	Societe Francaise d´Anesthesie et de Reanimation [Internet]. Scoring systems for ICU and surgical patients:  PIM 2 (Paediatric Index of Mortality). [consultado: junio de 2013 a abril de 2014]. Disponible en:  (http://www.sfar.org/scores2/pim22.html)</dc:source>
   <dc:source>16.	Pardo, R. Terapia transfusional en niños críticamente enfermos. Cuidado Intensivo Pediátrico y Neonatal. Editores: Jaime Forero, Jairo Alarcón, Gabriel Cassalet. Cali, Colombia. 2005</dc:source>
   <dc:source>17.	Sloniewsky D. Anemia and Transfusion in Critically Ill Pediatric Patients A Review of Etiology, Management, and Outcomes. Crit Care Clin 2013; 29:301–317.</dc:source>
   <dc:source>18.	Valentine S., Lightdale J., Tran Ch., Jiang H., Sloan S., Kleinman M., Randolph A. Assessment of Hemoglobin Threshold for Packed RBC Transfusion in a Medical-Surgical PICU. Pediatr Crit Care Med 2014; 15:e89–e94.</dc:source>
   <dc:source>19.	Parker R. Transfusion in Critically Ill Children: Indications, Risks, and Challenges. Crit Care Med 2014; 42:675–690.</dc:source>
   <dc:source>20.	Secher E.L., Stensballe J., A. Afshari A. Transfusion in critically ill children: an ongoing Dilema.  Acta Anaesthesiol Scand 2013; 57: 684–691)</dc:source>
   <dc:source>21.	Demaret P., Loeckx I., Mulder A., Devos P., Lebrun F. Anemia in the critically ill child and adult: a narrative review. Rev Med Liege. 2014; 69(1):26-34.</dc:source>
   <dc:source>22.	Demaret P., Tucci M., Ducruet Th., Trottier H., Lacroix J. Red blood cell transfusion in critically ill children.  TRANSFUSION 2014;54:365-375.</dc:source>
   <dc:source>instname:Universidad del Rosario</dc:source>
   <dc:source>reponame:Repositorio Institucional EdocUR</dc:source>
</qdc:qualifieddc></metadata></record></ListRecords></OAI-PMH>